document type sequence filename description text html head title title head body bgcolor white style margin margin bottom font size font family time roman align right exhibit style margin margin bottom font size font family time roman align right execution version style margin margin bottom font size font family time roman align center confidential material omitted filed separately with security exchange commission style margin margin bottom font size font family time roman align center triple asterisk denote omission style margin margin bottom font size font family time roman align center collaboration license agreement style margin margin bottom font size font family time roman align center between style margin margin bottom font size font family time roman align center macrogenics style margin margin bottom font size font family time roman align center style margin margin bottom font size font family time roman align center janssen biotech style page break before always size style color width align center style margin margin bottom font size font family time roman align right execution version style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center table content style font size margin margin bottom nbsp table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width width valign bottom width style font family time roman font size valign colspan style margin left text indent font size font family time roman article definition valign bottom valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign colspan style margin left text indent font size font family time roman article governance valign bottom valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font size height height colspan height colspan style font family time roman font size valign style margin left text indent font size font family time roman valign bottom valign bottom style margin left text indent font size font family time roman joint steering committee valign bottom valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman valign bottom valign bottom style margin left text indent font size font family time roman additional subcommittee working group valign bottom valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman valign bottom valign bottom style margin left text indent font size font family time roman authority valign bottom valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman valign bottom valign bottom style margin left text indent font size font family time roman alliance manager valign bottom valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman valign bottom valign bottom style margin left text indent font size font family time roman decision making restriction valign bottom valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font size height colspan height colspan style font family time roman font size valign colspan style margin left text indent font size font family time roman article license valign bottom valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font size height height colspan height colspan style font family time roman font size valign style margin left text indent font size font family time roman valign bottom valign bottom style margin left text indent font size font family time roman license company valign bottom valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman valign bottom valign bottom style margin left text indent font size font family time roman license macrogenics valign bottom valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman valign bottom valign bottom style margin left text indent font size font family time roman trademark license valign bottom valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman valign bottom valign bottom style margin left text indent font size font family time roman implied license valign bottom valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font size height colspan height colspan style font family time roman font size valign colspan style margin left text indent font size font family time roman article development valign bottom valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font size height height colspan height colspan style font family time roman font size valign style margin left text indent font size font family time roman valign bottom valign bottom style margin left text indent font size font family time roman transition development responsibility valign bottom valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman valign bottom valign bottom style margin left text indent font size font family time roman development valign bottom valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman valign bottom valign bottom style margin left text indent font size font family time roman decision making valign bottom valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman valign bottom valign bottom style margin left text indent font size font family time roman compliance with valign bottom valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman valign bottom valign bottom style margin left text indent font size font family time roman record valign bottom valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman valign bottom valign bottom style margin left text indent font size font family time roman cooperation valign bottom valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman valign bottom valign bottom style margin left text indent font size font family time roman progress report valign bottom valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman valign bottom valign bottom style margin left text indent font size font family time roman subcontracting valign bottom valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font size height colspan height colspan style font family time roman font size valign colspan style margin left text indent font size font family time roman article regulatory responsibility valign bottom valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font size height height colspan height colspan style font family time roman font size valign style margin left text indent font size font family time roman valign bottom valign bottom style margin left text indent font size font family time roman initial data transfer valign bottom valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman valign bottom valign bottom style margin left text indent font size font family time roman preparation regulatory material valign bottom valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman valign bottom valign bottom style margin left text indent font size font family time roman adverse event reporting safety data exchange valign bottom valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman valign bottom valign bottom style margin left text indent font size font family time roman recall voluntary withdrawal valign bottom valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman valign bottom valign bottom style margin left text indent font size font family time roman subcontracting valign bottom valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font size height colspan height colspan style font family time roman font size valign colspan style margin left text indent font size font family time roman article commercialization valign bottom valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font size height height colspan height colspan style font family time roman font size valign style margin left text indent font size font family time roman valign bottom valign bottom style margin left text indent font size font family time roman commercialization activity valign bottom valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman valign bottom valign bottom style margin left text indent font size font family time roman trademark valign bottom valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman valign bottom valign bottom style margin left text indent font size font family time roman decision making valign bottom valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman valign bottom valign bottom style margin left text indent font size font family time roman transparency reporting valign bottom valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman valign bottom valign bottom style margin left text indent font size font family time roman compliance with valign bottom valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman valign bottom valign bottom style margin left text indent font size font family time roman subcontracting valign bottom valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font size height colspan height colspan style font family time roman font size valign colspan style margin left text indent font size font family time roman article manufacturing valign bottom valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left nbsp align left valign portion this exhibit have been omitted pursuant request confidential treatment table table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left nbsp align left valign unredacted version this exhibit been filed separately with commission table style page break before always size style color width align center style margin margin bottom font size font family time roman align right execution version style font size margin margin bottom nbsp table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width width valign bottom width style font family time roman font size valign style margin left text indent font size font family time roman valign bottom valign bottom style margin left text indent font size font family time roman general supply term valign bottom valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman valign bottom valign bottom style margin left text indent font size font family time roman transition manufacturing responsibility valign bottom valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman valign bottom valign bottom style margin left text indent font size font family time roman decision making valign bottom valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman valign bottom valign bottom style margin left text indent font size font family time roman compliance with valign bottom valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman valign bottom valign bottom style margin left text indent font size font family time roman subcontracting valign bottom valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font size height colspan height colspan style font family time roman font size valign colspan style margin left text indent font size font family time roman article macrogenics option valign bottom valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font size height height colspan height colspan style font family time roman font size valign style margin left text indent font size font family time roman valign bottom valign bottom style margin left text indent font size font family time roman generally valign bottom valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman valign bottom valign bottom style margin left text indent font size font family time roman funding option valign bottom valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman valign bottom valign bottom style margin left text indent font size font family time roman promote option valign bottom valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font size height colspan height colspan style font family time roman font size valign colspan style margin left text indent font size font family time roman article consideration valign bottom valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font size height height colspan height colspan style font family time roman font size valign style margin left text indent font size font family time roman valign bottom valign bottom style margin left text indent font size font family time roman upfront payment valign bottom valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman valign bottom valign bottom style margin left text indent font size font family time roman reimbursement expense valign bottom valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman valign bottom valign bottom style margin left text indent font size font family time roman milestone payment valign bottom valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman valign bottom valign bottom style margin left text indent font size font family time roman company royalty obligation valign bottom valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman valign bottom valign bottom style margin left text indent font size font family time roman royalty term valign bottom valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman valign bottom valign bottom style margin left text indent font size font family time roman royalty rate reduction valign bottom valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman valign bottom valign bottom style margin left text indent font size font family time roman manner royalty payment valign bottom valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman valign bottom valign bottom style margin left text indent font size font family time roman currency valign bottom valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman valign bottom valign bottom style margin left text indent font size font family time roman allocation profit loss valign bottom valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman valign bottom valign bottom style margin left text indent font size font family time roman third party financial obligation valign bottom valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman valign bottom valign bottom style margin left text indent font size font family time roman valign bottom valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman valign bottom valign bottom style margin left text indent font size font family time roman return valign bottom valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman valign bottom valign bottom style margin left text indent font size font family time roman audit valign bottom valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman valign bottom valign bottom style margin left text indent font size font family time roman late payment valign bottom valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font size height colspan height colspan style font family time roman font size valign colspan style margin left text indent font size font family time roman article intellectual property matter valign bottom valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font size height height colspan height colspan style font family time roman font size valign style margin left text indent font size font family time roman valign bottom valign bottom style margin left text indent font size font family time roman ownership invention valign bottom valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman valign bottom valign bottom style margin left text indent font size font family time roman disclosure invention valign bottom valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman valign bottom valign bottom style margin left text indent font size font family time roman prosecution patent valign bottom valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman valign bottom valign bottom style margin left text indent font size font family time roman patent term extension territory valign bottom valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman valign bottom valign bottom style margin left text indent font size font family time roman infringement patent third party valign bottom valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman valign bottom valign bottom style margin left text indent font size font family time roman infringement third party right territory valign bottom valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman valign bottom valign bottom style margin left text indent font size font family time roman patent opposition other proceeding valign bottom valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font size height colspan height colspan style font family time roman font size valign colspan style margin left text indent font size font family time roman article representation warranty covenant valign bottom valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font size height height colspan height colspan style font family time roman font size valign style margin left text indent font size font family time roman valign bottom valign bottom style margin left text indent font size font family time roman mutual representation warranty covenant valign bottom valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman valign bottom valign bottom style margin left text indent font size font family time roman additional representation warranty macrogenics valign bottom valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman valign bottom valign bottom style margin left text indent font size font family time roman additional representation warranty company valign bottom valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman valign bottom valign bottom style margin left text indent font size font family time roman other representation warranty valign bottom valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font size height colspan height colspan style font family time roman font size valign colspan style margin left text indent font size font family time roman article confidentiality valign bottom valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left nbsp align left valign portion this exhibit have been omitted pursuant request confidential treatment table table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left nbsp align left valign unredacted version this exhibit been filed separately with commission table style page break before always size style color width align center style margin margin bottom font size font family time roman align right execution version style font size margin margin bottom nbsp table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width width valign bottom width style font family time roman font size valign style margin left text indent font size font family time roman valign bottom valign bottom style margin left text indent font size font family time roman nondisclosure valign bottom valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman valign bottom valign bottom style margin left text indent font size font family time roman exception valign bottom valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman valign bottom valign bottom style margin left text indent font size font family time roman authorized disclosure valign bottom valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman valign bottom valign bottom style margin left text indent font size font family time roman term this agreement valign bottom valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman valign bottom valign bottom style margin left text indent font size font family time roman publicity valign bottom valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman valign bottom valign bottom style margin left text indent font size font family time roman security filing valign bottom valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman valign bottom valign bottom style margin left text indent font size font family time roman relationship confidentiality agreement valign bottom valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman valign bottom valign bottom style margin left text indent font size font family time roman equitable relief valign bottom valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman valign bottom valign bottom style margin left text indent font size font family time roman publication valign bottom valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font size height colspan height colspan style font family time roman font size valign colspan style margin left text indent font size font family time roman article term termination valign bottom valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font size height height colspan height colspan style font family time roman font size valign style margin left text indent font size font family time roman valign bottom valign bottom style margin left text indent font size font family time roman term valign bottom valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman valign bottom valign bottom style margin left text indent font size font family time roman unilateral termination company valign bottom valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman valign bottom valign bottom style margin left text indent font size font family time roman termination material breach valign bottom valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman valign bottom valign bottom style margin left text indent font size font family time roman termination company safety reason valign bottom valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman valign bottom valign bottom style margin left text indent font size font family time roman termination valign bottom valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman valign bottom valign bottom style margin left text indent font size font family time roman filing termination upon denial valign bottom valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman valign bottom valign bottom style margin left text indent font size font family time roman termination bankruptcy valign bottom valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman valign bottom valign bottom style margin left text indent font size font family time roman effect termination valign bottom valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman valign bottom valign bottom style margin left text indent font size font family time roman remedy valign bottom valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman valign bottom valign bottom style margin left text indent font size font family time roman survival valign bottom valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font size height colspan height colspan style font family time roman font size valign colspan style margin left text indent font size font family time roman article dispute resolution valign bottom valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font size height height colspan height colspan style font family time roman font size valign style margin left text indent font size font family time roman valign bottom valign bottom style margin left text indent font size font family time roman exclusive dispute resolution mechanism valign bottom valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman valign bottom valign bottom style margin left text indent font size font family time roman resolution executive officer valign bottom valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman valign bottom valign bottom style margin left text indent font size font family time roman arbitration valign bottom valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman valign bottom valign bottom style margin left text indent font size font family time roman provisional remedy valign bottom valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman valign bottom valign bottom style margin left text indent font size font family time roman confidentiality valign bottom valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font size height colspan height colspan style font family time roman font size valign colspan style margin left text indent font size font family time roman article indemnification valign bottom valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font size height height colspan height colspan style font family time roman font size valign style margin left text indent font size font family time roman valign bottom valign bottom style margin left text indent font size font family time roman indemnification company valign bottom valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman valign bottom valign bottom style margin left text indent font size font family time roman indemnification macrogenics valign bottom valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman valign bottom valign bottom style margin left text indent font size font family time roman indemnification procedure valign bottom valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman valign bottom valign bottom style margin left text indent font size font family time roman insurance valign bottom valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman valign bottom valign bottom style margin left text indent font size font family time roman limitation liability valign bottom valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font size height colspan height colspan style font family time roman font size valign colspan style margin left text indent font size font family time roman article miscellaneous valign bottom valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font size height height colspan height colspan style font family time roman font size valign style margin left text indent font size font family time roman valign bottom valign bottom style margin left text indent font size font family time roman notice valign bottom valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman valign bottom valign bottom style margin left text indent font size font family time roman governing valign bottom valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman valign bottom valign bottom style margin left text indent font size font family time roman change control macrogenics valign bottom valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman valign bottom valign bottom style margin left text indent font size font family time roman assignment valign bottom valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman valign bottom valign bottom style margin left text indent font size font family time roman designation affiliate valign bottom valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman valign bottom valign bottom style margin left text indent font size font family time roman relationship party valign bottom valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left nbsp align left valign portion this exhibit have been omitted pursuant request confidential treatment table table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left nbsp align left valign unredacted version this exhibit been filed separately with commission table style page break before always size style color width align center style margin margin bottom font size font family time roman align right execution version style font size margin margin bottom nbsp table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width width valign bottom width style font family time roman font size valign style margin left text indent font size font family time roman valign bottom valign bottom style margin left text indent font size font family time roman force majeure valign bottom valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman valign bottom valign bottom style margin left text indent font size font family time roman entire agreement amendment valign bottom valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman valign bottom valign bottom style margin left text indent font size font family time roman severability valign bottom valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman valign bottom valign bottom style margin left text indent font size font family time roman english language valign bottom valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman valign bottom valign bottom style margin left text indent font size font family time roman waiver exclusion remedy valign bottom valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman valign bottom valign bottom style margin left text indent font size font family time roman further assurance valign bottom valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman valign bottom valign bottom style margin left text indent font size font family time roman heading valign bottom valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman valign bottom valign bottom style margin left text indent font size font family time roman construction valign bottom valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp style font family time roman font size valign style margin left text indent font size font family time roman valign bottom valign bottom style margin left text indent font size font family time roman counterpart valign bottom valign bottom nbsp valign bottom align right nowrap valign bottom nbsp nbsp table style margin margin bottom font size font family time roman align center list exhibit style font size margin margin bottom nbsp table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width valign bottom width width style font family time roman font size valign style margin left text indent font size font family time roman exhibit nbsp valign bottom valign bottom align center valign bottom valign bottom commercialization expense style font family time roman font size valign style margin left text indent font size font family time roman exhibit nbsp valign bottom valign bottom align center valign bottom valign bottom global development plan style font family time roman font size valign style margin left text indent font size font family time roman exhibit valign bottom valign bottom align center valign bottom valign bottom macrogenics patent style font family time roman font size valign style margin left text indent font size font family time roman exhibit valign bottom valign bottom align center valign bottom valign bottom style font family time roman font size valign style margin left text indent font size font family time roman exhibit valign bottom valign bottom align center valign bottom valign bottom universal calendar style font family time roman font size valign style margin left text indent font size font family time roman exhibit valign bottom valign bottom align center valign bottom valign bottom form press release style font size height colspan style font family time roman font size valign colspan align center list schedule style font size height height colspan height colspan style font family time roman font size valign style margin left text indent font size font family time roman schedule nbsp valign bottom valign bottom align center valign bottom valign bottom macrogenics estimated binding manufacturing cost table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left nbsp align left valign portion this exhibit have been omitted pursuant request confidential treatment table table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left nbsp align left valign unredacted version this exhibit been filed separately with commission table style page break before always size style color width align center style margin margin bottom font size font family time roman align center collaboration license agreement style margin margin bottom font size font family time roman this collaboration license agreement agreement entered into december nbsp execution date between janssen biotech pennsylvania corporation having principal place business ridgeview drive horsham hereinafter company macrogenics delaware corporation having principal place business medical center drive rockville together with affiliate macrogenics company macrogenics sometimes referred herein individually party collectively party style margin margin bottom text indent font size font family time roman whereas macrogenics discovered developing proprietary program that includes compound defined below containing specificity coded macrogenics with various potential human therapeutic style margin margin bottom text indent font size font family time roman whereas company desire obtain certain license right respect such compound accordance with term condition this agreement with macrogenics retaining certain option promote initial product defined below fund certain development cost participate profit loss initial product forth this agreement style margin margin bottom text indent font size font family time roman whereas macrogenics johnson nbsp johnson innovation jjdc affiliate defined below company contemporaneously entering into that certain stock purchase agreement that certain investor agreement each execution date style margin margin bottom text indent font size font family time roman therefore consideration foregoing premise condition forth herein party agree follows style margin margin bottom font size font family time roman align center article style margin margin bottom font size font family time roman align center definition style margin margin bottom font size font family time roman accelerated approval mean approval that nbsp includes clinical data from phase trial phase trial clinical data from phase trial nbsp been granted expedited review such been granted breakthrough therapy designation pursuant section nbsp ffdca fast track designation pursuant section nbsp ffdca nbsp been granted orphan drug status pursuant section nbsp ffdca style margin margin bottom font size font family time roman acquirer mean third party that party change control transaction such third party affiliate style margin margin bottom font size font family time roman affiliate mean with respect particular person person corporation partnership other entity that control controlled under common control with such first person purpose this definition word control including with correlative meaning term controlled under common control with mean actual power either directly indirectly through more intermediary direct cause direction management policy such entity whether ownership fifty percent nbsp more voting stock such entity contract otherwise style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left nbsp align left valign portion this exhibit have been omitted pursuant request confidential treatment table table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left nbsp align left valign unredacted version this exhibit been filed separately with commission table style page break before always size style color width align center style margin margin bottom font size font family time roman alliance manager mean person appointed each party from within their respective organization coordinate facilitate communication interaction cooperation party pursuant this agreement style margin margin bottom font size font family time roman antitrust mean relating competition that enforced nbsp federal trade commission antitrust division department justice nbsp equivalent foreign authority including european commission style margin margin bottom font size font family time roman applicable mean applicable statute ordinance regulation rule order kind whatsoever governmental authority including ffdca prescription drug marketing generic drug enforcement patent federal false claim anti kickback statute amended from time time together with rule regulation compliance guidance promulgated thereunder style margin margin bottom font size font family time roman mean nbsp biologics license application defined public health service regulation promulgated thereunder nbsp marketing authorization application europe nbsp equivalent comparable application registration certification other country region style margin margin bottom font size font family time roman business mean other than saturday sunday other that designated holiday universal calendar copy which year attached exhibit copy which prior beginning each such year succeeding year shall provided macrogenics style margin margin bottom font size font family time roman calendar quarter mean financial quarter based calendar year provided however that first calendar quarter last calendar quarter partial quarter applicable under relevant calendar year style margin margin bottom font size font family time roman calendar year mean year based johnson nbsp johnson universal calendar provided however that first calendar year last calendar year applicable period such royalty term partial year case style margin margin bottom font size font family time roman centralized approval procedure mean extent compulsory permitted regulatory approval compound product iceland liechtenstein norway country european union procedure administrated which result single marketing authorization that valid iceland liechtenstein norway country european union style margin margin bottom font size font family time roman cfda mean china food drug administration successor agency authority having substantially same function style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left nbsp align left valign portion this exhibit have been omitted pursuant request confidential treatment table table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left nbsp align left valign unredacted version this exhibit been filed separately with commission table style page break before always size style color width align center style margin margin bottom font size font family time roman change control shall occur nbsp third party acquires directly indirectly beneficial ownership voting security party percentage ownership such person entity voting security party increased through stock redemption cancellation other recapitalization immediately after such acquisition increase such third party directly indirectly beneficial owner voting security representing more than fifty percent nbsp total voting power then outstanding voting security party nbsp merger consolidation recapitalization reorganization party consummated other than such transaction which would result stockholder equity holder such party immediately prior such transaction owning least fifty percent nbsp outstanding security surviving entity parent entity immediately following such transaction nbsp stockholder equity holder party approve plan complete liquidation such party agreement sale disposition such party substantially such party asset other than pursuant transaction described above affiliate nbsp individual date hereof constitute board director party incumbent board cease reason constitute least majority board director such party provided however that individual becoming director subsequent date hereof whose election nomination election such party shareholder recommended approved vote least majority director then comprising incumbent board shall considered though such individual were member incumbent board excluding this purpose such individual whose initial assumption office occurs result actual threatened election contest with respect election removal director other actual threatened solicitation proxy consent behalf person other than board director such party nbsp sale transfer third party nbsp substantially such party asset taken whole nbsp majority such party asset which relate this agreement effected style margin margin bottom font size font family time roman clinical trial mean phase trial phase trial phase trial phase trial phase trial applicable style margin margin bottom font size font family time roman funding term mean time period commencing date that company receives funding option exercise notice concluding funding termination date style margin margin bottom font size font family time roman funding termination date mean last calendar quarter during which funding termination event occurs style margin margin bottom font size font family time roman funding termination event mean earlier nbsp after macrogenics receipt late payment notice provided that macrogenics paid entire disputed outstanding amount under applicable invoice nbsp company receipt funding notice nbsp sale initial product northern american territory than last such second calendar year nbsp after first commercial sale initial product northern american territory style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left nbsp align left valign portion this exhibit have been omitted pursuant request confidential treatment table table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left nbsp align left valign unredacted version this exhibit been filed separately with commission table style page break before always size style color width align center style margin margin bottom font size font family time roman combination product mean nbsp product that comprises consists incorporates nbsp more active pharmaceutical ingredient nbsp package that includes product least pharmaceutical product that product style margin margin bottom font size font family time roman commercial mean work devoted direct support commercialization product other than detailing that carried more qualified employee contractor consultant macrogenics affiliate company affiliate style margin margin bottom font size font family time roman commercial cost mean with respect period commercial rate multiplied number commercial ftes expended party during such period style margin margin bottom font size font family time roman commercial rate mean rate commercial calendar year rated period beginning effective date ending last first calendar year term provided however that such rate shall increased decreased annually beginning january nbsp percentage increase decrease commercial rate fully burdened cover employee salary benefit travel other cost separately accounted commercialization expense style margin margin bottom font size font family time roman commercialization mean activity directed marketing promoting distributing importing offering sell selling product when used verb commercialize mean engage commercialization activity style margin margin bottom font size font family time roman commercially reasonable effort mean with respect effort expended consideration undertaken party affiliate with respect objective activity decision undertaken hereunder reasonable good faith effort accomplish such objective activity decision such party would normally accomplish similar objective activity decision under similar circumstance being understood agreed that with respect development manufacture seeking obtaining regulatory approval commercialization compound product such effort resource shall consistent with those effort resource commonly used party under similar circumstance similar compound product which similar right which compound product applicable similar stage development product life similar market potential taking into account commercial scientific economic other factor including nbsp issue efficacy safety expected actual approved labeling nbsp expected actual competitiveness alternative product sold third party marketplace nbsp expected actual product profile compound product nbsp expected actual patent other proprietary position compound product nbsp likelihood regulatory approval compound product given regulatory structure involved including likelihood obtaining regulatory exclusivity nbsp expected actual profitability return investment compound product taking into consideration among other factor expected actual third party cost expense pricing reimbursement relating product payment party hereunder extent that performance party obligation hereunder adversely affected other party failure perform obligation hereunder impact such performance failure will taken into account determining whether such first party used commercially reasonable effort perform affected obligation style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left nbsp align left valign portion this exhibit have been omitted pursuant request confidential treatment table table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left nbsp align left valign unredacted version this exhibit been filed separately with commission table style page break before always size style color width align center style margin margin bottom font size font family time roman company applied technology mean with respect reverted product nbsp know controlled company effective date during term other than result license granted macrogenics company under this agreement that nbsp company applied such reverted product prior termination this agreement provided that such know necessary continued exploitation such reverted product exists time such termination nbsp company incorporated into such reverted product prior termination this agreement nbsp patent controlled company effective date during term that cover know described clause style margin margin bottom font size font family time roman company invention mean invention controlled company that necessary otherwise used exploit compound product field territory style margin margin bottom font size font family time roman company know mean know controlled company during term used exploit compound product field territory contemplated this agreement including company invention style margin margin bottom font size font family time roman company patent mean patent controlled company covering invention discovered invented during term pursuant activity under this agreement that nbsp cover composition matter method making using sale importation compound product extent included within company invention nbsp otherwise used exploit compound product field territory style margin margin bottom font size font family time roman company technology mean collectively company patent company know style margin margin bottom font size font family time roman competitive infringement mean infringement misappropriation that involves development manufacture commercialization product product candidate that style margin margin bottom font size font family time roman compound mean nbsp derivative variant including molecule that specifically claimed patent that specifically claim amino acid sequence nbsp other dart derived from dart platform that style margin margin bottom font size font family time roman confidential information mean subject article public proprietary information disclosed party other party under this agreement which include idea invention discovery concept compound composition formulation formula practice procedure process method knowledge know trade secret technology inventory machine technique development design drawing computer program skill experience document apparatus result clinical regulatory strategy regulatory documentation information submission pertaining made association with filing with governmental authority data including pharmacological toxicological clinical style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left nbsp align left valign portion this exhibit have been omitted pursuant request confidential treatment table table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left nbsp align left valign unredacted version this exhibit been filed separately with commission table style page break before always size style color width align center style margin margin bottom font size font family time roman data analytical quality control data manufacturing data description patent legal data market data financial data description device assay chemical formulation specification material product sample other sample physical chemical biological material compound like without regard whether foregoing marked confidential proprietary disclosed oral written graphic electronic form style margin margin bottom font size font family time roman confidential information shall include nbsp term condition this agreement nbsp confidential information disclosed either party pursuant confidential disclosure agreement prior style margin margin bottom font size font family time roman control controlled mean with respect information know patent other intellectual property right nbsp ownership party subject section nbsp affiliate such information know patent other intellectual property right nbsp possession party subject section nbsp affiliate ability without taking into account right granted party other party under term this agreement grant access license sublicense such information know patent other intellectual property right without violating term agreement other arrangement with necessitating consent third party such time that party would first required under this agreement grant other party such access license sublicense excluding each case information know patent other intellectual property right that come into control party pursuant change control such party except extent only extent that such information know patent other intellectual property right either nbsp actually used such party affiliate acquirer develop manufacture commercialize compound product following consummation such change control nbsp made conceived reduced practice acquirer through reference information know patent other intellectual property right such party style margin margin bottom font size font family time roman promote option deadline mean after company delivers promote material relating such second indication macrogenics accordance with section nbsp style margin margin bottom font size font family time roman cover covering mean with respect product technology process method that absence ownership license granted under valid claim practice exploitation such product technology process method would infringe such valid claim case valid claim that issued would infringe such valid claim were issue style margin margin bottom font size font family time roman mean consumer price index urban wage earner clerical worker city average item published department labor bureau labor statistic successor equivalent index style margin margin bottom font size font family time roman style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left nbsp align left valign portion this exhibit have been omitted pursuant request confidential treatment table table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left nbsp align left valign unredacted version this exhibit been filed separately with commission table style page break before always size style color width align center style margin margin bottom font size font family time roman dart mean dual affinity targeting molecule consisting style margin margin bottom font size font family time roman dart platform mean macrogenics proprietary platform generating dart style margin margin bottom font size font family time roman detail detailing mean interactive face face meeting between sale representative acting behalf applicable party health care professional having prescribing authority within target audience that occurs after regulatory approval product during which such product attribute including approved safety effectiveness contraindication side effect warning other relevant characteristic discussed effort increase prescribing preference such product approved manner consistent with applicable industry standard with quality similar presentation made party sale representative such party other product applicable detail include first position detail second position detail detailing shall include nbsp sample drop made sale representative nbsp medical affair activity related activity conducted medical support staff such medical science liaison nbsp activity conducted convention nbsp electronic detail nbsp activity performed market development specialist managed care account director other personnel performing face face sale call specifically trained with respect product style margin margin bottom font size font family time roman development mean research clinical clinical drug development activity process including toxicology pharmacology project management other clinical effort statistical analysis formulation development delivery system development statistical analysis manufacturing development performance clinical trial including manufacturing product clinical trial other activity reasonably necessary order obtain maintain regulatory approval product field territory when used verb develop mean engage development activity style margin margin bottom font size font family time roman development mean nbsp with respect company hour work devoted direct support global development activity more qualified employee contractor consultant company affiliate measured accordance with company normal time allocation practice nbsp with respect macrogenics work devoted direct support global development activity pursuant section nbsp providing assistance company pursuant section nbsp section nbsp more qualified employee contractor consultant company affiliate measured accordance with macrogenics normal time allocation practice provided that each case such employee contractor consultant must style margin margin bottom font size font family time roman development cost mean with respect period development rate multiplied number development ftes expended party during such period style margin margin bottom font size font family time roman evelopment rate mean rate calendar year rated period beginning effective date ending last first calendar year term provided however that such rate shall increased decreased annually beginning january nbsp development rate fully burdened will cover employee salary such facility equipment other material service including ordinary laboratory consumables procured from distributor relevant product they style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left nbsp align left valign portion this exhibit have been omitted pursuant request confidential treatment table table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left nbsp align left valign unredacted version this exhibit been filed separately with commission table style page break before always size style color width align center style margin margin bottom font size font family time roman development transition date mean earlier nbsp clearance date first phase trial initial product submitted macrogenics accordance with section nbsp nbsp date which determines that company shall assume responsibility preparation filing such accordance with section nbsp nbsp twelve nbsp month after effective date style margin margin bottom font size font family time roman style margin margin bottom font size font family time roman effective date mean first nbsp business immediately following date which party have actual knowledge that applicable waiting period under with respect transaction contemplated hereunder have expired have been terminated style margin margin bottom font size font family time roman mean european medicine agency successor agency authority having substantially same function style margin margin bottom font size font family time roman including each case territory possession each country style margin margin bottom font size font family time roman european union mean european union member state then currently constituted provided however that shall always deemed include execution date european union member state austria belgium bulgaria croatia cyprus czech republic denmark estonia finland france germany greece hungary ireland italy latvia lithuania luxembourg malta netherlands poland portugal romania slovakia slovenia spain sweden united kingdom style margin margin bottom font size font family time roman executive officer mean nbsp with respect company either nbsp prior first regulatory approval global head research development designee nbsp following first regulatory approval president oncology commercial operation designee nbsp with respect macrogenics chief executive officer designee style margin margin bottom font size font family time roman exploit exploitation mean research make have made distribute import export have used sell have sold offer sale develop commercialize register modify enhance improve manufacture have manufactured otherwise dispose compound product style margin margin bottom font size font family time roman mean food drug administration successor agency authority having substantially same function style margin margin bottom font size font family time roman ffdca mean federal food drug cosmetic amended from time time style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left nbsp align left valign portion this exhibit have been omitted pursuant request confidential treatment table table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left nbsp align left valign unredacted version this exhibit been filed separately with commission table style page break before always size style color width align center style margin margin bottom font size font family time roman field mean including diagnosis treatment prevention disease human style margin margin bottom font size font family time roman first commercial sale mean product product country country basis first sale monetary value such product under this agreement company affiliate sublicensees user consumption resale such product such country field after regulatory approval such product been obtained such country field where such sale result sale sale product under this agreement company affiliate company sublicensee company shall constitute first commercial sale unless such affiliate such sublicensee user such product avoidance doubt sale product clinical study purpose early access program such provide patient with product prior regulatory approval pursuant treatment inds protocol named patient program compassionate program similar shall constitute first commercial sale style margin margin bottom font size font family time roman first position detail mean detail which product detailed before other product predominant portion time devoted detailing such product style margin margin bottom font size font family time roman force majeure mean event beyond reasonable control affected party which include embargo including terrorism insurrection riot civil unrest strike lockout other labor disturbance epidemic fire flood earthquake other nature omission delay acting governmental authority other than delay incident ordinary course drug development failure plant machinery style margin margin bottom font size font family time roman mean with respect clinical trial first patient dosed such clinical trial style margin margin bottom font size font family time roman mean collectively development commercial sale clarity more than calendar year equivalent rata portion thereof period beginning effective date ending last first calendar year charged single individual contributing work factoring into reimbursable cost hereunder regardless much additional work time contributed such individual during such calendar year period beginning effective date ending last first calendar year individual contributing than calendar year equivalent rata portion thereof period beginning effective date ending last first calendar year shall deemed fraction rata basis style margin margin bottom font size font family time roman cost mean collectively development cost commercial cost style margin margin bottom font size font family time roman gaap mean generally accepted accounting principle consistently applied style margin margin bottom font size font family time roman global development activity mean following development activity relating initial product style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign performance phase trial pivotal trial initial product accordance with global development plan table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left nbsp align left valign portion this exhibit have been omitted pursuant request confidential treatment table table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left nbsp align left valign unredacted version this exhibit been filed separately with commission table style page break before always size style color width align center table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign manufacturing initial product conduct such phase trial pivotal trial associated manufacturing development except extent expressly table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign preparation filing maintenance regulatory documentation directly supporting such phase trial pivotal trial obtaining regulatory approval initial product table style margin margin bottom font size font family time roman provided however that global development activity shall specifically exclude style margin margin bottom font size font family time roman global development cost mean following expense related global development activity incurred company affiliate macrogenics affiliate pursuant section nbsp regardless whether such expense incurred before during funding term style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign third party expense table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign development cost table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign product liability arising from conduct global development activity before during funding term even such product liability incurred until after funding term provided that product liability which party obligated indemnify other party pursuant section nbsp because such product liability loss which such other party becomes subject result claim would loss such other party became subject such product liability result claim shall expressly excluded from this definition global development cost shall responsibility such first party extent that such first party would responsible such loss pursuant article table style margin margin bottom font size font family time roman purpose clarity global development cost shall include style margin margin bottom font size font family time roman global development plan mean high level written plan attached hereto exhibit covering planned development compound product amended from time time accordance with section style margin margin bottom font size font family time roman good clinical practice mean then current standard practice procedure promulgated endorsed forth guideline adopted international conference harmonization titled guidance industry good clinical practice consolidated guidance successor document including related regulatory requirement imposed comparable regulatory standard practice procedure promulgated pmda cfda other regulatory authority applicable territory they updated from time time style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left nbsp align left valign portion this exhibit have been omitted pursuant request confidential treatment table table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left nbsp align left valign unredacted version this exhibit been filed separately with commission table style page break before always size style color width align center style margin margin bottom font size font family time roman good laboratory practice mean then current standard practice procedure promulgated endorsed forth part successor statute regulation including related regulatory requirement imposed comparable regulatory standard practice procedure promulgated pmda cfda other regulatory authority applicable territory they updated from time time including applicable guideline promulgated under style margin margin bottom font size font family time roman good manufacturing practice mean then current good manufacturing practice required forth ffdca amended regulation promulgated thereunder manufacture testing pharmaceutical material comparable applicable related manufacture testing pharmaceutical material jurisdiction outside including quality guideline promulgated designated titled good manufacturing practice guidance active pharmaceutical ingredient regulation promulgated thereunder each case they updated from time time style margin margin bottom font size font family time roman governmental authority mean multi national federal state local municipal other government authority nature including governmental division subdivision department agency bureau branch office commission council court other tribunal style margin margin bottom font size font family time roman mean hart scott rodino antitrust improvement amended from time time comparable applicable jurisdiction outside related approval transaction similar those contemplated under this agreement style margin margin bottom font size font family time roman clearance date mean expiration termination applicable waiting period request information extension thereof under style margin margin bottom font size font family time roman filing mean nbsp filing company macrogenics with federal trade commission antitrust division department justice notification report form certain merger acquisition that term defined with respect matter forth this agreement together with required documentary attachment thereto nbsp equivalent filing with relevant foreign authority style margin margin bottom font size font family time roman mean nbsp investigational drug application defined ffdca applicable regulation promulgated thereunder nbsp clinical trial authorization application product filed with regulatory authority other regulatory jurisdiction outside filing which case nbsp necessary commence conduct clinical testing pharmaceutical product human such jurisdiction nbsp documentation issued regulatory authority that permit conduct clinical testing product human such jurisdiction style margin margin bottom font size font family time roman clearance date mean with respect date which sponsor such permitted initiate clinical trial following submission such applicable regulatory authority style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left nbsp align left valign portion this exhibit have been omitted pursuant request confidential treatment table table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left nbsp align left valign unredacted version this exhibit been filed separately with commission table style page break before always size style color width align center style margin margin bottom font size font family time roman indication mean style margin margin bottom font size font family time roman information mean information invention discovery compound composition formulation formula practice procedure process method knowledge know trade secret technology technique design drawing correspondence computer program document apparatus result strategy regulatory documentation information submission pertaining made association with filing with governmental authority patent office data including pharmacological toxicological clinical clinical data analytical quality control data manufacturing data description market data financial data description device assay chemical formulation specification material product sample other sample physical chemical biological material compound like written electronic oral other tangible intangible form known hereafter developed whether patentable style margin margin bottom font size font family time roman initial product mean initial product developed hereunder that either nbsp contains sole active pharmaceutical ingredient nbsp contains different compound approved development mutual agreement party style margin margin bottom font size font family time roman invention mean invention discovery development whether patentable made conceived reduced practice course performance this agreement whether made conceived reduced practice solely behalf macrogenics company party jointly affiliate same style margin margin bottom font size font family time roman johnson nbsp johnson universal calendar mean calendar particular period twelve nbsp month that constitutes financial year purpose johnson nbsp johnson jersey corporation ultimate parent company company johnson nbsp johnson affiliate style margin margin bottom font size font family time roman know mean information invention controlled party that necessary useful exploit compound product field territory know excludes information contained within party published patent style margin margin bottom font size font family time roman knowledge mean applied party that such party shall deemed have knowledge particular fact other matter extent that reasonably prudent person with primary responsibility applicable subject matter whether officer employee such party knew should have known such fact other matter style margin margin bottom font size font family time roman marketing authorization application mean application regulatory approval particular jurisdiction other than style margin margin bottom font size font family time roman macrogenics invention mean invention controlled macrogenics during term that necessary useful exploit compound product field territory style margin margin bottom font size font family time roman macrogenics know mean know controlled macrogenics execution date during term including macrogenics invention style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left nbsp align left valign portion this exhibit have been omitted pursuant request confidential treatment table table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left nbsp align left valign unredacted version this exhibit been filed separately with commission table style page break before always size style color width align center style margin margin bottom font size font family time roman macrogenics option mean individually funding option promote option style margin margin bottom font size font family time roman macrogenics pocket patent cost mean third party expense incurred macrogenics pursuant filing prosecution maintenance macrogenics patent style margin margin bottom font size font family time roman macrogenics patent mean patent controlled macrogenics execution date during term that nbsp cover composition matter method making using sale importation compound product nbsp otherwise necessary useful exploit compound product field territory macrogenics patent execution date include those forth exhibit macrogenics patent include patent covering macrogenics invention style margin margin bottom font size font family time roman macrogenics platform patent mean macrogenics patent that platform patent style margin margin bottom font size font family time roman macrogenics product patent mean macrogenics patent that product patent style margin margin bottom font size font family time roman macrogenics technology mean collectively macrogenics patent macrogenics know style margin margin bottom font size font family time roman macrogenics trademark mean trademark dart style font size vertical align trademark which incorporate acronym dart related logo style margin margin bottom font size font family time roman major market mean style margin margin bottom font size font family time roman manufacture mean activity process related manufacturing compound product ingredient thereof including manufacturing finished product development commercialization labeling packaging process finished product testing release product component ingredient thereof including compound quality assurance activity related manufacturing release compound product ongoing stability test regulatory activity related foregoing where context requires manufacture shall also include obtaining product from contract manufacturer when used verb manufacture mean engage manufacturing activity style margin margin bottom font size font family time roman manufacturing development mean following with respect compound product style margin margin bottom font size font family time roman mean compound with chemical structure amino acid sequence forth exhibit style margin margin bottom font size font family time roman profit loss mean profit loss resulting from commercialization initial product northern american territory which shall equal style margin margin bottom font size font family time roman sale mean with respect product gross amount invoiced company affiliate sublicensees sale such product unaffiliated third party style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left nbsp align left valign portion this exhibit have been omitted pursuant request confidential treatment table table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left nbsp align left valign unredacted version this exhibit been filed separately with commission table style page break before always size style color width align center style margin margin bottom font size font family time roman purchaser length transaction following deduction calculated accordance with gaap standard internal policy procedure accounting standard consistently applied throughout johnson nbsp johnson extent reasonable customary specifically solely allocated such product whether fixed variable actually taken paid accrued allowed included allocated based good faith estimate gross sale price with respect such sale consistently applied forth below style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign normal customary cash trade quantity discount allowance credit allowed form deduction actually allowed with respect sale such product extent already reflected amount invoiced excluding commission commercialization such product table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign charge back payment rebate administrative discount equivalent thereof payable trade customer managed health care organization pharmacy benefit manager equivalent thereof group purchasing organization specialty pharmacy provider federal state provincial local other government their agency purchaser reimbursers table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign retroactive price reduction credit actually granted upon rejection return such product where such adjustment limited recall damaged good billing error reserve return actual amount write offs debt table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign outbound freight shipment insurance cost extent included price separately itemized invoice price table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign other than income assessed against income arising from sale such product duty tariff mandated contribution other governmental charge imposed sale such product including custom duty only extent that such reimbursable refundable excise sale each case extent included price separately itemized invoice price table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign compulsory payment cash rebate related sale such product payable governmental authority agent thereof pursuant applicable reason national local health insurance program similar program including government levied resulting from healthcare reform policy annual paid pursuant patient protection affordable care provided that such annual shall reasonably allocable product table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign amount payable patient through assistance card similar form rebate directly related prescribing such product table style margin margin bottom font size font family time roman aforementioned deduction shall determined country country basis style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left nbsp align left valign portion this exhibit have been omitted pursuant request confidential treatment table table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left nbsp align left valign unredacted version this exhibit been filed separately with commission table style page break before always size style color width align center style margin margin bottom font size font family time roman incurred ordinary course business type amount consistent with company applicable affiliate sublicensee case business practice consistently applied across product line accounting standard verifiable based johnson nbsp johnson sale reporting system such deduction shall fairly equitably allocated such product other product company affiliate sublicensees such that such product bear disproportionate portion such deduction style margin margin bottom font size font family time roman notwithstanding foregoing amount invoiced company affiliate sublicensees sale product among company affiliate sublicensees resale shall included computation sale hereunder unless such affiliate such sublicensee user such product long such product subsequently resold third party user addition following shall included computation sale nbsp transfer disposition reasonable quantity sample product cost promotional educational purpose nbsp transfer disposition reasonable customary quantity product free sample donation patient assistance testing marketing program other similar program cost nbsp sale product clinical study other scientific testing purpose early access program such provide patient with such product prior regulatory approval pursuant treatment inds protocol named patient program compassionate program similar style margin margin bottom font size font family time roman with respect sale combination product country party shall determine sale such combination product such country mutual agreement based relative contribution product other active ingredient combination product style margin margin bottom font size font family time roman with respect product that sold combination with service from company selling affiliate sublicensee where customer receives specific discount bundling product service sale such combination product product shall determined mutual agreement party style margin margin bottom font size font family time roman northern american territory shall mean canada including each case territory possession such country style margin margin bottom font size font family time roman patent mean nbsp patent including utility design patent nbsp patent application including provisionals substitution divisionals continuation continuation part renewal nbsp patent addition restoration extension supplementary protection certificate registration confirmation patent patent resulting from post grant proceeding issue examination nbsp other patent patent application claiming priority directly indirectly nbsp such specified patent patent application specified nbsp through nbsp patent patent application from which patent patent application specified nbsp through nbsp claim direct indirect priority nbsp inventor certificate nbsp other right issued from governmental authority similar foregoing each case nbsp through irrespective whether such patent patent application other right arises other jurisdiction territory style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left nbsp align left valign portion this exhibit have been omitted pursuant request confidential treatment table table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left nbsp align left valign unredacted version this exhibit been filed separately with commission table style page break before always size style color width align center style margin margin bottom font size font family time roman person mean individual sole proprietorship partnership limited partnership limited liability partnership corporation limited liability company business trust joint stock company trust incorporated association joint venture similar entity organization including government political subdivision department agency government style margin margin bottom font size font family time roman phase trial mean clinical trial product that nbsp nbsp first human trial subject patient nbsp purpose establishing initial safety tolerability pharmacokinetic pharmacodynamic information product nbsp expose subject product nbsp designed provide sponsor clinical trial with sufficient information about product initiate phase trial nbsp meet definition foreign equivalent solely purpose determining which activity global development activity that included global development cost shared pursuant section nbsp during funding term phase trial included global development plan shall treated style margin margin bottom font size font family time roman phase trial mean clinical trial product that combine both phase trial phase trial such product into single protocol where phase trial portion performed first nbsp establish initial safety tolerability pharmacokinetic pharmacodynamic information product monotherapy combination with another agent nbsp determine maximum tolerable dose such product subject phase trial portion performed second further evaluate safety efficacy such product monotherapy combination with another agent subject treated with selected dose style margin margin bottom font size font family time roman phase trial mean clinical trial product nbsp with endpoint evaluating effectiveness particular indication indication short term tolerance safety well pharmacokinetic pharmacodynamic information patient with indication under study intended pivotal support regulatory approval product nbsp that meet definition foreign equivalent style margin margin bottom font size font family time roman phase trial mean phase trial involving sufficient number subject that prior commencement trial other defined point trial satisfies both following style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign such trial designed nbsp establish that product safe efficacious intended nbsp define determine warning precaution adverse reaction that associated with product dosage range prescribed which trial intended support regulatory approval such product similar clinical study prescribed table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign such trial becomes registration trial sufficient filing application regulatory approval such product evidenced nbsp agreement with statement from special protocol assessment equivalent nbsp other guidance minute issued such registration trial table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left nbsp align left valign portion this exhibit have been omitted pursuant request confidential treatment table table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left nbsp align left valign unredacted version this exhibit been filed separately with commission table style page break before always size style color width align center style margin margin bottom font size font family time roman phase trial mean clinical trial product nbsp sufficient number patient which trial nbsp designed establish that product safe efficacious intended nbsp designed define warning precaution adverse reaction that associated with product dosage range prescribed nbsp pivotal support regulatory approval product nbsp that meet definition foreign equivalent style margin margin bottom font size font family time roman phase trial mean clinical trial product possibly including pharmacokinetic study which trial nbsp required completed prior obtaining regulatory approval indication nbsp either nbsp required applicable regulatory authority mandatory conducted after regulatory approval indication nbsp conducted voluntarily enhance marketing scientific knowledge product providing additional drug profile safety data marketing support information supporting expansion product labeling style margin margin bottom font size font family time roman pivotal trial mean phase trial phase trial style margin margin bottom font size font family time roman platform claim mean patent claim that cover style margin margin bottom font size font family time roman platform patent mean patent that includes platform claim product claim style margin margin bottom font size font family time roman pmda mean pharmaceutical medical device agency japan successor agency authority having substantially same function style margin margin bottom font size font family time roman style margin margin bottom font size font family time roman style margin margin bottom font size font family time roman product mean pharmaceutical product including form presentation strength formulation including method delivery containing compound alone combination with other active pharmaceutical ingredient other than active pharmaceutical ingredient that owned controlled macrogenics affiliate that compound including combination product sake clarity form presentation formulation pharmaceutical product containing compound shall considered same product purpose this agreement long each form presentation dose formulation contains same compound other active pharmaceutical ingredient other compound other active pharmaceutical ingredient style margin margin bottom font size font family time roman product claim mean patent claim that nbsp cover style margin margin bottom font size font family time roman product liability mean loss incurred company affiliate sublicensee resulting from relating compound product human including clinical trial commercialization territory incurred after effective date avoidance doubt product liability shall include nbsp reasonable attorney expert cost relating claim potential claim against party affiliate style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left nbsp align left valign portion this exhibit have been omitted pursuant request confidential treatment table table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left nbsp align left valign unredacted version this exhibit been filed separately with commission table style page break before always size style color width align center style margin margin bottom font size font family time roman sublicensee loss damage cost associated therewith nbsp loss associated with recall voluntary involuntary withdrawal compound product except extent party obligated indemnify other party pursuant section nbsp such loss nbsp fine penalty assessment other financial sanction levied governmental authority related such claim except extent party obligated indemnify other party such amount pursuant section nbsp because such amount loss which such other party becomes subject result claim would loss such other party became subject such amount result claim style margin margin bottom font size font family time roman product patent mean patent that include platform claim includes product claim style margin margin bottom font size font family time roman product target mean mean style margin margin bottom font size font family time roman promotional material mean written printed graphic electronic audio video presentation information including journal advertisement sale visual formulary binder reprint direct mail direct consumer advertising disease awareness material internet posting broadcast advertisement sale reminder aide example note other such item appropriate which each case permitted under applicable intended used behalf party affiliate sublicensees connection with commercialization product territory style margin margin bottom font size font family time roman regulatory approval mean approval including supplement amendment post approval license registration authorization national regional state local regulatory authority department bureau commission council other governmental entity that necessary market sell product country jurisdiction territory more including pricing reimbursement approval that necessary conduct launch such product such country jurisdiction even such approval legally required launch such product such country jurisdiction style margin margin bottom font size font family time roman regulatory approval application mean drug approval application biologics license application each defined ffdca corresponding application regulatory approval country jurisdiction territory outside including with respect european union filed with pursuant centralized approval procedure with applicable regulatory authority country europe with respect decentralized procedure mutual recognition national approval procedure style margin margin bottom font size font family time roman regulatory authority mean applicable governmental authority involved granting regulatory approval country jurisdiction territory including nbsp other applicable governmental authority having jurisdiction over product nbsp other applicable governmental authority having jurisdiction over product nbsp japan pmda nbsp china cfda nbsp country jurisdiction other than japan china applicable governmental authority having jurisdiction over product style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left nbsp align left valign portion this exhibit have been omitted pursuant request confidential treatment table table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left nbsp align left valign unredacted version this exhibit been filed separately with commission table style page break before always size style color width align center style margin margin bottom font size font family time roman regulatory documentation mean with respect compound product regulatory filing supporting document created submitted received from applicable governmental agency regulatory authority relating such compound product data contained therein including regulatory material well content minute from meeting whether person audio conference videoconference with regulatory authority registration license regulatory drug list advertising promotion document shared with regulatory authority adverse event file complaint file manufacturing record style margin margin bottom font size font family time roman regulatory exclusivity mean exclusive marketing right data protection other exclusivity right conferred regulatory authority with respect product country jurisdiction territory including orphan drug exclusivity pediatric exclusivity right conferred under drug price competition patent term restoration amended hatch waxman european union under directive amended regulation nbsp amended right similar thereto other country regulatory jurisdiction territory that prevent such regulatory authority from granting regulatory approval under biologics price competition innovation similar applicable third party product that amino acid sequence that same substantially identical amino acid sequence such product provided however that event that regulatory authority confers more than type exclusivity with respect product country jurisdiction grant both chemical entity exclusivity orphan drug exclusivity with respect such product regulatory exclusivity will deemed apply such product such country long regulatory exclusivity granted such product prevents such regulatory authority from granting regulatory approval under biologics price competition innovation similar applicable third party product that amino acid sequence that same substantially identical amino acid sequence such product regulatory exclusivity shall include exclusivity conferred patent right style margin margin bottom font size font family time roman regulatory material mean regulatory application submission notification registration regulatory approval other regulatory submission including written correspondence meeting minute made made with received from regulatory authority that necessary reasonably desirable order research develop manufacture commercialize product particular country jurisdiction territory regulatory material include inds regulatory approval application amendment supplement foregoing application pricing reimbursement approval style margin margin bottom font size font family time roman royalty term mean time period beginning with first commercial sale such product such country continuing until later nbsp expiration last valid claim covering composition matter method making using such product included macrogenics patent licensed company under company license nbsp nbsp regulatory exclusivity granted with respect such product such country expiration termination such regulatory exclusivity such country style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left nbsp align left valign portion this exhibit have been omitted pursuant request confidential treatment table table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left nbsp align left valign unredacted version this exhibit been filed separately with commission table style page break before always size style color width align center style margin margin bottom font size font family time roman second position detail mean detail which product detailed second position more than other product presented discussed with applicable healthcare professional before such product second most predominant portion time devoted detailing such product style margin margin bottom font size font family time roman mean present future levy impost duty charge assessment nature including interest thereon style margin margin bottom font size font family time roman territory mean country world style margin margin bottom font size font family time roman third party mean person other than nbsp company nbsp macrogenics nbsp affiliate either company macrogenics style margin margin bottom font size font family time roman third party expense mean pocket expense incurred party affiliate service performed third party behalf company macrogenics course such party performance this agreement clarity such third party expense will include cost material resin used manufacture clinical trial material style margin margin bottom font size font family time roman mean united state america including territory possession style margin margin bottom font size font family time roman commercialization plan mean plan prepared company pursuant section nbsp event that macrogenics exercise promote option coordination detailing activity style margin margin bottom font size font family time roman valid claim tmeans nbsp claim issued unexpired patent extent such claim been revoked held invalid unenforceable patent office court other governmental authority competent jurisdiction final order from which further appeal taken which claim been disclaimed denied admitted invalid unenforceable through reissue examination disclaimer otherwise nbsp claim within patent application that been pending more than from date first priority patent application filing anywhere territory which claim been revoked cancelled withdrawn held invalid abandoned style margin margin bottom font size font family time roman additional definition each following definition forth section this agreement indicated below style font size margin margin bottom nbsp table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width width style font family time roman font size valign bottom nowrap style border bottom solid width font size font family time roman definition valign bottom nbsp nbsp valign bottom nowrap style border bottom solid width font size font family time roman section style font family time roman font size valign valign bottom nbsp nbsp valign bottom style font family time roman font size valign advertising market research expense valign bottom nbsp nbsp valign bottom exhibit style font family time roman font size valign agreement valign bottom nbsp nbsp valign bottom preamble style font family time roman font size valign approval milestone valign bottom nbsp nbsp valign bottom style font family time roman font size valign approval milestone payment valign bottom nbsp nbsp valign bottom style font family time roman font size valign bankruptcy valign bottom nbsp nbsp valign bottom style font family time roman font size valign breaching party valign bottom nbsp nbsp valign bottom table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left nbsp align left valign portion this exhibit have been omitted pursuant request confidential treatment table table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left nbsp align left valign unredacted version this exhibit been filed separately with commission table style page break before always size style color width align center table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width width style font family time roman font size valign bottom nowrap style border bottom solid width font size font family time roman definition valign bottom nbsp nbsp valign bottom nowrap style border bottom solid width font size font family time roman section style font family time roman font size valign valign bottom nbsp nbsp valign bottom style font family time roman font size valign valign bottom nbsp nbsp valign bottom style font family time roman font size valign claim valign bottom nbsp nbsp valign bottom style font family time roman font size valign clinical supply agreement valign bottom nbsp nbsp valign bottom style font family time roman font size valign funding approval milestone valign bottom nbsp nbsp valign bottom style font family time roman font size valign funding approval milestone payment valign bottom nbsp nbsp valign bottom style font family time roman font size valign funding material valign bottom nbsp nbsp valign bottom style font family time roman font size valign funding option valign bottom nbsp nbsp valign bottom style font family time roman font size valign funding option deadline valign bottom nbsp nbsp valign bottom style font family time roman font size valign funding option exercise notice valign bottom nbsp nbsp valign bottom style font family time roman font size valign funding valign bottom nbsp nbsp valign bottom style font family time roman font size valign funding notice valign bottom nbsp nbsp valign bottom style font family time roman font size valign funding sale milestone valign bottom nbsp nbsp valign bottom style font family time roman font size valign funding sale milestone payment valign bottom nbsp nbsp valign bottom style font family time roman font size valign commercialization expense valign bottom nbsp nbsp valign bottom exhibit style font family time roman font size valign company valign bottom nbsp nbsp valign bottom preamble style font family time roman font size valign company detailing expense valign bottom nbsp nbsp valign bottom exhibit style font family time roman font size valign company indemnitee valign bottom nbsp nbsp valign bottom style font family time roman font size valign company license valign bottom nbsp nbsp valign bottom style font family time roman font size valign cooperating party valign bottom nbsp nbsp valign bottom style font family time roman font size valign promote material valign bottom nbsp nbsp valign bottom style font family time roman font size valign promote option valign bottom nbsp nbsp valign bottom style font family time roman font size valign promote option exercise notice valign bottom nbsp nbsp valign bottom style font family time roman font size valign promotion agreement valign bottom nbsp nbsp valign bottom style font family time roman font size valign cost valign bottom nbsp nbsp valign bottom style font family time roman font size valign cost valign bottom nbsp nbsp valign bottom exhibit style font family time roman font size valign cost variance valign bottom nbsp nbsp valign bottom exhibit style font family time roman font size valign valign bottom nbsp nbsp valign bottom style font family time roman font size valign cure period valign bottom nbsp nbsp valign bottom style font family time roman font size valign valign bottom nbsp nbsp valign bottom style font family time roman font size valign development milestone valign bottom nbsp nbsp valign bottom style font family time roman font size valign development milestone payment valign bottom nbsp nbsp valign bottom style font family time roman font size valign disclosing party valign bottom nbsp nbsp valign bottom style font family time roman font size valign dispute valign bottom nbsp nbsp valign bottom style font family time roman font size valign distribution expense valign bottom nbsp nbsp valign bottom exhibit style font family time roman font size valign expense valign bottom nbsp nbsp valign bottom exhibit style font family time roman font size valign education expense valign bottom nbsp nbsp valign bottom exhibit style font family time roman font size valign valign bottom nbsp nbsp valign bottom style font family time roman font size valign execution date valign bottom nbsp nbsp valign bottom preamble style font family time roman font size valign valign bottom nbsp nbsp valign bottom style font family time roman font size valign valign bottom nbsp nbsp valign bottom style font family time roman font size valign valign bottom nbsp nbsp valign bottom table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left nbsp align left valign portion this exhibit have been omitted pursuant request confidential treatment table table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left nbsp align left valign unredacted version this exhibit been filed separately with commission table style page break before always size style color width align center table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width width style font family time roman font size valign bottom nowrap style border bottom solid width font size font family time roman definition valign bottom nbsp nbsp valign bottom nowrap style border bottom solid width font size font family time roman section style font family time roman font size valign valign bottom nbsp nbsp valign bottom style font family time roman font size valign invoice valign bottom nbsp nbsp valign bottom style font family time roman font size valign late payment notice valign bottom nbsp nbsp valign bottom style font family time roman font size valign repayment option valign bottom nbsp nbsp valign bottom style font family time roman font size valign good faith dispute valign bottom nbsp nbsp valign bottom style font family time roman font size valign hatch waxman valign bottom nbsp nbsp valign bottom style font family time roman font size valign valign bottom nbsp nbsp valign bottom style font family time roman font size valign incumbent board valign bottom nbsp nbsp valign bottom style font family time roman font size valign indemnifying party valign bottom nbsp nbsp valign bottom style font family time roman font size valign indemnitee valign bottom nbsp nbsp valign bottom style font family time roman font size valign infringement recovery valign bottom nbsp nbsp valign bottom style font family time roman font size valign insolvency event valign bottom nbsp nbsp valign bottom style font family time roman font size valign insolvent party valign bottom nbsp nbsp valign bottom style font family time roman font size valign johnson nbsp johnson valign bottom nbsp nbsp valign bottom style font family time roman font size valign joint invention valign bottom nbsp nbsp valign bottom style font family time roman font size valign joint patent valign bottom nbsp nbsp valign bottom style font family time roman font size valign valign bottom nbsp nbsp valign bottom style font family time roman font size valign licensed patent valign bottom nbsp nbsp valign bottom style font family time roman font size valign loss valign bottom nbsp nbsp valign bottom style font family time roman font size valign macrogenics valign bottom nbsp nbsp valign bottom preamble style font family time roman font size valign macrogenics indemnitee valign bottom nbsp nbsp valign bottom style font family time roman font size valign manufacturing expense valign bottom nbsp nbsp valign bottom exhibit style font family time roman font size valign manufacturing process valign bottom nbsp nbsp valign bottom style font family time roman font size valign manufacturing technology transfer valign bottom nbsp nbsp valign bottom style font family time roman font size valign manufacturing transition plan valign bottom nbsp nbsp valign bottom style font family time roman font size valign marketing expense valign bottom nbsp nbsp valign bottom exhibit style font family time roman font size valign marketing management expense valign bottom nbsp nbsp valign bottom exhibit style font family time roman font size valign medical affair expense valign bottom nbsp nbsp valign bottom exhibit style font family time roman font size valign milestone event valign bottom nbsp nbsp valign bottom style font family time roman font size valign milestone payment valign bottom nbsp nbsp valign bottom style font family time roman font size valign valign bottom nbsp nbsp valign bottom style font family time roman font size valign insolvent party valign bottom nbsp nbsp valign bottom style font family time roman font size valign other cost valign bottom nbsp nbsp valign bottom exhibit style font family time roman font size valign other cost included standard valign bottom nbsp nbsp valign bottom exhibit style font family time roman font size valign party party valign bottom nbsp nbsp valign bottom preamble style font family time roman font size valign patent extension valign bottom nbsp nbsp valign bottom style font family time roman font size valign valign bottom nbsp nbsp valign bottom exhibit style font family time roman font size valign phase trial expense valign bottom nbsp nbsp valign bottom exhibit style font family time roman font size valign valign bottom nbsp nbsp valign bottom style font family time roman font size valign prior valign bottom nbsp nbsp valign bottom style font family time roman font size valign protocol valign bottom nbsp nbsp valign bottom style font family time roman font size valign valign bottom nbsp nbsp valign bottom table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left nbsp align left valign portion this exhibit have been omitted pursuant request confidential treatment table table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left nbsp align left valign unredacted version this exhibit been filed separately with commission table style page break before always size style color width align center table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width width style font family time roman font size valign bottom nowrap style border bottom solid width font size font family time roman definition valign bottom nbsp nbsp valign bottom nowrap style border bottom solid width font size font family time roman section style font family time roman font size valign quarterly profit loss report valign bottom nbsp nbsp valign bottom style font family time roman font size valign recall expense valign bottom nbsp nbsp valign bottom exhibit style font family time roman font size valign receiving party valign bottom nbsp nbsp valign bottom style font family time roman font size valign requesting party valign bottom nbsp nbsp valign bottom style font family time roman font size valign reverted product valign bottom nbsp nbsp valign bottom style font family time roman font size valign sale milestone valign bottom nbsp nbsp valign bottom style font family time roman font size valign sale milestone payment valign bottom nbsp nbsp valign bottom style font family time roman font size valign sale valign bottom nbsp nbsp valign bottom exhibit style font family time roman font size valign sale rate valign bottom nbsp nbsp valign bottom exhibit style font family time roman font size valign sale total valign bottom nbsp nbsp valign bottom exhibit style font family time roman font size valign valign bottom nbsp nbsp valign bottom style font family time roman font size valign selling cost valign bottom nbsp nbsp valign bottom exhibit style font family time roman font size valign sole invention valign bottom nbsp nbsp valign bottom style font family time roman font size valign standard cost good manufactured valign bottom nbsp nbsp valign bottom exhibit style font family time roman font size valign term valign bottom nbsp nbsp valign bottom style font family time roman font size valign terminated country valign bottom nbsp nbsp valign bottom style font family time roman font size valign terminated product valign bottom nbsp nbsp valign bottom style font family time roman font size valign terminating party valign bottom nbsp nbsp valign bottom style font family time roman font size valign third party obligation valign bottom nbsp nbsp valign bottom style font family time roman font size valign third party obligation expense valign bottom nbsp nbsp valign bottom exhibit style font family time roman font size valign third party patent challenge valign bottom nbsp nbsp valign bottom style font family time roman font size valign transition plan valign bottom nbsp nbsp valign bottom table style margin margin bottom font size font family time roman align center article style margin margin bottom font size font family time roman align center governance style margin margin bottom font size font family time roman joint steering committee style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign formation purpose party agree establish convene joint steering committee within after effective date shall consist representative from each party further described section nbsp operate accordance with this section nbsp purpose shall provide forum overall coordination communication oversight party activity under this agreement including resolution dispute properly referred under this agreement table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign responsibility overall responsibility shall table style margin margin bottom margin left text indent font size font family time roman discus approve oversee macrogenics development regulatory manufacturing activity with respect initial product style margin margin bottom margin left text indent font size font family time roman discus approve oversee transition plan manufacturing transition plan style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left nbsp align left valign portion this exhibit have been omitted pursuant request confidential treatment table table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left nbsp align left valign unredacted version this exhibit been filed separately with commission table style page break before always size style color width align center style margin margin bottom margin left text indent font size font family time roman macrogenics exercise funding option accordance with section nbsp encourage facilitate communication information sharing regarding global development activity commercialization initial product northern american territory including review discussion company then current global development plan during funding term style margin margin bottom margin left text indent font size font family time roman coordinate fulfillment those right obligation arising from macrogenics exercise macrogenics option style margin margin bottom margin left text indent font size font family time roman decide matter resolve dispute referred which authority decide resolve under this agreement style margin margin bottom margin left text indent font size font family time roman perform other obligation specifically delegated under this agreement style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign decision action action taken shall taken only following with each party having fails reach unanimous agreement matter before decision within from date that matter first presented writing such matter shall referred executive officer discussion resolution pursuant section nbsp resolution such matter executive officer shall final binding party executive officer able resolve matter within period specified section nbsp then with respect such matter such matter shall final binding party subject limitation forth section table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign membership promptly after effective date each party shall designate three nbsp such representative elect vary number representative from time time provided that unless otherwise agreed party writing shall maintain equal number representative from each party each representative shall have appropriate level experience subject area least nbsp representative shall have sufficient seniority within applicable party organization have necessary decision making authority order fulfill responsibility either party designate substitute representative nbsp more such party designated representative unable present meeting from time time each party replace representative written notice other party specifying prior representative their replacement each representative shall bound confidentiality obligation least restrictive those forth this agreement table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign align left style font family time roman font size chairperson will have chairperson designated company chairperson shall responsible calling convening meeting shall have special authority over other member table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left nbsp align left valign portion this exhibit have been omitted pursuant request confidential treatment table table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left nbsp align left valign unredacted version this exhibit been filed separately with commission table style page break before always size style color width align center table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp align left valign shall have additional voting right chairperson designate shall nbsp prepare circulate agenda reasonably advance each upcoming meeting nbsp prepare issue minute meeting within thirty nbsp thereafter such minute shall finalized until each representative review approves such minute provided that minute shall deemed approved unless representative object accuracy such minute within after circulation minute table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign meeting table style margin margin bottom margin left text indent font size font family time roman timing frequency later than after effective date will hold person meeting establish operating procedure shall meet least once every calendar quarter until later funding option deadline final promote option deadline which time shall dissolve provided however that nbsp event macrogenics exercise funding option shall meet least style margin margin bottom margin left font size font family time roman once every calendar quarter until funding term unless otherwise agreed party nbsp event that macrogenics exercise promote option oversight promotion activity shall specified promotion agreement additional meeting held with consent each party such consent unreasonably withheld delayed conditioned required under this agreement resolve matter dispute referred accordance with this agreement case matter dispute referred such meeting shall held within following referral soon reasonably possible thereafter style margin margin bottom margin left text indent font size font family time roman meeting procedure meeting shall effective only majority representative each party present participating other than initial meeting meet either nbsp person either party facility such location party otherwise agree least twice every calendar year nbsp audio video teleconference each party shall responsible expense incurred connection with representative participation meeting including travel lodging other third party expense incurred furtherance meeting such expense associated with site meeting shall shared equally party style margin margin bottom margin left text indent font size font family time roman member participation additional member having relevant experience from time time invited participate meeting provided that such participant shall have voting right power member participant employee party affiliate shall only allowed attend nbsp other party representative have consented attendance such consent unreasonably withheld delayed conditioned nbsp such member participant subject confidentiality obligation least restrictive those forth this agreement style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left nbsp align left valign portion this exhibit have been omitted pursuant request confidential treatment table table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left nbsp align left valign unredacted version this exhibit been filed separately with commission table style page break before always size style color width align center style margin margin bottom font size font family time roman additional subcommittee working group establish other subcommittee working group needed further purpose this agreement including responsibility assigned under this agreement provided however that shall delegate dispute resolution authority particular macrogenics exercise funding option party contemplate establishment joint development committee facilitate communication regarding global development activity during funding term joint marketing committee facilitate communication information sharing regarding commercialization initial product northern american territory purpose scope procedure such subcommittee working group shall mutually agreed writing action taken subcommittee working group shall taken only following unanimous vote with each party having nbsp vote subcommittee working group fails reach unanimous agreement matter before decision relating development commercialization product period excess from date that matter first presented such subcommittee working group writing such matter shall referred resolution pursuant section style margin margin bottom font size font family time roman authority party agree that shall conclusively presumed that unless otherwise explicitly stated each voting member each subcommittee working group established authority approval such member respective senior management casting vote each subcommittee working group established shall each have only power assigned expressly this article elsewhere this agreement shall have power amend modify global development plan commercialization plan amend modify waive compliance with this agreement style margin margin bottom font size font family time roman alliance manager promptly following effective date each party shall designate writing alliance manager serve primary point contact party regarding collaboration activity contemplated under this agreement each alliance manager shall facilitate communication coordination party activity under this agreement relating compound product alliance manager shall member alliance manager shall allowed attend voting observer meeting well subcommittee working group established which alliance manager member style margin margin bottom font size font family time roman decision making restriction notwithstanding anything contrary this agreement extent that with respect matter pursuant section nbsp shall nbsp expand under this agreement nbsp determine that under this agreement nbsp that expressly stated nbsp resolve dispute regarding whether style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left nbsp align left valign portion this exhibit have been omitted pursuant request confidential treatment table table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left nbsp align left valign unredacted version this exhibit been filed separately with commission table style page break before always size style color width align center style margin margin bottom font size font family time roman align center article style margin margin bottom font size font family time roman align center license style margin margin bottom font size font family time roman license company subject term condition this agreement macrogenics hereby grant company exclusive even macrogenics royalty bearing transferable except accordance with section nbsp license with right grant sublicenses provided section nbsp under macrogenics technology exploit compound product field territory company license style margin margin bottom margin left font size font family time roman sublicensing company shall have right grant sublicenses right granted company under this section nbsp nbsp affiliate through multiple tier nbsp third party through multiple tier subject condition this subsection nbsp provided below sublicenses third party that include only granted with macrogenics prior consent unreasonably withheld conditioned delayed unless such sublicense nbsp connection with only extent necessary useful enable third party perform service company affiliate sublicensee course performance development manufacturing commercialization right obligation under this agreement nbsp more third party distributor only extent reasonably necessary useful enable such third party distributor commercialize product such country company shall identify each third party sublicensee macrogenics which company each sublicense shall refer subordinate this agreement except extent party otherwise agree writing sublicense must consistent material respect with term condition this agreement company shall remain responsible performance this agreement performance sublicensees hereunder company shall provide macrogenics copy sublicenses which grant right directly third party jurisdiction territory provided that company shall have right redact commercially sensitive information from such copy information regarding scope license grant territory term each such sublicense shall considered commercially sensitive style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign company termination license company shall have right terminate company license with respect more macrogenics patent included company license providing prior written notice macrogenics specifying macrogenics patent subject such termination upon effectiveness such termination nbsp company license will longer extend such macrogenics patent nbsp such macrogenics patent shall longer subject provision article macrogenics shall have sole right prosecute maintain enforce defend such macrogenics patent macrogenics sole expense nbsp claim such macrogenics patent shall considered valid claim purpose section nbsp section nbsp table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left nbsp align left valign portion this exhibit have been omitted pursuant request confidential treatment table table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left nbsp align left valign unredacted version this exhibit been filed separately with commission table style page break before always size style color width align center style margin margin bottom font size font family time roman license macrogenics subject term condition this agreement style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign company hereby grant back macrogenics exclusive fully paid royalty free transferable except accordance with section nbsp sublicensable sublicense under company license with compound product field territory solely extent necessary macrogenics exercise right perform obligation under this agreement including right obligation that arise event macrogenics elect exercise macrogenics option table style margin margin bottom margin left font size font family time roman company hereby grant back macrogenics exclusive fully paid royalty free transferable except accordance with section nbsp sublicensable license under nbsp company technology nbsp know controlled company execution date during term that incorporated into embodiment product developed hereunder nbsp patent controlled company execution date during term that cover technology incorporated into embodiment product developed hereunder each case nbsp with compound product field territory solely extent necessary macrogenics exercise right perform obligation under this agreement including right obligation that arise event macrogenics elect exercise macrogenics option style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign company hereby grant back macrogenics exclusive fully paid royalty free transferable except accordance with section nbsp sublicensable license under company license provided that macrogenics shall without prior written consent company table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign company hereby grant macrogenics exclusive fully paid royalty free transferable except accordance with section nbsp license with right sublicense under platform patent controlled company virtue macrogenics know exercise company license that claim technology applied product table style margin margin bottom font size font family time roman trademark license macrogenics hereby grant company exclusive license macrogenics trademark connection with development commercialization product subject customary reasonable quality control procedure mutually agreed upon party prior launch product style margin margin bottom font size font family time roman implied license license right granted only expressly provided this agreement license other right shall created granted under this agreement implication estoppel otherwise right expressly granted party under this agreement reserved such party used other party purpose style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left nbsp align left valign portion this exhibit have been omitted pursuant request confidential treatment table table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left nbsp align left valign unredacted version this exhibit been filed separately with commission table style page break before always size style color width align center style margin margin bottom font size font family time roman align center article style margin margin bottom font size font family time roman align center development style margin margin bottom font size font family time roman transition development responsibility style margin margin bottom margin left font size font family time roman during period beginning effective date ending development transition date macrogenics shall diligent effort perform nbsp development activity necessary other than nbsp development activity assigned macrogenics transition plan provided however that event that macrogenics after effective date upon company request shall discus determine whether company should assume responsibility determines that company should assume responsibility then promptly following such determination macrogenics shall transfer company information controlled macrogenics that reasonably necessary company provide reasonable assistance company with respect style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign following development transition date macrogenics shall transfer company company shall cooperate good faith support macrogenics transfer activity responsibility related compound product accordance with transition plan approved promptly after effective date transition plan transition plan shall designed effect efficient transfer from macrogenics company compound product related development manufacturing regulatory other related responsibility documentation well information controlled macrogenics that reasonably necessary useful company exploitation compound product including copy tangible embodiment thereof updated amended necessary effect such transfer transition plan shall include itemized list deliverable date which such deliverable expected provided macrogenics company dispute between party regarding conduct activity forth transition plan shall referred resolution table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign macrogenics shall report status activity conducted pursuant this section nbsp each meeting otherwise requested company table style margin margin bottom font size font family time roman development style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign company development activity except development activity undertaken prior development transition date macrogenics pursuant section nbsp company shall solely responsible have sole authority with respect expense subject macrogenics exercise funding option development compound product company shall commercially reasonable effort develop seek regulatory approval addition company shall commercially reasonable effort table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left nbsp align left valign portion this exhibit have been omitted pursuant request confidential treatment table table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left nbsp align left valign unredacted version this exhibit been filed separately with commission table style page break before always size style color width align center table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign global development plan except with respect specified below company shall commercially reasonable effort conduct development product territory accordance with global development plan expense subject macrogenics sharing expense upon exercise funding option company shall have right make amendment global development plan which shall consistent with company development obligation forth section nbsp each amended global development plan shall include material development activity anticipated required obtain regulatory approval product well timeline regarding such activity including plan timeline preparing necessary regulatory material global development plan shall include development activity with respect that company elect conduct provided that company shall have obligation conduct development seek regulatory approval product beginning with delivery funding material continuing through funding option deadline macrogenics exercise funding option funding termination date macrogenics exercise funding option company shall update global development plan include then current binding budget global development cost during funding term company shall update amend appropriate then current global development plan shall submit such update amendment review while global development plan shall require approval company shall review consider comment global development plan received from macrogenics good faith company will consider including global development plan clinical trial using initial product extent that company reasonably determines that such clinical trial feasible from medical scientific regulatory commercial perspective party acknowledge agree that company ability conduct such clinical trial subject that company shall have obligation conduct such clinical trial unless conduct such clinical trial table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign align left style font family time roman font size macrogenics development event that macrogenics time during funding term wish conduct clinical trial initial product that consistent with currently included global development plan shall submit written proposal conduct such clinical trial approval together with draft protocol clinical plan budget shall consider such proposal good faith approves such proposal then nbsp such clinical trial shall deemed global development activity shall become part global development plan nbsp cost associated with such table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left nbsp align left valign portion this exhibit have been omitted pursuant request confidential treatment table table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left nbsp align left valign unredacted version this exhibit been filed separately with commission table style page break before always size style color width align center table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp align left valign clinical trial shall global development cost shared accordance with section nbsp nbsp upon company request party shall enter into clinical trial agreement governing conduct such clinical trial which agreement shall account necessary regulatory other consideration shall consistent with term this agreement nbsp macrogenics agreement with site which such clinical trial conducted shall consistent with company form clinical trial site agreement with term this agreement nbsp party shall amend necessary provide sharing information data relating such clinical trial nbsp macrogenics shall commercially reasonable effort conduct such clinical trial accordance with global development plan approve such proposal shall inform macrogenics reason such determination specific suggestion revision protocol that address reason underlying such determination such suggestion macrogenics submit revised proposal macrogenics shall conduct clinical trial initial product without express approval thereof table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign clinical trial registry clinical trial field territory company shall responsible accordance with applicable registering appropriate clinical trial registry posting result such clinical trial table style margin margin bottom font size font family time roman decision making company shall have sole authority with respect development compound product field territory accordance with this agreement style margin margin bottom font size font family time roman compliance with each party shall conduct development activity related compound product material respect good scientific manner compliance material respect with applicable including applicable national international guideline style margin margin bottom font size font family time roman record company shall prepare maintain shall cause prepared maintained complete accurate written record account note report data with respect development activity conducted pursuant this agreement including global development plan conformity with applicable company standard practice provided that case shall such record maintained following calendar year which such record pertain longer period required applicable style margin margin bottom font size font family time roman cooperation upon reasonable advance notice request each party agrees make employee consultant reasonably available their respective place employment consult with other party issue arising connection with global development plan style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left nbsp align left valign portion this exhibit have been omitted pursuant request confidential treatment table table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left nbsp align left valign unredacted version this exhibit been filed separately with commission table style page break before always size style color width align center style margin margin bottom font size font family time roman progress report later than company shall provide macrogenics writing been dissolved pursuant section nbsp verbally report detailing company effort progress during such date applicable exploit each compound product each such report shall describe among other matter nbsp material development activity completed since last report including object parameter development when initiated when completed summary material result nbsp material development activity planned undertaken before next report including type object clinical trial conducted their projected starting completion date nbsp material change company development commercialization plan addition company shall reasonably respond reasonable request macrogenics information regarding company style margin margin bottom font size font family time roman development commercialization activity such compound product extent such information necessary company compliance with obligation hereunder addition macrogenics exercise funding option macrogenics exercise funding accordance with section nbsp request macrogenics party shall meet discus development commercialization progress either party facility such other location agreed upon party semi annual basis style margin margin bottom font size font family time roman subcontracting company subcontract performance development activity conducted accordance with this agreement affiliate third party provided that company shall oversee performance subcontracted activity manner that would reasonably expected result their successful timely completion shall remain responsible performance such subcontracted activity accordance with this agreement style margin margin bottom font size font family time roman align center article style margin margin bottom font size font family time roman align center regulatory responsibility style margin margin bottom font size font family time roman initial data transfer style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign within after development transition date macrogenics shall deliver company electronic copy unless otherwise required applicable regulatory material relating product field territory which controlled macrogenics upon completion such transfer macrogenics shall hereby assign company such regulatory material shall promptly case within take step reasonably necessary effectuate assignment inds regulatory approval application regulatory approval included such regulatory material including submitting applicable regulatory authority letter other necessary documentation with copy company notifying regulatory authority assignment event that such regulatory approval application regulatory approval transferred within such period macrogenics shall take action reasonably requested company with respect maintenance transfer such regulatory approval application regulatory approval table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left nbsp align left valign portion this exhibit have been omitted pursuant request confidential treatment table table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left nbsp align left valign unredacted version this exhibit been filed separately with commission table style page break before always size style color width align center table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign within after development transition date macrogenics shall make available company separate electronic copy remaining regulatory documentation including study report from clinical trial clinical trial each case whether completed prior development transition date then progress that controlled macrogenics extent previously provided company table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign notwithstanding section nbsp section nbsp from time time after development transition date extent done already macrogenics shall shall cause affiliate without additional compensation disclose make available company whatever form company reasonably request soon reasonably practicable after earlier development making conception reduction practice regulatory documentation other information controlled macrogenics which each case reasonably necessary useful company exploitation compound product including copy tangible embodiment thereof clarity macrogenics will have right unless otherwise required applicable retain original copy foregoing subject article table style margin margin bottom font size font family time roman preparation regulatory material style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign macrogenics during period beginning effective date ending development transition date consultation with shall nbsp soon possible after effective date provided that company shall provide nbsp take action necessary maintain regulatory material relating product field territory which controlled macrogenics table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign company except activity undertaken prior development transition date macrogenics pursuant section nbsp company shall with respect product field territory have sole right sole authority expense subject macrogenics exercise funding option nbsp develop implement overall regulatory strategy with respect obtaining regulatory approval product field territory nbsp prepare obtain maintain regulatory documentation including inds regulatory approval application regulatory approval nbsp conduct communication with relevant regulatory authority regulatory strategy territory shall consistent with global development plan term this agreement regulatory material including regulatory approval generated with respect product under this agreement shall owned shall sole property held name company designee table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left nbsp align left valign portion this exhibit have been omitted pursuant request confidential treatment table table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left nbsp align left valign unredacted version this exhibit been filed separately with commission table style page break before always size style color width align center table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign macrogenics assistance macrogenics shall assist company reasonably requested connection with preparation filing regulatory documentation territory macrogenics sole expense provided however that company shall reimburse macrogenics cost third party expense incurred macrogenics providing such assistance later than nbsp month after effective date table style margin margin bottom font size font family time roman adverse event reporting safety data exchange style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign company responsibility upon transfer ownership inds regulatory approval application regulatory approval accordance with section nbsp company will assume responsibility monitoring clinical experience maintaining global safety database safety monitoring pharmacovigilance surveillance compliance filing required safety report regulatory authority territory with respect compound product including annual safety report throughout development commercialization each compound product table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign safety information exchange pharmacovigilance agreement event macrogenics exercise promote option party shall cooperate develop method procedure sharing information relating clinical experience referred section nbsp with respect initial product accordance with safety reporting requirement respective governmental authority necessary comply with applicable specific detail regarding management safety information including adverse event report related development commercialization initial product territory will delineated separate global pharmacovigilance agreement party shall meet discus within after macrogenics exercise promote option shall agree upon term soon practicable event later than anticipated date first commercial sale product provided however that event party reach agreement term prior first commercial sale product then party shall enter into interim prior first commercial sale product shall agree upon term final soon practicable thereafter event conflict inconsistency between this agreement term shall take precedence matter relating pharmacovigilance table style margin margin bottom font size font family time roman recall voluntary withdrawal company shall reasonable effort notify macrogenics promptly event later than following determination that event incident circumstance related safety issue regulatory concern occurred that reasonably likely result need recall market suspension market withdrawal product territory shall include such notice reasoning behind such determination style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left nbsp align left valign portion this exhibit have been omitted pursuant request confidential treatment table table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left nbsp align left valign unredacted version this exhibit been filed separately with commission table style page break before always size style color width align center style margin margin bottom font size font family time roman supporting fact company shall have sole right make final determination whether voluntarily implement such recall market suspension market withdrawal territory provided that prior implementation such recall market suspension market withdrawal company shall extent practical consult with macrogenics shall consider macrogenics comment good faith recall market suspension market withdrawal undertaken pursuant this section nbsp company shall solely responsible execution thereof macrogenics shall reasonably cooperate such recall effort subject article company shall responsible cost conducting such recall market suspension market withdrawal sake clarity during funding term certain associated with recall market withdrawal accordance with section nbsp style margin margin bottom font size font family time roman subcontracting company subcontract performance activity conducted accordance with this article affiliate third party provided that company shall oversee performance subcontracted activity manner that would reasonably expected result their successful timely completion shall remain responsible performance such subcontracted activity accordance with this agreement style margin margin bottom font size font family time roman align center article style margin margin bottom font size font family time roman align center commercialization style margin margin bottom font size font family time roman commercialization activity style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign company commercialization activity subject macrogenics exercise promote option company shall solely responsible have sole authority with respect expense subject macrogenics sharing expense upon exercise funding option aspect commercialization product field territory including nbsp developing executing commercial launch launch plan nbsp marketing promotion including detailing nbsp booking sale distribution performance related service nbsp handling aspect order processing invoicing collection inventory receivables nbsp publication nbsp providing customer support including handling medical query performing other related function nbsp review approval promotional material compliance with applicable including submission where appropriate applicable regulatory authority viii nbsp conforming practice procedure material respect applicable relating marketing detailing promotion product field territory company shall commercially reasonable effort commercialize product which regulatory approval received territory table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign ordering macrogenics shall accept order purchase product from third party make sale product third party field territory account company account macrogenics receives order product field territory shall refer such order company acceptance rejection table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left nbsp align left valign portion this exhibit have been omitted pursuant request confidential treatment table table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left nbsp align left valign unredacted version this exhibit been filed separately with commission table style page break before always size style color width align center table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign commercialization plan event macrogenics exercise promote option accordance with section nbsp company shall submit initial commercialization plan such subcommittee designated review such subcommittee thereafter company shall submit updated commercialization plan such subcommittee designated least once each calendar year until termination expiration promotion agreement review such subcommittee table style margin margin bottom font size font family time roman trademark company shall have sole responsibility expense matter relating shall trademark used sale product field territory excluding macrogenics trademark trademark that confusingly similar macrogenics trademark including selection filing prosecution maintenance defense enforcement thereof notwithstanding foregoing event macrogenics exercise funding option cost related product trademark northern american territory shall treated commercialization expense style margin margin bottom font size font family time roman decision making except with respect macrogenics decision exercise promote option forth section nbsp macrogenics right conduct upon such exercise after effective date company shall have sole authority with respect aspect commercialization product field territory accordance with this agreement including decision regarding pricing discount term sale style margin margin bottom font size font family time roman transparency reporting company event exercise either both funding option promote option macrogenics shall each responsible tracking reporting transfer value initiated controlled affiliate employee contractor agent pursuant requirement marketing reporting research expense reporting governmental authority territory including section nbsp commonly referred sunshine style margin margin bottom font size font family time roman compliance with company macrogenics exercise promote option macrogenics shall conduct commercialization activity related compound product compliance material respect with applicable style margin margin bottom font size font family time roman subcontracting company subcontract performance commercialization activity conducted accordance with this agreement affiliate third party provided that company shall oversee performance subcontracted activity manner that would reasonably expected result their successful timely completion shall remain responsible performance such subcontracted activity accordance with this agreement style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left nbsp align left valign portion this exhibit have been omitted pursuant request confidential treatment table table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left nbsp align left valign unredacted version this exhibit been filed separately with commission table style page break before always size style color width align center style margin margin bottom font size font family time roman align center article style margin margin bottom font size font family time roman align center manufacturing style margin margin bottom font size font family time roman general supply term after effective date except provided below company shall have sole responsibility sole authority with respect expense subject macrogenics exercise funding option manufacturing clinical commercial supply compound product field territory upon company request nbsp macrogenics shall transfer company cost nucleotide molecule cell line protein material compound product finished form process effective date macrogenics inventory effective date provided that macrogenics retain reasonable quantity such material such inventory nbsp macrogenics shall commercially reasonable effort manufacture macrogenics facility supply company nbsp nbsp nbsp based timeline reasonably acceptable macrogenics sole discretion clinical supply compound other each case nbsp cost equal incurred macrogenics connection with such manufacture with respect clinical supply manufactured after execution date binding estimate such cost forth schedule macrogenics shall obligated fulfilling such company request pursuant clause nbsp this section nbsp unless otherwise agreed party macrogenics shall continue conduct complete that being conducted execution date with respect through execution date company shall reimburse macrogenics reasonable third party expense development cost incurred macrogenics after execution date conducting such promptly after effective date party shall enter into good faith negotiation conclude clinical supply agreement clinical supply agreement related quality agreement within after execution date which clinical supply agreement shall include specification procedure delivery acceptance product such quality agreement will reflect finding supply qualification audit conducted company macrogenics critical supplier company shall have right negotiated under clinical supply agreement style margin margin bottom font size font family time roman transition manufacturing responsibility style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign align left style font family time roman font size subject approval manufacturing transition plan manufacturing transition plan macrogenics shall effect transfer company designee which designee affiliate third party manufacturer which third party manufacturer backup manufacturer second manufacturer compound product macrogenics know right under third party agreement relating then current process manufacture compound product manufacturing process facilitate implementation manufacturing process facility designated company such transfer implementation more fully described this section nbsp manufacturing technology transfer macrogenics shall provide reasonable assistance requested company enable company affiliate designated third party manufacturer applicable implement manufacturing process facility designated table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left nbsp align left valign portion this exhibit have been omitted pursuant request confidential treatment table table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left nbsp align left valign unredacted version this exhibit been filed separately with commission table style page break before always size style color width align center table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp align left valign company company shall reimburse macrogenics personnel cost development rate reimburse third party expense incurred macrogenics providing such assistance table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign without limitation foregoing connection with manufacturing technology transfer macrogenics shall cause appropriate employee representative macrogenics affiliate meet with employee representative company affiliate designated third party manufacturer applicable applicable manufacturing facility mutually convenient time assist with working manufacturing process with training personnel company affiliate designated third party manufacturer applicable extent reasonably necessary useful enable company affiliate designated third party manufacturer applicable practice manufacturing process table style margin margin bottom font size font family time roman decision making company shall have sole authority with respect aspect manufacturing compound product field territory including development style margin margin bottom font size font family time roman compliance with each party shall conduct manufacturing activity related compound product compliance material respect with applicable including applicable national international guideline style margin margin bottom font size font family time roman subcontracting company subcontract performance manufacturing activity conducted accordance with this agreement affiliate third party provided that company shall oversee performance subcontracted activity manner that would reasonably expected result their successful timely completion shall remain responsible performance such subcontracted activity accordance with this agreement style margin margin bottom font size font family time roman align center article style margin margin bottom font size font family time roman align center macrogenics option style margin margin bottom font size font family time roman generally subject term this agreement macrogenics discretion exercise promote option funding option macrogenics exercise promote option funding option separate independent each other such that macrogenics exercise only promote option only funding option both promote option funding option neither style margin margin bottom font size font family time roman funding option style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign align left style font family time roman font size option grant exercise company hereby grant macrogenics option fund global development cost share profit loss lieu royalty sale initial product northern american table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left nbsp align left valign portion this exhibit have been omitted pursuant request confidential treatment table table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left nbsp align left valign unredacted version this exhibit been filed separately with commission table style page break before always size style color width align center table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp align left valign territory further described this section nbsp funding option macrogenics discretion exercise funding option delivering written notice thereof company funding option exercise notice time before date that funding option deadline company shall promptly provide written notice macrogenics occurrence funding option shall deemed exercised date that company receives funding option exercise notice funding option deadline pass without company receiving funding option exercise notice funding option shall immediately permanently expire after funding option deadline table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign funding material later than company shall deliver macrogenics nbsp projected timeline global development activity nbsp summary nbsp then current that included global development plan which global development activity annual basis thereafter nbsp then current binding which shall nbsp then current funding material after delivery funding material prior funding option deadline upon macrogenics reasonable request with reasonable notice company shall promptly make available macrogenics nbsp during normal business hour employee consultant performed activity behalf company preparation funding material answer macrogenics question about funding material nbsp additional information company possession relating initial product that reasonably useful evaluating funding material macrogenics acknowledges agrees that nothing funding material will deemed representation warranty either express implied that company will able successfully develop commercialize initial product northern american territory commercialized that will achieve particular sale level initial product northern american territory table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign term funding during funding term nbsp macrogenics shall responsible global development cost nbsp profit loss shall allocated between party provided section nbsp nbsp section nbsp shall apply lieu section nbsp nbsp section nbsp shall apply lieu section nbsp nbsp royalty with respect sale product shall payable only under section nbsp royalty shall payable with respect sale initial product northern american territory table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign invoicing payment global development cost table style margin margin bottom margin left text indent font size font family time roman company shall provide macrogenics later than before during funding term rolling binding annual forecast global development cost that company expects incur during final forecast with addition company shall provide style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left nbsp align left valign portion this exhibit have been omitted pursuant request confidential treatment table table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left nbsp align left valign unredacted version this exhibit been filed separately with commission table style page break before always size style color width align center style margin margin bottom margin left font size font family time roman macrogenics later than before during funding term first calendar year each final forecast shall referred current forecast final forecast shall consistent with global development plan with company internal budget relevant period style margin margin bottom margin left text indent font size font family time roman except with respect calendar quarter which funding option exercised within thirty nbsp after each calendar quarter during funding term including calendar quarter which funding termination date occurs nbsp company will provide written report invoice macrogenics setting forth reasonable detail global development cost incurred company during such calendar quarter nbsp macrogenics will provide written report invoice company setting forth reasonable detail global development cost incurred company pursuant section nbsp during such calendar quarter company share nbsp such global development cost each invoice invoice first calendar quarter during funding term shall also include global development cost incurred company prior such calendar quarter global development cost relating global development activity incurred prior exercise funding option within sixty nbsp after receipt each invoice macrogenics extent amount forth nbsp such invoice reasonable dispute after netting company share invoice provided macrogenics such calendar quarter shall invoice full subject cost provision forth section nbsp macrogenics fails company total amount forth invoice within from date such invoice company shall notify macrogenics writing late payment notice macrogenics shall notify company amount reasonably disputed invoice including basis such dispute company shall notify macrogenics amount reasonably disputed invoice provided macrogenics including basis such dispute dispute with respect amount forth invoice that nbsp resolved party after such dispute first raised shall referred attempted resolution provided however that such dispute shall subject company final decision making authority under section nbsp resolve such dispute within provision article shall apply audit right forth section nbsp shall apply payment made pursuant this section nbsp style margin margin bottom margin left text indent font size font family time roman notwithstanding section nbsp during calendar year which global development cost paid macrogenics macrogenics elect providing written notice such election company within after receipt first invoice such calendar year that following company receipt during calendar year macrogenics shall obligated that have been paid style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left nbsp align left valign portion this exhibit have been omitted pursuant request confidential treatment table table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left nbsp align left valign unredacted version this exhibit been filed separately with commission table style page break before always size style color width align center style margin margin bottom margin left font size font family time roman deducted from payment hereunder calendar quarter shall carried forward next calendar quarter provided however that shall paid macrogenics deducted within during which such excess cost were incurred that carried forward from calendar year subsequent calendar year purpose determining whether used above mean nbsp with respect during period beginning ending period beginning ending during such calendar year nbsp each thereafter during such calendar year example that became payable pursuant during applicable style margin margin bottom margin left text indent font size font family time roman notwithstanding subsection during which global development cost greater than such calendar year company shall style margin margin bottom margin left text indent font size font family time roman upon request either party finance team party will meet attempt agree good faith change process reporting calculating invoicing global development cost including pursuant this section nbsp reflect process improvement identified with respect thereto style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign funding notwithstanding foregoing time during funding term after macrogenics paid least cumulative total global development cost pursuant section nbsp macrogenics discretion elect cease funding global development cost sharing profit loss funding providing written notice such election company funding notice before applicable calendar year macrogenics delivers funding notice accordance with this section nbsp then following provision shall apply beginning funding termination date remainder term table style margin margin bottom margin left text indent font size font family time roman macrogenics obligation fund global development cost shall terminate font style white space nowrap funding font termination date macrogenics shall have obligation fund global development cost including global development cost incurred macrogenics performing clinical trial accordance with section nbsp incurred after funding termination date clarity macrogenics shall responsible paying invoiced global development cost incurred prior funding termination date style margin margin bottom margin left text indent font size font family time roman sharing profit loss pursuant section nbsp shall terminate funding termination date style margin margin bottom margin left text indent font size font family time roman macrogenics exercise funding then macrogenics elect font style white space nowrap funding nbsp nbsp notice font reimbursed style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left nbsp align left valign portion this exhibit have been omitted pursuant request confidential treatment table table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left nbsp align left valign unredacted version this exhibit been filed separately with commission table style page break before always size style color width align center style margin margin bottom margin left font size font family time roman global development cost paid macrogenics prior funding termination date repayment option which case nbsp company shall macrogenics global development cost previously funded macrogenics with made within after funding termination date made before last next immediately following payment provided that company obligation make such payment shall terminate effective date termination this agreement company pursuant section nbsp nbsp beginning with first calendar quarter after font style white space nowrap funding font termination date royalty with respect sale product shall payable under section nbsp style margin margin bottom margin left text indent font size font family time roman nbsp macrogenics exercise funding nbsp macrogenics exercise font style white space nowrap funding font prior elect repayment option funding notice then each case beginning with first calendar quarter after font style white space nowrap funding font termination date royalty with respect sale product shall payable under section nbsp style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign termination funding term failure global development cost macrogenics fails entire disputed outstanding invoiced amount forth invoice within after receiving late payment notice macrogenics delivered accordance with section nbsp then following provision shall apply beginning funding termination date remainder term table style margin margin bottom margin left text indent font size font family time roman macrogenics obligation fund global development cost shall terminate font style white space nowrap funding font termination date except with respect global development cost incurred prior font style white space nowrap funding font termination date macrogenics shall have obligation fund global development cost incurred after font style white space nowrap funding font termination date clarity macrogenics shall responsible paying invoiced global development cost incurred prior funding termination date style margin margin bottom margin left text indent font size font family time roman sharing profit loss pursuant section nbsp shall terminate funding termination date style margin margin bottom margin left text indent font size font family time roman beginning with first calendar quarter after font style white space nowrap funding font termination date royalty with respect sale product shall payable under section nbsp style margin margin bottom margin left text indent font size font family time roman company setoff against amount that then owed macrogenics that subsequently become macrogenics pursuant this agreement amount such disputed outstanding invoiced global development cost other global development cost macrogenics subsequently becomes obligated pursuant section style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left nbsp align left valign portion this exhibit have been omitted pursuant request confidential treatment table table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left nbsp align left valign unredacted version this exhibit been filed separately with commission table style page break before always size style color width align center table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign expiration funding term funding termination event result application subsection nbsp nbsp section nbsp then following provision shall apply beginning funding termination date remainder term table style margin margin bottom margin left text indent font size font family time roman macrogenics obligation fund global development cost shall terminate funding termination date except with respect global development cost incurred prior funding termination date macrogenics shall have obligation fund global development cost incurred after funding termination date clarity macrogenics shall responsible paying invoiced global development cost incurred prior funding termination date style margin margin bottom margin left text indent font size font family time roman sharing profit loss pursuant section nbsp shall terminate funding termination date style margin margin bottom margin left text indent font size font family time roman company shall have obligation make payment macrogenics hereunder with respect sale initial product northern american territory beginning with first calendar quarter after font style white space nowrap funding font termination date style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign change control event occurrence change control macrogenics before during font style white space nowrap funding font term following provision shall apply until funding term table style margin margin bottom margin left text indent font size font family time roman upon consummation change control macrogenics macrogenics shall have further right pursuant section nbsp commencing within after such change control macrogenics shall reimburse company outstanding under section nbsp that have previously been recouped company forth therein style margin margin bottom margin left text indent font size font family time roman upon consummation change control macrogenics nbsp shall dissolved except extent necessary perform activity described clause nbsp this sentence nbsp prior dissolution shall establish reasonable procedure protect secrecy company macrogenics competitively sensitive confidential information with respect such other product including example limiting access such information requiring each party representative employee performing activity connection with this agreement sign individual confidentiality agreement agreeing comply with confidentiality provision this agreement understood that such procedure shall established required that would diminish macrogenics right style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left nbsp align left valign portion this exhibit have been omitted pursuant request confidential treatment table table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left nbsp align left valign unredacted version this exhibit been filed separately with commission table style page break before always size style color width align center style margin margin bottom margin left font size font family time roman under this agreement information regarding product diminish macrogenics operational responsibility under this agreement meaningful otherwise impair macrogenics right with respect compound product style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign decision making clarity macrogenics exercise funding option shall alter either party respective right with respect development compound product including company decision making right forth section table style margin margin bottom font size font family time roman promote option style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign option grant exercise company hereby grant macrogenics option promote initial product approved indication further described this section nbsp promote option macrogenics discretion exercise promote option delivering written notice thereof company font style white space nowrap promote font option exercise notice time before case case indication planned provided however that macrogenics shall only have right exercise promote option with respect company obtains seek obtain purpose clarity macrogenics exercise promote option company obtained seeking obtain then promote option shall expire upon nbsp macrogenics exercise promote option prior company obtained seeking obtain then promote option shall remain exercisable until expiration furthermore once macrogenics exercise promote option such exercise shall notwithstanding foregoing event occurrence change control macrogenics prior macrogenics exercise promote option company terminate promote option upon immediate written notice macrogenics within consummation such change control after such change control macrogenics acquirer affiliate would conducting clinical trial commercializing product that would directly compete field with initial product whether through same mechanism action treatment same indication initial product with such competitive product upon receipt such notice macrogenics this section nbsp shall further force effect table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign align left style font family time roman font size promote material with respect company shall deliver macrogenics nbsp binding nbsp summary term promotion agreement promote material provided however that company shall obligated deliver promote material which unless company obtains seek obtain after table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left nbsp align left valign portion this exhibit have been omitted pursuant request confidential treatment table table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left nbsp align left valign unredacted version this exhibit been filed separately with commission table style page break before always size style color width align center table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp align left valign delivery promote material prior applicable promote option deadline upon macrogenics reasonable request with reasonable notice company shall promptly make available macrogenics nbsp during normal business hour employee consultant performed activity behalf company preparation font style white space nowrap promote font material answer macrogenics question about promote material nbsp additional information company possession relating initial product that reasonably useful evaluating font style white space nowrap promote font material table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign term promote promptly following company receipt promote option exercise notice accordance with section nbsp party shall enter into good faith negotiation separate promotion agreement with respect promotion initial product promotion agreement addition such usual customary term that typically found within contract sale force agreement including with respect diligence obligation macrogenics promotion agreement shall include term forth below this section nbsp macrogenics shall commit promotion agreement employ number sale representative sufficient provide detail initial product sake clarity macrogenics exercise font style white space nowrap promote font option shall have affect company authority with respect commercialization product under section nbsp macrogenics shall have right detail initial product unless until party execute promotion agreement table style margin margin bottom margin left text indent font size font family time roman macrogenics detailing percentage unless otherwise agreed party macrogenics shall contribute total detail initial product each calendar year forth commercialization plan provided however that company increase total number detail given calendar year macrogenics shall have right obligation increase total sale force effort within receipt notice from company order maintain agreed upon percentage detail assigned macrogenics company will have right allocate planned detail initial product each calendar year between party which allocation shall forth company call plan such calendar year party agree treat electronic detailing such live video conferencing form detail which event party shall mutually agree upon cost such electronic detail such cost shall deemed commercialization expense during funding term style margin margin bottom margin left text indent font size font family time roman detail company shall reimburse macrogenics detail initial product performed macrogenics cost measured approved prior first commercial sale initial product northern american territory clarity company shall responsible cost associated with macrogenics detailing initial product other than cost style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left nbsp align left valign portion this exhibit have been omitted pursuant request confidential treatment table table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left nbsp align left valign unredacted version this exhibit been filed separately with commission table style page break before always size style color width align center style margin margin bottom margin left font size font family time roman agreed upon party event party agree treat electronic detail form detail such electronic detail shall reimbursed cost instead shall reimbursed cost mutually agreed upon party described section nbsp style margin margin bottom margin left text indent font size font family time roman audit right each party shall have right audit other party record regarding performance under promotion agreement solely purpose determining other party compliance with promotion agreement style margin margin bottom margin left text indent font size font family time roman termination promotion agreement macrogenics terminate promotion agreement prior written notice company company terminate promotion agreement immediately nbsp macrogenics fails contribute least detail initial product northern american territory that macrogenics obligated provide under commercialization plan fails remedy such shortfall within after receiving written notice such shortfall from company nbsp macrogenics materially breach promotion agreement fails cure such breach within after receiving written notice such breach from company promotion agreement shall subordinate coterminous with this agreement style margin margin bottom margin left text indent font size font family time roman promotional material sample except macrogenics trademark company shall remain solely responsible production product labeling promotional material initial product training testing material sale representative including those acting behalf macrogenics detail initial product restriction with respect ability such sale representative detail other product macrogenics sale representative initial product shall only promotional material provided company without alteration shall such promotional material company will provide macrogenics company expense reasonable quantity promotional material product sample sample voucher initial product support macrogenics detailing initial product company shall macrogenics trademark promotional material without macrogenics written consent such consent unreasonably withheld delayed conditioned style margin margin bottom margin left text indent font size font family time roman training related macrogenics sale force issue company will responsible designing providing training material representative including those acting behalf macrogenics detail initial product company shall provide training macrogenics sale representative detail initial product macrogenics expense company will ship training material macrogenics reasonably required macrogenics ongoing training need macrogenics expense macrogenics shall compensate sale representative detail initial product using sale compensation structure similar that used company with respect sale representative detail initial product each sale representative detail initial product behalf macrogenics shall employee macrogenics affiliate style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left nbsp align left valign portion this exhibit have been omitted pursuant request confidential treatment table table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left nbsp align left valign unredacted version this exhibit been filed separately with commission table style page break before always size style color width align center style margin margin bottom margin left text indent font size font family time roman compliance macrogenics sale representative performing detail initial product shall comply with applicable company reasonable instruction quality standard policy guideline which relate commercialization initial product which macrogenics been given sufficient written notice company appropriately train such sale representative macrogenics shall establish compliance program appoint compliance officer ensure that macrogenics detailing initial product compliance with applicable such company instruction quality standard policy guideline style margin margin bottom margin left text indent font size font family time roman viii governance party shall establish committee oversee facilitate communication between party with respect detailing initial product style margin margin bottom margin left text indent font size font family time roman change control event occurrence change control macrogenics during term company terminate promotion agreement upon immediate written notice macrogenics within consummation such change control after such change control macrogenics acquirer would developing commercializing assisting third party affiliate conduct pivotal trial commercialize product that would directly compete field with initial product whether through same mechanism action bind product target treatment same indication initial product with such competitive product style margin margin bottom font size font family time roman align center article style margin margin bottom font size font family time roman align center consideration style margin margin bottom font size font family time roman upfront payment within after effective date company shall macrogenics fifty million dollar time refundable creditable upfront payment style margin margin bottom font size font family time roman reimbursement expense company shall reimburse macrogenics cost third party expense incurred macrogenics providing assistance pursuant section nbsp this agreement contemplated thereby company shall also reimburse macrogenics pocket patent cost incurred pursuant section nbsp company shall reimburse such cost third party expense macrogenics pocket patent cost within sixty nbsp after receipt invoice issued macrogenics describing such cost reasonable detail providing appropriate supporting documentation style margin margin bottom font size font family time roman milestone payment company will notify macrogenics within following achievement company affiliate sublicensee each development milestone each approval milestone funding approval milestone applicable each sale milestone funding sale milestone applicable collectively milestone event within after achievement each milestone event company shall remit applicable development milestone payment approval milestone payment funding approval style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left nbsp align left valign portion this exhibit have been omitted pursuant request confidential treatment table table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left nbsp align left valign unredacted version this exhibit been filed separately with commission table style page break before always size style color width align center style margin margin bottom font size font family time roman milestone payment applicable sale milestone payment funding sale milestone payment applicable collectively milestone payment macrogenics each milestone payment company pursuant this section nbsp shall payable only once sake clarity development first product discontinued prior time which milestone payment pursuant this section nbsp made with respect such product then achievement subsequent product milestone event which development such first product result achievement milestone payment under this section nbsp shall deemed first achievement such milestone event under this section nbsp addition reason development milestone occur prior occurrence development milestone then development milestone shall deemed occur concurrently with occurrence development milestone development milestone occurs with respect milestone previously occurred with respect such indication other indication then development milestone will deemed occur concurrently with development milestone development milestone payment shall become payable accordance with this section nbsp similarly reason development milestone occur with respect indication prior occurrence development milestone with respect such indication then development milestone shall deemed occur concurrently with occurrence such development milestone only least development milestone occurred with respect another indication nbsp development milestone occurs with respect indication other than none development milestone have occurred with respect such indication other indication then development milestone will deemed occur concurrently with development milestone development milestone payment shall become payable accordance with this section nbsp nbsp development milestone occurs with respect development milestone occurred with respect then development milestone will deemed occur concurrently with development milestone development milestone payment shall become payable accordance with this section nbsp style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign development milestone following payment each development milestone payment shall made time basis with respect first product achieve corresponding milestone event each development milestone table style font size margin margin bottom nbsp table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width style font family time roman font size valign bottom nowrap style border bottom solid width font size font family time roman development milestone valign bottom nbsp nbsp valign bottom align center style border bottom solid development milestone payment nbsp bgcolor cceeff style font family time roman font size valign style margin left text indent font size font family time roman trial development milestone valign bottom nbsp nbsp valign bottom style font size height height colspan style font family time roman font size valign style margin left text indent font size font family time roman valign bottom nbsp nbsp valign bottom align center style font size height height colspan bgcolor cceeff style font family time roman font size valign style margin left text indent font size font family time roman trial development milestone valign bottom nbsp nbsp valign bottom table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left nbsp align left valign portion this exhibit have been omitted pursuant request confidential treatment table table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left nbsp align left valign unredacted version this exhibit been filed separately with commission table style page break before always size style color width align center table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center valign bottom width width valign bottom width style font family time roman font size valign bottom colspan nowrap style margin margin bottom border bottom solid width font size font family time roman development milestone valign bottom nbsp nbsp valign bottom align center style border bottom solid development milestone payment nbsp bgcolor cceeff style font family time roman font size valign valign bottom nbsp valign bottom valign bottom nbsp nbsp valign bottom align center style font size height height colspan height colspan style font family time roman font size valign valign bottom nbsp valign bottom style font size vertical align valign bottom nbsp nbsp valign bottom align center style font size height height colspan height colspan bgcolor cceeff style font family time roman font size valign valign bottom nbsp valign bottom with respect which development milestone achieved style font size vertical align valign bottom nbsp nbsp valign bottom align center style font size height height colspan height colspan style font family time roman font size valign valign bottom nbsp valign bottom with respect which development milestone achieved with respect which development milestone achieved style font size vertical align valign bottom nbsp nbsp valign bottom align center style font size height height colspan height colspan bgcolor cceeff style font family time roman font size valign valign bottom nbsp valign bottom valign bottom nbsp nbsp valign bottom align center style font size height height colspan height colspan style font family time roman font size valign valign bottom nbsp valign bottom style font size vertical align valign bottom nbsp nbsp valign bottom align center style font size height height colspan height colspan bgcolor cceeff style font family time roman font size valign valign bottom nbsp valign bottom respect which development milestone achieved style font size vertical align valign bottom nbsp nbsp valign bottom align center style font size height height colspan height colspan style font family time roman font size valign valign bottom nbsp valign bottom with respect which development milestone achieved with respect which development milestone achieved style font size vertical align valign bottom nbsp nbsp valign bottom align center table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left style font size vertical align nbsp align left valign development milestone payment this development milestone when achieved will regardless whether table table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left style font size vertical align nbsp align left valign development milestone payment this milestone when achieved will regardless whether table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign regulatory approval milestone following payment each approval milestone payment shall made time basis with respect first product achieve corresponding milestone event each approval milestone only funding term effect when such approval milestone achieved table style font size margin margin bottom nbsp table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center valign bottom width width valign bottom width style font family time roman font size valign bottom colspan nowrap style margin margin bottom border bottom solid width font size font family time roman approval milestone valign bottom nbsp nbsp valign bottom align center style border bottom solid approval nbsp milestone payment bgcolor cceeff style font family time roman font size valign valign bottom nbsp valign bottom valign bottom nbsp nbsp valign bottom align center style font size height height colspan height colspan style font family time roman font size valign valign bottom nbsp valign bottom style font size vertical align valign bottom nbsp nbsp valign bottom align center style font size height height colspan height colspan bgcolor cceeff style font family time roman font size valign valign bottom nbsp valign bottom with respect which approval valign bottom nbsp nbsp valign bottom align center table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left nbsp align left valign portion this exhibit have been omitted pursuant request confidential treatment table table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left nbsp align left valign unredacted version this exhibit been filed separately with commission table style page break before always size style color width align center table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center valign bottom width width valign bottom width style font family time roman font size valign bottom colspan nowrap style margin margin bottom border bottom solid width font size font family time roman approval milestone valign bottom nbsp nbsp valign bottom align center style border bottom solid approval nbsp milestone payment bgcolor cceeff style font family time roman font size valign valign bottom nbsp valign milestone achieved style font size vertical align valign bottom nbsp nbsp valign bottom style font family time roman font size valign valign bottom nbsp valign valign bottom nbsp nbsp valign bottom align center style font size height height colspan height colspan bgcolor cceeff style font family time roman font size valign valign bottom nbsp valign style font size vertical align valign bottom nbsp nbsp valign bottom align center style font size height height colspan height colspan style font family time roman font size valign valign bottom nbsp valign with respect which approval milestone achieved style font size vertical align valign bottom nbsp nbsp valign bottom align center table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left style font size vertical align nbsp align left valign approval milestone payment this approval milestone when achieved will regardless whether table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left style font size vertical align nbsp align left valign approval milestone payment this approval milestone when achieved will regardless whether table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign regulatory approval milestone during funding term following payment each funding approval milestone payment shall made time basis with respect first product achieve corresponding milestone event each funding approval milestone only such funding approval milestone achieved during funding term sake clarity this section nbsp shall only apply during funding term table style font size margin margin bottom nbsp table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center valign bottom width width valign bottom width style font family time roman font size valign bottom colspan nowrap style margin margin bottom border bottom solid width font size font family time roman funding approval milestone valign bottom nbsp nbsp valign bottom align center style border bottom solid funding approval nbsp milestone payment bgcolor cceeff style font family time roman font size valign valign bottom nbsp valign bottom valign bottom nbsp nbsp valign bottom align center style font size height height colspan height colspan style font family time roman font size valign valign bottom nbsp valign bottom style font size vertical align valign bottom nbsp nbsp valign bottom align center style font size height height colspan height colspan bgcolor cceeff style font family time roman font size valign valign bottom nbsp valign bottom with respect which approval milestone achieved style font size vertical align valign bottom nbsp nbsp valign bottom align center table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left style font size vertical align nbsp align left valign funding approval milestone payment this funding approval milestone when achieved will regardless whether table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign annual sale milestone milestone payment forth this section nbsp each sale milestone payment shall each payable macrogenics time only upon first time during term that total aggregate sale product calendar year company affiliate sublicensees territory during applicable royalty term product applicable country exceed amount forth following table each sale milestone only funding term effect when such sale milestone achieved table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left nbsp align left valign portion this exhibit have been omitted pursuant request confidential treatment table table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left nbsp align left valign unredacted version this exhibit been filed separately with commission table style page break before always size style color width align center style margin margin bottom font size font family time roman align center annual aggregate worldwide sale milestone style font size margin margin bottom nbsp table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width style font family time roman font size valign bottom nowrap style border bottom solid width font size font family time roman sale milestone valign bottom nbsp nbsp valign bottom align center style border bottom solid sale nbsp milestone payment nbsp bgcolor cceeff style font family time roman font size valign style margin left text indent font size font family time roman upon first occasion that aggregate annual sale product exceeds valign bottom nbsp nbsp valign bottom align center style font size height height colspan style font family time roman font size valign style margin left text indent font size font family time roman upon first occasion that aggregate annual sale product exceeds valign bottom nbsp nbsp valign bottom align center style font size height height colspan bgcolor cceeff style font family time roman font size valign style margin left text indent font size font family time roman upon first occasion that aggregate annual sale product exceeds valign bottom nbsp nbsp valign bottom align center table style margin margin bottom margin left font size font family time roman more than sale milestone described this section nbsp achieved during same calendar year company shall macrogenics each sale milestone payment that corresponds such sale milestone purpose clarity only milestone payment shall owed first occasion that aggregate annual sale product exceeds under section nbsp section nbsp style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign annual sale milestone during funding term milestone payment forth this section nbsp each funding sale milestone payment shall each payable macrogenics time only upon first time during funding term that total aggregate sale product company affiliate sublicensees territory during applicable royalty term product applicable country excluding sale initial product northern american territory during funding term exceed amount forth following table each funding sale milestone only such funding sale milestone achieved during funding term table style margin margin bottom font size font family time roman align center annual aggregate sale milestone territory style margin margin bottom font size font family time roman align center excluding only sale northern american territory with style margin margin bottom font size font family time roman align center respect initial product style font size margin margin bottom nbsp table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width style font family time roman font size valign bottom nowrap style border bottom solid width font size font family time roman funding sale milestone valign bottom nbsp nbsp valign bottom nowrap align center style border bottom solid funding nbsp sale milestone payment bgcolor cceeff style font family time roman font size valign style margin left text indent font size font family time roman upon first occasion that aggregate annual sale product exceeds valign bottom nbsp nbsp valign bottom align center style font size height height colspan style font family time roman font size valign style margin left text indent font size font family time roman upon first occasion that aggregate annual sale product exceeds valign bottom nbsp nbsp valign bottom align center style font size height height colspan bgcolor cceeff style font family time roman font size valign style margin left text indent font size font family time roman upon first occasion that aggregate annual sale product exceeds valign bottom nbsp nbsp valign bottom align center table style margin margin bottom margin left font size font family time roman more than funding sale milestone described this section nbsp achieved during same calendar year company shall macrogenics each funding sale milestone payment that corresponds such funding sale style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left nbsp align left valign portion this exhibit have been omitted pursuant request confidential treatment table table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left nbsp align left valign unredacted version this exhibit been filed separately with commission table style page break before always size style color width align center style margin margin bottom margin left font size font family time roman milestone purpose clarity only milestone payment shall owed first occasion that aggregate annual sale product exceeds under section nbsp section nbsp style margin margin bottom font size font family time roman company royalty obligation further consideration right granted hereunder company shall macrogenics royalty aggregate annual sale each product rate forth this section nbsp each case subject section nbsp section nbsp section nbsp below style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign royalty funding event that macrogenics exercise funding option prior funding option deadline accordance with section nbsp then company shall macrogenics with respect sale each product each country territory during applicable royalty term such product such country royalty following rate table style font size margin margin bottom nbsp table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width style font family time roman font size valign bottom nowrap style border bottom solid width font size font family time roman annual sale valign bottom nbsp nbsp valign bottom align center style border bottom solid royalty nbsp rate bgcolor cceeff style font family time roman font size valign style margin left text indent font size font family time roman portion worldwide annual sale such product than equal valign bottom nbsp nbsp valign bottom align center style font size height height colspan style font family time roman font size valign style margin left text indent font size font family time roman portion worldwide annual sale such product greater than than equal valign bottom nbsp nbsp valign bottom align center style font size height height colspan bgcolor cceeff style font family time roman font size valign style margin left text indent font size font family time roman portion worldwide annual sale such product greater than valign bottom nbsp nbsp valign bottom align center table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign royalty during funding term event that macrogenics exercise funding option prior funding option deadline accordance with section nbsp then company shall macrogenics during funding term royalty rate forth below this section table style margin margin bottom margin left text indent font size font family time roman initial product with respect sale initial product each country territory during applicable royalty term initial product such country excluding sale initial product northern american territory royalty following royalty rate style font size margin margin bottom nbsp table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width style font family time roman font size valign bottom nowrap style border bottom solid width font size font family time roman annual sale initial product valign bottom nbsp nbsp valign bottom align center style border bottom solid royalty nbsp rate bgcolor cceeff style font family time roman font size valign style margin left text indent font size font family time roman portion worldwide annual sale initial product excluding sale initial product northern american territory than equal valign bottom nbsp nbsp valign bottom align center style font size height height colspan style font family time roman font size valign style margin left text indent font size font family time roman portion worldwide annual sale initial product excluding sale initial product northern american territory greater than than equal valign bottom nbsp nbsp valign bottom align center style font size height height colspan bgcolor cceeff style font family time roman font size valign style margin left text indent font size font family time roman portion worldwide annual sale initial product excluding sale initial product northern american territory greater than valign bottom nbsp nbsp valign bottom align center table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left nbsp align left valign portion this exhibit have been omitted pursuant request confidential treatment table table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left nbsp align left valign unredacted version this exhibit been filed separately with commission table style page break before always size style color width align center style margin margin bottom margin left font size font family time roman avoidance doubt aggregate annual sale initial product northern american territory during funding term shall excluded from calculation royalty threshold forth above royalty payable macrogenics pursuant this section nbsp style margin margin bottom margin left text indent font size font family time roman product other than initial product with respect sale product other than initial product each country territory during applicable royalty term such product such country royalty following royalty rate style font size margin margin bottom nbsp table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width style font family time roman font size valign bottom nowrap style border bottom solid width font size font family time roman annual sale product other than initial product valign bottom nbsp nbsp valign bottom align center style border bottom solid royalty nbsp rate bgcolor cceeff style font family time roman font size valign style margin left text indent font size font family time roman portion worldwide annual sale such product than equal valign bottom nbsp nbsp valign bottom style font size height height colspan style font family time roman font size valign style margin left text indent font size font family time roman portion worldwide annual sale such initial product greater than than equal valign bottom nbsp nbsp valign bottom style font size height height colspan bgcolor cceeff style font family time roman font size valign style margin left text indent font size font family time roman portion worldwide annual sale such product greater than valign bottom nbsp nbsp valign bottom table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign royalty after funding term table style margin margin bottom margin left font size font family time roman macrogenics exercise funding elect repayment option event that macrogenics exercise funding option accordance with section nbsp macrogenics thereafter exercise funding accordance with section nbsp elect repayment option then company shall macrogenics during part term after funding term nbsp with respect sale initial product northern american territory royalty rate forth second column following table nbsp with respect nbsp sale initial product country outside northern american territory nbsp sale product other than initial product country territory style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left nbsp align left valign portion this exhibit have been omitted pursuant request confidential treatment table table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left nbsp align left valign unredacted version this exhibit been filed separately with commission table style page break before always size style color width align center style margin margin bottom margin left font size font family time roman royalty rate forth third column following table each case during applicable royalty term such product such country style font size margin margin bottom nbsp table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width valign bottom width style font family time roman font size valign bottom nowrap style border bottom solid width font size font family time roman annual sale valign bottom nbsp nbsp valign bottom nowrap align center style border bottom solid nbsp royalty rate northern american territory nbsp nbsp sale nbsp nbsp initial product valign bottom nbsp valign bottom nowrap align center style border bottom solid royalty rate outside northern american territory sale initial product territory sale nbsp nbsp each nbsp product other than initial product bgcolor cceeff style font family time roman font size valign style margin left text indent font size font family time roman portion worldwide annual sale such product than equal valign bottom nbsp nbsp valign bottom valign bottom nbsp valign bottom style font size height height colspan height colspan style font family time roman font size valign style margin left text indent font size font family time roman portion worldwide annual sale such product greater than than equal valign bottom nbsp nbsp valign bottom valign bottom nbsp valign bottom style font size height height colspan height colspan bgcolor cceeff style font family time roman font size valign style margin left text indent font size font family time roman portion worldwide annual sale such product greater than valign bottom nbsp nbsp valign bottom valign bottom nbsp valign bottom table style margin margin bottom margin left text indent font size font family time roman macrogenics exercise funding elect repayment option termination funding cause event that macrogenics exercise funding option accordance with section nbsp nbsp macrogenics thereafter exercise funding accordance with section nbsp elect repayment option nbsp funding term thereafter terminated pursuant section nbsp then each case during part term after funding term company shall macrogenics with respect sale each product each country territory during applicable royalty term such product such country royalty following rate style font size margin margin bottom nbsp table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width style font family time roman font size valign bottom nowrap style border bottom solid width font size font family time roman annual sale valign bottom nbsp nbsp valign bottom align center style border bottom solid royalty nbsp rate bgcolor cceeff style font family time roman font size valign style margin left text indent font size font family time roman portion worldwide annual sale such product than equal valign bottom nbsp nbsp valign bottom align center style font size height height colspan style font family time roman font size valign style margin left text indent font size font family time roman portion worldwide annual sale such product greater than than equal valign bottom nbsp nbsp valign bottom align center style font size height height colspan bgcolor cceeff style font family time roman font size valign style margin left text indent font size font family time roman portion worldwide annual sale such product greater than valign bottom nbsp nbsp valign bottom align center table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign align left style font family time roman font size example royalty calculation initial product example global aggregate annual sale initial product macrogenics exercise funding option royalty rate reduction under section nbsp applies then royalty payable company macrogenics initial table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left nbsp align left valign portion this exhibit have been omitted pursuant request confidential treatment table table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left nbsp align left valign unredacted version this exhibit been filed separately with commission table style page break before always size style color width align center table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp align left valign product such calendar year subject other applicable reduction would follows table style font size margin margin bottom nbsp table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width valign bottom width style font family time roman font size valign bottom align center global sale valign bottom nbsp nbsp valign bottom align center royalty nbsp tier valign bottom nbsp valign bottom align center royalty nbsp bgcolor cceeff style font family time roman font size valign align center style margin left text indent font size font family time roman align center valign bottom nbsp nbsp valign bottom align center valign bottom nbsp valign bottom align center style font family time roman font size valign align center style margin left text indent font size font family time roman align center valign bottom nbsp nbsp valign bottom align center valign bottom nbsp valign bottom align center bgcolor cceeff style font family time roman font size valign align center style margin left text indent font size font family time roman align center valign bottom nbsp nbsp valign bottom align center valign bottom nbsp valign bottom align center style font family time roman font size valign align center style margin left text indent font size font family time roman align center valign bottom nbsp nbsp valign bottom align center valign bottom nbsp valign bottom align center table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign multiple royalty each sale product only royalty under section nbsp shall payable table style margin margin bottom font size font family time roman royalty term royalty under section nbsp shall payable sale product product country country basis beginning upon first commercial sale relevant product relevant country territory until expiration royalty term such product such country following expiration royalty term with respect product country territory subject term condition this agreement company shall have perpetual irrevocable exclusive fully paid royalty free right license with right grant sublicenses under macrogenics technology exploit such product field such country territory style margin margin bottom font size font family time roman royalty rate reduction royalty rate forth section nbsp shall subject reduction follows style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign royalty rate shall reduced country country basis product product basis each country which given time both nbsp valid claim macrogenics patent applicable product such country nbsp either nbsp product such country nbsp product such country table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign royalty rate shall reduced country country product product basis each country which given time nbsp applicable product such country nbsp there product such country table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign event that royalty rate reduction section nbsp applies product country product such country reduction forth section nbsp shall thereafter apply such product such country table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign event that company country which macrogenics elect accordance with section nbsp which would have been sole expense requirement forth clause table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left nbsp align left valign portion this exhibit have been omitted pursuant request confidential treatment table table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left nbsp align left valign unredacted version this exhibit been filed separately with commission table style page break before always size style color width align center table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left nbsp nbsp align left valign section shall deemed have been satisfied there shall reduction applicable royalty rate until global expiration date family such table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign event shall cumulative effect reduction available company under this agreement decrease royalty rate otherwise applicable rate table style margin margin bottom font size font family time roman manner royalty payment within following each calendar quarter after first commercial sale product territory excluding first commercial sale northern american territory that occurs during funding term company shall provide macrogenics with report setting forth product product country country basis excluding country northern american territory during funding term sale such product such country reasonably detailed statement calculation royalty payment with respect such sale such report shall also include exchange rate other methodology used converting sale into dollar from currency which such sale were made purpose calculating appropriate royalty rate royalty payment application reduction made accordance with term section nbsp section nbsp company shall amount macrogenics pursuant section nbsp with respect sale company affiliate their respective sublicensees such calendar quarter dollar time submission such quarterly report style margin margin bottom font size font family time roman currency payment under this agreement shall payable dollar with respect sale product invoiced commercialization expense incurred currency other than dollar such amount amount payable hereunder shall expressed their dollar equivalent calculated using currency hedge rate described below each calendar year during which royalty become under section nbsp company shall provide macrogenics nbsp used each country territory which royalty bearing sale expected occur nbsp detail each such each case writing later than after available from affiliate which customarily each will remain constant throughout upcoming calendar year company shall convert sale dollar purpose calculating royalty payment profit loss hereunder style margin margin bottom font size font family time roman allocation profit loss during funding term profit loss initial product shall allocated company macrogenics style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign align left style font family time roman font size expense report within after each calendar quarter following first commercial sale initial product northern american territory during funding term each party shall submit other party party during such calendar quarter within after each calendar quarter following first commercial sale initial product northern american territory during funding term each party shall submit other party written report setting forth reasonable detail table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left nbsp align left valign portion this exhibit have been omitted pursuant request confidential treatment table table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left nbsp align left valign unredacted version this exhibit been filed separately with commission table style page break before always size style color width align center table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp align left valign commercialization expense incurred such party during such calendar quarter provided that commercialization expense incurred either party during funding term before first commercial sale northern american territory shall included first commercialization expense report submitted party shall used determine allocation profit loss between party such calendar quarter each party shall have right review submit reasonable objection commercialization expense forth other party report within following receipt commercialization expense report from other party dispute with respect commercialization expense that resolved party within after such dispute first raised shall referred attempted resolution provided however that such dispute shall resolve such dispute within provision article shall apply until resolution such dispute pursuant article table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign profit loss report within after each calendar quarter following first commercial sale initial product northern american territory remainder funding term company shall submit macrogenics report setting forth reasonable detail with detail forth section nbsp mutatis mutandis allocation profit loss between party quarterly profit loss report company shall amount macrogenics pursuant this section nbsp time submission quarterly profit loss report provided however that quarterly profit loss report indicates loss such calendar quarter macrogenics shall amount company pursuant this section nbsp within following receipt such quarterly profit loss report table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign financial report format timing upon request either party finance team party will meet attempt agree good faith alternative financial report format timetable lieu report deadline described section nbsp table style margin margin bottom font size font family time roman third party financial obligation style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign align left style font family time roman font size macrogenics shall solely responsible payment royalty sublicense revenue milestone other payment either party their affiliate sublicensees third party arising with respect each third party obligation nbsp extent such third party nbsp extent such third party obligation macrogenics fails amount third party obligation related dart platform compound product such payment failure make such payment upon prior notice company elect sole discretion make such payment table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left nbsp align left valign portion this exhibit have been omitted pursuant request confidential treatment table table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left nbsp align left valign unredacted version this exhibit been filed separately with commission table style page break before always size style color width align center table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp align left valign such third party behalf macrogenics company make such payment such third party company deduct amount such payment from payment that owed that become owed macrogenics under this agreement such deduction applicable macrogenics shall reimburse company amount such payment within after company make such payment table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign except third party obligation forth section nbsp company shall responsible third party obligation including license company credit third party obligation resulting from patent know owned third party that paid company pursuant this section nbsp against royalty payable macrogenics under section nbsp company shall take such credit during calendar quarter which royalty payable hereunder provided that event will such credit together with reduction under section nbsp reduce royalty payable macrogenics such calendar quarter more than share such third party obligation that remains uncredited application such floor carried forward subsequent calendar quarter table style margin margin bottom font size font family time roman style margin margin bottom margin left font size font family time roman company will make payment macrogenics under this agreement without deduction withholding except extent that such deduction withholding required applicable effect time payment required withheld amount payable under this agreement will paid company behalf macrogenics appropriate governmental authority company will furnish macrogenics with proof payment such such required withheld will expense borne macrogenics such assessed against paid company then macrogenics will indemnify hold harmless company from against such style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign company macrogenics will cooperate with respect documentation required taxing authority reasonably requested company secure reduction rate applicable withholding table style margin margin bottom margin left font size font family time roman company assigns right obligation hereunder affiliate third party compliance with section nbsp such affiliate third party shall required applicable withhold additional from respect amount payable under this agreement result such assignment then such amount payable under this agreement shall increased take into account additional withheld necessary that after making required withholding macrogenics receives amount equal would have received such assignment been made foregoing sentence shall apply additional withheld extent macrogenics obtain foreign credit therefor style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left nbsp align left valign portion this exhibit have been omitted pursuant request confidential treatment table table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left nbsp align left valign unredacted version this exhibit been filed separately with commission table style page break before always size style color width align center style margin margin bottom font size font family time roman return style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign party hereby agree that each party share global development cost including amount paid under section nbsp shall accounted each party separately research credit orphan drug credit purpose table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign party hereby agree that deduction purpose attributable amount paid incurred macrogenics pursuant this agreement shall deductible amortizable solely macrogenics deduction purpose attributable amount paid incurred company pursuant this agreement shall deductible amortizable solely company return reflecting such amount shall filed available election effect such intent including remedial allocation election shall made consistent with foregoing table style margin margin bottom font size font family time roman audit each party shall maintain complete accurate record ordinary course such party operation order permit other party confirm accuracy calculation royalty milestone profit loss global development cost cost third party expense other payment under this agreement upon reasonable prior notice more than such record shall available during regular business hour period from calendar year which they pertain examination independent certified public accountant selected requesting party reasonably acceptable other party sole purpose verifying accuracy financial report correctness payment furnished other party pursuant this agreement such auditor shall disclose other party confidential information except extent such disclosure necessary verify accuracy financial report furnished other party amount payment other party under this agreement amount shown owed unpaid shall paid within from accountant report plus interest forth section nbsp from original date amount shown have been overpaid shall refunded within from accountant report requesting party shall bear full cost such audit unless such audit discloses underpayment other party more than amount except extent caused improper reporting requesting party which case other party shall bear full cost such audit style margin margin bottom font size font family time roman late payment payment party hereunder shall made dollar wire transfer immediately available fund into account designated receiving party party receive payment before date simple interest shall thereafter accrue such party until date payment annum rate over then current prime rate quoted maximum rate allowable applicable whichever lower style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left nbsp align left valign portion this exhibit have been omitted pursuant request confidential treatment table table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left nbsp align left valign unredacted version this exhibit been filed separately with commission table style page break before always size style color width align center style margin margin bottom font size font family time roman align center article style margin margin bottom font size font family time roman align center intellectual property matter style margin margin bottom font size font family time roman ownership invention each party shall invention made solely affiliate employee agent independent contractor course conducting activity under this agreement together with intellectual property right therein sole invention party shall jointly invention which inventor include least employee agent independent contractor each party respective affiliate course performing activity under this agreement together with intellectual property right therein joint invention inventorship shall determined accordance with patent subject license granted under this agreement each party will have right practice exploit joint invention without duty accounting other party seeking consent licensing assigning otherwise exploiting joint invention from other party reason joint ownership thereof each party hereby waif right such party have under jurisdiction require such approval accounting extent there applicable that prohibit such waiver each party will deemed have consented furtherance thereof reasonable written request party other party will writing grant such consent confirm that such accounting required effect foregoing regarding joint invention style margin margin bottom font size font family time roman disclosure invention each party shall promptly disclose other party invention that necessary useful exploit compound product field territory during term with respect joint invention each party shall promptly disclose other party invention disclosure other similar document submitted employee agent independent contractor describing joint invention information relating such invention extent necessary such invention development commercialization compound product field extent patentable preparation filing maintenance patent with respect such invention style margin margin bottom font size font family time roman prosecution patent style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign macrogenics platform patent except otherwise provided this section nbsp between party macrogenics shall have sole right authority prepare file prosecute maintain macrogenics platform patent worldwide basis sole expense macrogenics shall provide company reasonable opportunity review comment effort prepare file prosecute maintain macrogenics platform patent territory including providing company with copy material communication from patent authority territory regarding macrogenics platform patent providing draft material filing response made such patent authority advance submitting such filing response macrogenics shall consider company comment regarding such communication draft good faith table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left nbsp align left valign portion this exhibit have been omitted pursuant request confidential treatment table table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left nbsp align left valign unredacted version this exhibit been filed separately with commission table style page break before always size style color width align center table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign macrogenics product patent party shall jointly prepare file prosecute maintain macrogenics product patent worldwide basis through outside counsel selected company acceptable macrogenics provided that company shall reasonably consider utilizing outside counsel currently prosecuting macrogenics product patent company shall reimburse macrogenics macrogenics pocket patent cost incurred filing prosecution maintenance macrogenics product patent party shall good faith effort agree upon patent strategy with respect macrogenics product patent including scope protection sought such patent country which such patent maintained party disagree with respect preparation filing prosecution maintenance macrogenics product patent such disagreement shall such provide potential resolution dispute provided however that such disagreement relates whether then such disagreement shall party that desire file maintain such shall have right party agree with such potential resolution such resolution shall final binding party agree with such potential resolution with respect disputed matter each party shall have access copy document relating preparation filing prosecution maintenance macrogenics product patent shall permitted access such document timely manner table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign company patent company shall have sole right authority prepare file prosecute maintain company patent worldwide basis expense company shall provide macrogenics reasonable opportunity review comment effort prepare file prosecute maintain company patent territory including providing macrogenics with copy material communication from patent authority regarding company patent territory providing draft material filing response made such patent authority advance submitting such filing response company shall consider macrogenics comment regarding such communication draft good faith table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign align left style font family time roman font size joint patent except otherwise provided this section nbsp company shall have primary right authority prepare file prosecute maintain patent included joint invention joint patent worldwide basis expense company shall provide macrogenics with reasonable opportunity review comment effort prepare file prosecute maintain joint patent including providing macrogenics with copy material communication from patent authority regarding joint patent providing draft material filing response made advance submitting such filing response company shall consider macrogenics comment regarding such communication draft good faith company determines discretion abandon maintain joint patent table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left nbsp align left valign portion this exhibit have been omitted pursuant request confidential treatment table table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left nbsp align left valign unredacted version this exhibit been filed separately with commission table style page break before always size style color width align center table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp align left valign country world then company shall provide macrogenics with written notice such determination within period time reasonably necessary allow macrogenics determine interest such joint patent which notice from company shall given later than prior final deadline pending action response that with respect such joint patent with applicable patent authority macrogenics provides written notice expressing interest obtaining such joint patent company shall free charge assign transfer macrogenics ownership interest such joint patent such country macrogenics expense company shall cooperate with macrogenics assignment transfer such joint patent such country thereafter such assigned transferred patent will deemed macrogenics platform patent macrogenics shall have right prepare file prosecute maintain such patent forth section nbsp table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign cooperation prosecution each party shall provide other party reasonable assistance cooperation patent prosecution effort provided above this section nbsp including providing necessary power attorney executing other required document instrument such prosecution well further action forth below such assistance cooperation shall include making party inventor other scientific advisor reasonably available assist other party patent prosecution effort table style margin margin bottom margin left text indent font size font family time roman party shall respectively prepare file maintain prosecute macrogenics patent company patent joint patent forth this section nbsp used herein prosecution such patent shall include communication other interaction with patent office patent authority having jurisdiction over patent application connection with grant proceeding style margin margin bottom margin left text indent font size font family time roman communication between party relating preparation filing prosecution maintenance macrogenics patent company patent joint patent including copy draft final document communication received from sent patent office patenting authority with respect such patent shall considered confidential information party controlling relevant patent subject confidentiality provision article style margin margin bottom margin left text indent font size font family time roman assignment macrogenics patent joint patent company patent shall effected follows nbsp employee agent macrogenics affiliate that named inventor macrogenics patent shall assign their interest such patent macrogenics affiliate nbsp employee agent company macrogenics their respective affiliate that named inventor joint patent shall assign their interest such patent their respective employer nbsp employee agent company affiliate that named inventor company patent shall assign their interest such patent company affiliate style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left nbsp align left valign portion this exhibit have been omitted pursuant request confidential treatment table table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left nbsp align left valign unredacted version this exhibit been filed separately with commission table style page break before always size style color width align center style margin margin bottom font size font family time roman patent term extension territory company shall decide which macrogenics product patent joint patent company patent other patent controlled company affiliate designees party should seek patent term extension supplemental protection certificate their equivalent each patent extension collectively patent extension territory company shall have right seek such patent extension event that opportunity seek patent extension supplemental protection certificate equivalent becomes available product territory based company affiliate designees seek patent extension subject provision this section nbsp macrogenics shall have right obligation company shall reasonably cooperate with macrogenics macrogenics shall seek patent extension that reasonably likely have material adverse effect commercialization product there good faith dispute between party whether patent extension being sought patent that cover applicable product good faith dispute event that company intend seek patent extension shall inform macrogenics writing sufficient time permit macrogenics seek patent extension macrogenics shall seek such patent extension unless first engages good faith discussion with company regarding company reason seeking patent extension macrogenics rationale plan seeking patent extension unless good faith dispute still exists thereafter shall have right seek such patent extension party that apply patent extension hereunder will cooperate fully with other party making such filing action including making available required regulatory data information executing required authorization apply such patent extension expense incurred connection with activity each party with respect patent which such party seek patent extension pursuant this section nbsp shall entirely borne such party style margin margin bottom font size font family time roman infringement patent third party style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign notification each party shall promptly notify other party writing existing alleged threatened infringement macrogenics patent joint patent company patent which becomes aware shall provide information such party possession control demonstrating such infringement table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign infringement macrogenics patent joint patent table style margin margin bottom margin left text indent font size font family time roman company subject section nbsp through shall have first right obligation bring appropriate suit other action against third party engaged existing alleged threatened infringement nbsp macrogenics product patent joint patent nbsp macrogenics platform patent with respect competitive infringement style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left nbsp align left valign portion this exhibit have been omitted pursuant request confidential treatment table table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left nbsp align left valign unredacted version this exhibit been filed separately with commission table style page break before always size style color width align center style margin margin bottom margin left text indent font size font family time roman company shall notify macrogenics election take action accordance with section nbsp within earlier after first notice under section nbsp nbsp before time limit forth applicable regulation including time limit forth under hatch waxman notwithstanding foregoing sentence company shall initiate such suit take such other action with respect macrogenics product patent joint patent without first consulting with macrogenics giving good faith consideration reasonable objection from macrogenics regarding company proposed course action company shall initiate such suit take such other action with respect macrogenics platform patent without prior written consent macrogenics such consent unreasonably withheld delayed conditioned should macrogenics reasonably withhold such consent macrogenics shall keep company reasonably informed enforcement effort with respect macrogenics platform patent shall consider company comment regarding such enforcement good faith macrogenics shall cooperate prosecution suit under this section nbsp reasonably requested company event that company elect initiate lawsuit take other reasonable action with respect infringement described section nbsp macrogenics shall have right obligation initiate such suit take such other action after providing notice company giving good faith consideration company reason initiating suit taking other action style margin margin bottom margin left text indent font size font family time roman party elect bring suit take action under this section nbsp against infringement then other party shall have right prior commencement suit action join such suit action style margin margin bottom margin left text indent font size font family time roman each party shall provide party enforcing such right under this section nbsp reasonable assistance such enforcement such enforcing party request expense including joining such action party plaintiff required applicable pursue such action enforcing party shall keep other party regularly informed status progress such enforcement effort shall reasonably consider other party comment such effort shall consult other party important aspect such enforcement including determination material litigation strategy filing important paper competent court style margin margin bottom margin left text indent font size font family time roman each party shall bear internal cost incurred connection with activity under this section nbsp event that party joined suit action against infringement enforcing party elect join such suit action either case elect represented same outside counsel enforcing party then enforcing party shall responsible expense arising from such outside counsel provided that enforcing party consent such joint representation outside counsel such consent unreasonably withheld delayed conditioned style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left nbsp align left valign portion this exhibit have been omitted pursuant request confidential treatment table table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left nbsp align left valign unredacted version this exhibit been filed separately with commission table style page break before always size style color width align center style margin margin bottom margin left text indent font size font family time roman party bringing action with respect infringement territory under this section nbsp shall entitled separate representation such matter counsel choice expense such party shall time cooperate fully with party bringing such action style margin margin bottom margin left text indent font size font family time roman neither party shall settle claim suit action that brought under this section nbsp involving macrogenics product patent joint patent without prior written consent other party such consent unreasonably withheld delayed conditioned style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign infringement company patent infringement company patent company shall have sole exclusive right obligation bring company expense sole control appropriate suit other action against person entity engaged such infringement company patent table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign allocation proceeds either party recovers monetary damage from third party suit action brought under section nbsp royalty milestone other payment from license agreement with third party related alleged infringement related product whether such damage royalty result from infringement macrogenics patent joint patent company patent such recovery infringement recovery shall allocated first reimbursement expense incurred party such litigation action license negotiation remaining amount shall allocated follows table style margin margin bottom margin left text indent font size font family time roman with respect suit action brought company resulting infringement recovery relating initial product northern american territory during funding term company macrogenics style margin margin bottom margin left text indent font size font family time roman with respect suit action brought company resulting infringement recovery relating nbsp initial product outside northern american territory during funding term nbsp initial product northern american territory after funding term funding term terminated nbsp initial product anywhere world macrogenics exercise funding option nbsp product other than initial product anywhere world then nbsp reward based lost profit amount equal royalty that would payable pursuant section nbsp imputed amount sale relevant product country where such infringement occurred nbsp reward reflects royalty payment such reward shall considered sale subject applicable royalty accordance with section nbsp style margin margin bottom margin left text indent font size font family time roman with respect suit action brought macrogenics infringement recovery shall retained macrogenics style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left nbsp align left valign portion this exhibit have been omitted pursuant request confidential treatment table table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left nbsp align left valign unredacted version this exhibit been filed separately with commission table style page break before always size style color width align center style margin margin bottom font size font family time roman infringement third party right territory style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign notice product used sold either party affiliate sublicensees field becomes subject third party claim assertion infringement patent granted jurisdiction within territory party first having notice claim assertion shall promptly notify other party table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign defense table style margin margin bottom margin left text indent font size font family time roman company shall have first right obligation defend such third party claim assertion infringement other than patent described section nbsp company expense company commence action defend such claim within after receives notice thereof within after should have given notice thereof macrogenics required section nbsp then extent allowed applicable macrogenics shall have right obligation control defense such claim counsel choice macrogenics expense defending party shall reasonably cooperate with party conducting defense claim assertion including required conduct such defense furnishing power attorney style margin margin bottom margin left text indent font size font family time roman macrogenics shall have first right obligation defend macrogenics expense macrogenics commence action defend settle such within after receives notice thereof then extent allowed applicable company shall have right obligation control defense such claim counsel choice macrogenics expense defending party shall reasonably cooperate with party conducting defense claim assertion including required conduct such defense furnishing power attorney style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign settlement license macrogenics shall enter into settlement claim described this section that affect company right interest without company prior written consent such consent unreasonably withheld delayed conditioned purpose clarification macrogenics shall required obtain company consent enter into settlement that elect settle under section provided that company given prior notice such proposed settlement with reasonable amount time review comment unless such settlement likely detrimentally affect company material right interest communicated macrogenics company except settlement that macrogenics declined defend settle under section company shall enter into settlement claim described this section that detrimentally affect macrogenics table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left nbsp align left valign portion this exhibit have been omitted pursuant request confidential treatment table table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left nbsp align left valign unredacted version this exhibit been filed separately with commission table style page break before always size style color width align center table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp align left valign material right interest without macrogenics written consent such consent unreasonably withheld delayed conditioned each party shall have right decline defend tender defense claim described this section nbsp upon reasonable notice other party including other party fails agree settlement that declining party proposes event that determined court competent jurisdiction that research development manufacture commercialization product conducted accordance with term condition this agreement infringes company determines reasonably good faith that such activity likely infringe patent copyright trademark data exclusivity right trade secret right arising under applicable third party company shall commercially reasonable effort extent such license relates commercialization product cost such license shall considered third party obligation allocated between party accordance with section nbsp event that company decides that neither foregoing alternative reasonably available commercially feasible company discretion terminate this agreement product affected accordance with section nbsp table style margin margin bottom font size font family time roman patent opposition other proceeding style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign third party patent right either party desire bring opposition action declaratory judgment nullity action interference declaration infringement reexamination other attack upon validity title enforceability patent owned controlled third party having more claim that cover product sale offer sale importation product except insofar such action counterclaim defense accompanies defense third party claim assertion infringement under section nbsp which case provision section nbsp shall govern such party shall notify other party party shall promptly confer determine whether bring such action manner which settle such action company shall have exclusive right obligation bring expense sole control such action territory company bring such action territory within notification thereof pursuant this section nbsp earlier required nature proceeding then macrogenics shall have right obligation bring such action macrogenics expense party bringing action under this section nbsp shall entitled separate representation such proceeding counsel choice expense shall cooperate fully with party bringing such action award amount received bringing such action shall first allocated reimburse initiating party expense such action remaining amount shall allocated between party provided section nbsp table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left nbsp align left valign portion this exhibit have been omitted pursuant request confidential treatment table table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left nbsp align left valign unredacted version this exhibit been filed separately with commission table style page break before always size style color width align center table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign party patent right macrogenics product patent joint patent becomes subject proceeding commenced third party within territory connection with opposition reexamination request action declaratory judgment nullity action interference other attack upon validity title enforceability thereof third party patent challenge except insofar such action counterclaim defense accompanies defense action infringement against third party under section nbsp which case provision section nbsp shall govern then party responsible filing preparing prosecuting maintaining such patent forth section nbsp hereof shall control such defense expense controlling party shall permit controlling party participate proceeding extent permissible under applicable represented counsel such proceeding controlling party expense either party decides that wish defend against such action then other party shall have backup right assume defense such third party action expense award amount received defending such third party action shall allocated between party provided section nbsp macrogenics shall have sole discretion whether defend shall solely control defense platform patent which subject third party patent challenge provided that macrogenics shall keep company reasonably informed regarding such enforcement shall consider company comment regarding such enforcement good faith table style margin margin bottom font size font family time roman align center article style margin margin bottom font size font family time roman align center representation warranty covenant style margin margin bottom font size font family time roman mutual representation warranty covenant each party hereby represents warrant other party execution date applicable hereinafter covenant that style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign organization corporation duly organized validly existing good standing under jurisdiction organization requisite power authority corporate otherwise execute deliver perform this agreement table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign binding agreement this agreement legal valid obligation binding upon such party enforceable accordance with term subject effect bankruptcy insolvency other general application affecting enforcement creditor right judicial principle affecting availability specific performance general principle equity whether enforceability considered proceeding equity table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign align left style font family time roman font size authorization execution delivery performance this agreement such party have been duly authorized necessary corporate action table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left nbsp align left valign portion this exhibit have been omitted pursuant request confidential treatment table table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left nbsp align left valign unredacted version this exhibit been filed separately with commission table style page break before always size style color width align center table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp align left valign conflict with agreement obligation instrument understanding oral written which party which bound violate applicable order writ judgment injunction decree determination award governmental authority presently effect applicable such party table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign further approval aware government authorization consent approval license exemption filing registration with governmental authority under applicable currently effect necessary connection with transaction contemplated this agreement other agreement instrument executed connection herewith performance obligation under this agreement such other agreement save regulatory approval similar authorization from governmental authority necessary exploitation compound product contemplated hereunder except required obtain clearance this agreement under table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign inconsistent obligation under obligation contractual otherwise person that conflict with inconsistent material respect with term this agreement that would impede diligent complete fulfillment obligation hereunder table style margin margin bottom font size font family time roman additional representation warranty macrogenics macrogenics represents warrant execution date applicable covenant company that style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign macrogenics affiliate sole exclusive owner otherwise control pursuant existing third party agreement macrogenics technology regulatory material macrogenics right necessary grant license under macrogenics technology right cross reference under regulatory material that grant company this agreement during term macrogenics shall shall cause affiliate grant third party right that encumber conflict with right granted company hereunder with respect macrogenics technology regulatory material table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign align left style font family time roman font size patent forth exhibit licensed patent represent patent that macrogenics affiliate owns control that cover disclose invention necessary used exploitation compound product territory field execution date licensed patent free clear lien charge encumbrance other than license granted third party that inconsistent with right license granted company hereunder third party challenged threatened writing challenge scope validity enforceability licensed patent including example through opposition institution written threat institution interference nullity similar invalidity proceeding before patent trademark office analogous foreign governmental authority macrogenics affiliate have timely paid filing renewal payable table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left nbsp align left valign portion this exhibit have been omitted pursuant request confidential treatment table table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left nbsp align left valign unredacted version this exhibit been filed separately with commission table style page break before always size style color width align center table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp align left valign with respect licensed patent which macrogenics control prosecution maintenance development licensed patent been funded whole part government table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign macrogenics affiliate owns control macrogenics know necessary useful exploitation compound product territory field macrogenics know free clear lien charge encumbrance other than license granted third party that inconsistent with right license granted company hereunder macrogenics affiliate have taken commercially reasonable measure consistent with industry practice protect secrecy confidentiality value macrogenics know that constitutes trade secret under applicable including requiring employee consultant independent contractor execute binding enforceable agreement requiring such employee consultant independent contractor maintain confidentiality such macrogenics know development macrogenics know been funded whole part government table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign there actual macrogenics knowledge threatened infringement misappropriation macrogenics technology person territory macrogenics received written notice threat material suit legal claim action proceeding investigation against macrogenics affiliate that relates macrogenics technology judgment settlement owed macrogenics affiliate connection with macrogenics technology table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign macrogenics technology collectively constitutes intellectual property controlled macrogenics that necessary useful exploitation compound product macrogenics knowledge except otherwise disclosed macrogenics company discussed party during course preparing this agreement exploitation compound product field territory will infringe misappropriate patent including third party patent application published execution date when claim thereunder issue their current form other intellectual property proprietary right third party territory table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign align left style font family time roman font size current former officer employee agent advisor consultant contractor other representative macrogenics affiliate inventor have otherwise contributed material manner creation development macrogenics technology have executed delivered macrogenics such affiliate valid enforceable assignment other agreement regarding protection proprietary information assignment macrogenics such affiliate such person entire right title interest macrogenics technology macrogenics knowledge current table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left nbsp align left valign portion this exhibit have been omitted pursuant request confidential treatment table table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left nbsp align left valign unredacted version this exhibit been filed separately with commission table style page break before always size style color width align center table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp align left valign officer employee agent advisor consultant other representative macrogenics affiliate violation term assignment other agreement regarding protection macrogenics patent other macrogenics technology employment contract other contractual obligation relating relationship such person with macrogenics such affiliate company shall have obligation contribute remuneration inventor employed previously employed macrogenics affiliate respect such invention information discovery intellectual property right therein that assigned macrogenics affiliate macrogenics will such remuneration such inventor with respect such invention other know intellectual property right therein table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign macrogenics nbsp prepared maintained retained regulatory material compound product territory pursuant accordance material respect with applicable including applicable such regulatory material contain materially false misleading statement nbsp macrogenics conducted used commercially reasonable effort cause contractor consultant conduct study test clinical trial compound product conducted prior being conducted execution date accordance with applicable experimental protocol procedure control pursuant accepted professional scientific standard accepted ethical standard applicable including applicable nbsp except disclosed writing macrogenics company prior execution date adverse event involving human subject occurred connection with study test clinical trial compound product nbsp macrogenics disclosed company material data other information control generated design approval undertaking reporting study clinical trial involving compound product table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign align left style font family time roman font size neither macrogenics affiliate been debarred subject conviction described section nbsp ffdca subject similar sanction other governmental authority territory neither macrogenics affiliate used capacity person either been debarred subject conviction described section nbsp ffdca subject such similar sanction macrogenics shall engage capacity connection with this agreement ancillary agreement person either been debarred subject conviction described section nbsp ffdca subject such similar sanction macrogenics shall inform company writing promptly person engaged macrogenics affiliate performing service under this agreement ancillary agreement debarred subject conviction described section nbsp ffdca action table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left nbsp align left valign portion this exhibit have been omitted pursuant request confidential treatment table table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left nbsp align left valign unredacted version this exhibit been filed separately with commission table style page break before always size style color width align center table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp align left valign suit claim investigation legal administrative proceeding pending macrogenics knowledge threatened relating debarment conviction macrogenics affiliate such person performing service hereunder thereunder table style margin margin bottom font size font family time roman additional representation warranty company company represents warrant execution date covenant macrogenics that style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign neither company affiliate been debarred subject conviction described section nbsp ffdca subject similar sanction other governmental authority territory neither company affiliate used capacity person either been debarred subject conviction described section nbsp ffdca subject such similar sanction company shall engage capacity connection with this agreement ancillary agreement person either been debarred subject conviction described section nbsp ffdca subject such similar sanction company shall inform macrogenics writing promptly person engaged company affiliate performing service under this agreement ancillary agreement debarred subject conviction described section nbsp ffdca action suit claim investigation legal administrative proceeding pending company knowledge threatened relating debarment conviction company affiliate such person performing service hereunder thereunder table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign company subject agreement with third party which would limit restrict ability perform obligation under this agreement material respect table style margin margin bottom font size font family time roman other representation warranty except expressly forth this article party make representation warranty kind whatsoever either express implied written oral fact operation statute otherwise each party specifically disclaims other warranty including express implied warranty quality merchantability fitness particular purpose warranty infringement validity patent each party hereby disclaims representation warranty that development manufacture commercialization product pursuant this agreement will successful that particular sale level with respect product will achieved style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left nbsp align left valign portion this exhibit have been omitted pursuant request confidential treatment table table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left nbsp align left valign unredacted version this exhibit been filed separately with commission table style page break before always size style color width align center style margin margin bottom font size font family time roman align center article style margin margin bottom font size font family time roman align center confidentiality style margin margin bottom font size font family time roman nondisclosure each party agrees that during term period thereafter party receiving party receiving confidential information other party disclosing party shall nbsp maintain confidence such confidential information using than effort such receiving party maintain confidence confidential proprietary information similar kind value nbsp disclose such confidential information third party without prior written consent disclosing party except disclosure expressly permitted below nbsp such confidential information purpose except those permitted this agreement being understood that this section nbsp shall create imply right license expressly granted under this agreement notwithstanding anything contrary foregoing obligation confidentiality with respect trade secret within such confidential information shall survive such period long such confidential information remains protected trade secret under applicable style margin margin bottom font size font family time roman exception obligation section nbsp shall apply with respect portion confidential information that receiving party show competent evidence style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign publicly disclosed disclosing party either before after disclosed receiving party hereunder table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign known receiving party affiliate without obligation keep confidential restriction each case disclosing party prior disclosure receiving party affiliate disclosing party table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign subsequently disclosed receiving party affiliate confidential basis third party that receiving party knowledge bound similar duty confidentiality restriction each case disclosing party table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign hereafter becomes through failure part receiving party affiliate violation this agreement generally known available either before after disclosed receiving party disclosing party table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign independently discovered developed behalf receiving party affiliate without reference confidential information belonging disclosing party table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign subject written permission disclose provided disclosing party table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left nbsp align left valign portion this exhibit have been omitted pursuant request confidential treatment table table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left nbsp align left valign unredacted version this exhibit been filed separately with commission table style page break before always size style color width align center style margin margin bottom font size font family time roman authorized disclosure receiving party disclose confidential information belonging disclosing party only extent such disclosure reasonably necessary following instance style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign filing prosecuting maintaining enforcing defending patent permitted this agreement table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign reasonably required generating regulatory material obtaining regulatory approval table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign prosecuting defending litigation including responding subpoena third party litigation table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign complying with applicable court administrative order table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign complying with obligation under this agreement table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign communication with existing bona fide prospective acquirer merger partner financing source investment banker lender investor consultant advisor receiving party connection with transaction bona fide prospective transaction with foregoing each case need know basis under appropriate confidentiality provision substantially equivalent those this agreement provided however that receiving party shall remain responsible violation such confidentiality provision third party receiving such confidential information table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign affiliate sublicensees prospective sublicensees subcontractor prospective subcontractor consultant agent advisor need know basis order receiving party exercise right fulfill obligation under this agreement each whom prior disclosure must bound obligation confidentiality restriction such confidential information that restrictive than those forth this article provided however that each above situation receiving party shall remain responsible failure person receives confidential information pursuant this section nbsp treat such confidential information required under this article table style margin margin bottom margin left font size font family time roman whenever confidential information disclosed accordance with this section nbsp such disclosure shall cause such information cease confidential information except extent that such disclosure result public disclosure such information other than breach this agreement notwithstanding foregoing event party required make disclosure other party confidential information pursuant section nbsp through section nbsp will except where impracticable legally permitted give reasonable advance notice other party such disclosure than same effort secure confidential treatment such information would protect confidential information from disclosure style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left nbsp align left valign portion this exhibit have been omitted pursuant request confidential treatment table table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left nbsp align left valign unredacted version this exhibit been filed separately with commission table style page break before always size style color width align center style margin margin bottom font size font family time roman term this agreement party acknowledge that this agreement respective term this agreement shall treated confidential information both party subject provision section style margin margin bottom font size font family time roman publicity style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign each party obligated make public announcement execution this agreement form attached exhibit this agreement which shall issued time mutually agreed party later than after execution date except required comply with applicable forth subsection each party agrees issue other press release other public statement disclosing other information relating this agreement transaction contemplated hereby without prior written consent other party such consent unreasonably withheld delayed conditioned table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign align left style font family time roman font size party acknowledge importance supporting each other effort publicly disclose result significant development regarding product other activity connection with this agreement that include information that otherwise permitted disclosed under this article that beyond what required applicable each case consistent with need keep investor informed regarding such party business accordance with customary investor relation each party request right make such disclosure from time time such disclosure include achievement milestone significant event development regulatory process commercialization activity like except initial press release described subsection whenever party requesting party elect make such public disclosure shall first notify other party cooperating party such planned press release public announcement provide draft review least advance issuing such press release making such public announcement with respect press release public announcement that required applicable regulation rule public stock exchange including nasdaq with much advance notice possible under circumstance possible provide notice least advance requesting party cooperating party will discus such proposed public disclosure good faith unless otherwise permitted pursuant section nbsp required applicable regulation rule public stock exchange including nasdaq requesting party will issue such press release make such public announcement without prior written consent cooperating party unreasonably withheld conditioned delayed provided that party issue such press release make such public announcement nbsp content such press release public announcement have table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left nbsp align left valign portion this exhibit have been omitted pursuant request confidential treatment table table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left nbsp align left valign unredacted version this exhibit been filed separately with commission table style page break before always size style color width align center table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp align left valign previously been made public other than through breach this agreement requesting party nbsp such press release public announcement materially differ from previously issued press release other publicly available information nbsp such press release public announcement contain cooperating party name nbsp requesting party notifies cooperating party reasonably advance issuance principle observed such disclosure shall include accuracy compliance with applicable regulatory guidance document reasonable sensitivity potential negative reaction foreign counterpart need protect competitively sensitive information regarding product need keep investor informed regarding requesting party business table style margin margin bottom font size font family time roman security filing notwithstanding anything contrary this article event either party proposes file with security exchange commission security regulator state other jurisdiction registration statement other disclosure document that describes refers term condition this agreement related agreement between party requires filing this agreement exhibit such registration statement disclosure document such party shall notify other party such intention shall provide other party with copy relevant portion proposed filing least prior such filing revision such portion proposed filing reasonable time prior filing thereof including exhibit thereto that refer other party term condition this agreement related agreement between party party making such filing shall cooperate good faith with other party obtain confidential treatment term condition this agreement related agreement between party that other party reasonably request kept confidential otherwise afforded confidential treatment shall only disclose confidential information that advised outside counsel legally required disclosed each party acknowledges that other party required security regulator including security exchange commission advised such other party outside counsel that financial term including milestone amount royalty rate must included such filing notice shall required under this section nbsp description reference this agreement related agreement between party contained proposed filing been included previous filing made either party accordance with this section nbsp otherwise approved other party style margin margin bottom font size font family time roman relationship confidentiality agreement this agreement supersedes prior provided however that confidential information disclosed received party their affiliate thereunder shall deemed confidential information hereunder shall subject term condition this agreement style margin margin bottom font size font family time roman equitable relief given nature confidential information competitive damage that could result party upon unauthorized disclosure transfer confidential information third party party agree that monetary damage sufficient remedy breach this article addition other remedy party shall entitled seek specific performance injunctive other equitable relief remedy breach threatened breach this article style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left nbsp align left valign portion this exhibit have been omitted pursuant request confidential treatment table table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left nbsp align left valign unredacted version this exhibit been filed separately with commission table style page break before always size style color width align center style margin margin bottom font size font family time roman publication company shall have right publish result clinical trial conducted with respect compound product provided however that macrogenics shall have right review proposed publication prior submission such publication solely purpose identifying relevant intellectual property confidential information macrogenics company shall provide macrogenics with copy applicable proposed abstract manuscript presentation than case abstract prior intended submission publication macrogenics shall respond writing promptly event later than case abstract after receipt proposed material with concern regarding patentability protection macrogenics confidential information event concern over patent protection company agrees submit such publication make such presentation that contains such information until macrogenics given reasonable period time event than seek patent protection material such publication presentation which belief patentable unless company reasonably determines that publication such information required applicable subject section nbsp confidential information macrogenics shall requested reviewing party removed company from such publication presentation except extent inclusion such confidential information required comply with johnson nbsp johnson clinical trial publication policy style margin margin bottom font size font family time roman align center article style margin margin bottom font size font family time roman align center term termination style margin margin bottom font size font family time roman term this agreement shall become effective execution date unless earlier terminated pursuant this article shall continue full force effect long company continues exploit compound product accordance with term condition this agreement term provision article definition article representation warranty covenant article confidentiality article dispute resolution article indemnification article miscellaneous section nbsp termination material breach section nbsp filing termination upon denial shall become effective execution date other provision this agreement shall become effective until effective date style margin margin bottom font size font family time roman unilateral termination company company shall have right terminate this agreement entirety product product basis time after execution date reason upon providing prior written notice macrogenics notwithstanding foregoing event that company provides such notice termination macrogenics sole discretion reduce notice period period determined macrogenics written notice company style margin margin bottom font size font family time roman termination material breach style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign align left style font family time roman font size either party terminating party terminate this agreement entirety country country product product basis event table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left nbsp align left valign portion this exhibit have been omitted pursuant request confidential treatment table table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left nbsp align left valign unredacted version this exhibit been filed separately with commission table style page break before always size style color width align center table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp align left valign other party breaching party materially breached this agreement such material breach been cured within after receipt written notice such breach breaching party from terminating party cure period written notice describing alleged material breach shall provide sufficient detail breaching party notice such material breach termination this agreement pursuant this section nbsp shall become effective cure period unless breaching party cured such material breach prior expiration such cure period such material breach reasonably able cured within cure period breaching party notified terminating party plan curing such commenced sustained effort cure such material breach during cure period right either party terminate this agreement provided this section nbsp shall affected such party waiver failure take action with respect previous breach under this agreement table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign party reasonably good faith disagree whether there been material breach cure thereof party that dispute whether there been material breach cure contest allegation accordance with article notwithstanding anything contrary contained section nbsp cure period material breach that subject dispute will from date that written notice first provided breaching party terminating party through resolution such dispute pursuant article thereafter understood acknowledged that during pendency dispute pursuant this section nbsp term condition this agreement shall remain effect party shall continue perform their respective obligation under this agreement except that payment obligation from party other party under this agreement which subject dispute shall tolled until resolution such dispute accordance with article table style margin margin bottom font size font family time roman termination company safety reason company shall have right terminate this agreement time after effective date with respect product territory time upon providing prior written notice macrogenics nbsp senior executive responsible company pharmacovigilance clinical science function determine good faith that risk benefit profile product such that product continue developed administered patient safely nbsp upon occurrence serious adverse event related product that cause company conclude that continued product patient will result patient being exposed product which risk outweigh benefit style margin margin bottom font size font family time roman termination macrogenics terminate this agreement with respect product this agreement entirety such product only product which this agreement applicable provided however macrogenics acknowledges agrees that nothing this section nbsp this section nbsp provided further that macrogenics shall have right terminate company style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left nbsp align left valign portion this exhibit have been omitted pursuant request confidential treatment table table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left nbsp align left valign unredacted version this exhibit been filed separately with commission table style page break before always size style color width align center table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign macrogenics affiliate sublicensees successor designer table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign either nbsp that table style margin margin bottom font size font family time roman filing termination upon denial company macrogenics determine that filing necessary each party shall within execution date such later time agreed writing party file with united state federal trade commission antitrust division united state department justice with equivalent foreign authority filing required under reasonable opinion either party with respect transaction contemplated hereby each party will reasonable effort cause done thing necessary proper advisable promptly practicable take action necessary make filing required such party affiliate under party shall cooperate with another extent necessary preparation such filing each party shall responsible cost expense filing associated with filing provided however that company shall solely responsible other than penalty that incurred result action omission part macrogenics required paid governmental agency connection with making such filing party make filing hereunder then this agreement shall terminate nbsp election either party immediately upon notice other party federal trade commission department justice equivalent authority european union seek preliminary injunction under antitrust against company macrogenics enjoin transaction contemplated this agreement nbsp election either party immediately upon notice other party event that clearance date shall have occurred prior after effective date filing event such termination this agreement shall further force effect style margin margin bottom font size font family time roman termination bankruptcy style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign either party terminate this agreement entirety upon providing written notice other party after time that such other party make general assignment benefit creditor file insolvency petition bankruptcy petition acquiesces appointment receiver trustee similar officer liquidate conserve business substantial part asset commences under jurisdiction proceeding involving insolvency bankruptcy reorganization adjustment debt dissolution liquidation other similar proceeding release financially distressed debtor becomes party proceeding action type described above each insolvency event such proceeding action remains dismissed stayed period more than table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left nbsp align left valign portion this exhibit have been omitted pursuant request confidential treatment table table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left nbsp align left valign unredacted version this exhibit been filed separately with commission table style page break before always size style color width align center table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign align left style font family time roman font size right license granted under pursuant this agreement including avoidance doubt license granted company pursuant section nbsp shall otherwise deemed purpose section nbsp title code other similar jurisdiction outside collectively bankruptcy license right intellectual property defined under bankruptcy upon occurrence insolvency event with respect party insolvent party insolvent party agrees that other party insolvent party licensee such right under this agreement shall retain fully exercise right election under bankruptcy further each party agrees acknowledges that payment hereunder other than milestone payment pursuant section nbsp royalty payment pursuant section nbsp payment pursuant section nbsp constitute royalty within meaning section nbsp bankruptcy code relate license intellectual property hereunder each party shall during term this agreement create maintain current copy amenable copying detailed description other appropriate embodiment extent feasible such intellectual property macrogenics technology case macrogenics company technology case company each party agrees acknowledges that embodiment intellectual property within meaning section nbsp include without limitation laboratory notebook cell line product sample inventory research study data regulatory approval regulatory material each case extent related compound product nbsp case commenced during term against party under bankruptcy nbsp this agreement rejected provided under bankruptcy nbsp insolvent party elect retain right hereunder provided under bankruptcy then insolvent party capacity including debtor possession successor assigns including title trustee shall nbsp provide insolvent party immediately upon insolvent party written request copy such intellectual property including embodiment thereof held insolvent party such successor assigns otherwise available them nbsp interfere with insolvent party right under this agreement related agreement between party such intellectual property including such embodiment including right obtain such intellectual property such embodiment from another entity extent provided bankruptcy whenever insolvent party successor assigns provides insolvent party intellectual property licensed hereunder embodiment thereof pursuant this section nbsp insolvent party shall have right perform insolvent party obligation hereunder with respect such intellectual property neither such provision such performance insolvent party shall release table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left nbsp align left valign portion this exhibit have been omitted pursuant request confidential treatment table table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left nbsp align left valign unredacted version this exhibit been filed separately with commission table style page break before always size style color width align center table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp align left valign insolvent party from liability resulting from rejection license failure perform such obligation right power remedy insolvent party provided herein addition substitution other right power remedy hereafter existing equity including bankruptcy event commencement case against party under bankruptcy particular intention understanding party this agreement that right granted party under this section nbsp essential party respective business party acknowledge that damage adequate remedy party agree that they intend following right extend maximum extent permitted applicable enforceable under section nbsp title code nbsp right access intellectual property including embodiment thereof insolvent party third party with whom insolvent party contract perform obligation insolvent party under this agreement case third party which necessary exploitation compound product nbsp right contract directly with third party complete contracted work upon failure insolvent party comply with applicable obligation table style margin margin bottom font size font family time roman effect termination following effect termination addition other right remedy that available either party under this agreement shall construed limit such right remedy event this agreement terminated entirety rather terminated product product country country basis with respect more product specified herein each terminated product more country each terminated country then notwithstanding anything contrary contained section consequence termination described under this section nbsp shall only apply terminated product terminated country this agreement shall remain full force effect accordance with term with respect product other than terminated product country territory other than terminated country style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign consequence termination macrogenics company event termination this agreement nbsp macrogenics pursuant section nbsp section nbsp nbsp company pursuant section nbsp section nbsp section nbsp following provision this section nbsp shall apply from after effective date termination except extent otherwise provided section table style margin margin bottom margin left text indent font size font family time roman without limiting effect that such termination shall have provision this agreement other than those provision that this agreement expressly provides shall survive such termination right license granted herein company shall terminate company shall cease development manufacturing commercialization activity with respect product extent such activity were being performed using such right license soon reasonably practicable under applicable style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left nbsp align left valign portion this exhibit have been omitted pursuant request confidential treatment table table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left nbsp align left valign unredacted version this exhibit been filed separately with commission table style page break before always size style color width align center style margin margin bottom margin left text indent font size font family time roman payment obligation hereunder shall terminate other than those that accrued unpaid effective date such termination royalty that become under section nbsp with respect sale reverted product made janssen following effective date termination pursuant section nbsp style margin margin bottom margin left text indent font size font family time roman macrogenics shall have reversion right previously licensed company hereunder which relevant license have terminated fully paid royalty free basis itself with through affiliate third party develop manufacture commercialize product macrogenics discretion provided that third party obligation arising pursuant section nbsp passed through macrogenics style margin margin bottom margin left text indent font size font family time roman company hereby grant macrogenics effective effective date such termination exclusive transferable fully paid royalty free sublicenseable license field territory under company applied technology company right joint invention joint patent solely exploit product that active clinical development been commercialized company time termination each reverted product provided however that macrogenics shall reimburse company amount paid company third party connection with macrogenics exercise such license style margin margin bottom margin left text indent font size font family time roman macrogenics written request company shall grant macrogenics effective date such request exclusive transferable fully paid royalty free sublicensable license trademark owned controlled company affiliate which solely used commercialization reverted product territory excluding company house mark style margin margin bottom margin left text indent font size font family time roman then existence committee formed party purpose effecting transition responsibility then existence shall coordinate wind down company effort under this agreement company soon reasonably practicable after effective date such termination shall provide macrogenics applicable extent permitted under applicable third party contract material information including copy clinical trial data result controlled company extent solely relating reverted product including control information relating global safety database company will reasonably cooperate with macrogenics provide transfer such material information beginning date that notice termination this agreement given macrogenics pursuant section nbsp section nbsp section nbsp company pursuant section nbsp section nbsp section nbsp nbsp company shall have further obligation commence provide funding clinical trial that commenced purpose this sentence commencement mean style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left nbsp align left valign portion this exhibit have been omitted pursuant request confidential treatment table table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left nbsp align left valign unredacted version this exhibit been filed separately with commission table style page break before always size style color width align center style margin margin bottom margin left font size font family time roman before such date notice termination this agreement nbsp macrogenics request macrogenics shall have right company shall cooperate good faith with macrogenics enable macrogenics commence such clinical trial included then current global development plan prior effective date termination this agreement provided however that such cooperation shall include obligation provide funding such clinical trial macrogenics request company shall reasonable effort nbsp assign macrogenics third party agreement which company affiliate party that relate exclusively development commercialization manufacturing activity conducted connection with reverted product prior such termination including agreement relating sourcing manufacture reverted product extent first commercial sale reverted product occurred sale promotion distribution such reverted product nbsp such assignment permitted under relevant third party agreement nbsp grant macrogenics other right provide macrogenics benefit such assignable agreement macrogenics expense extent permitted under term such assignable agreement nbsp extent permitted under term such assignable agreement party shall discus good faith alternative solution enable macrogenics receive macrogenics expense benefit term such assignable agreement event more reverted product material relating such reverted product manufactured company affiliate then upon written request macrogenics company shall supply macrogenics with such reverted product material transitional period mutually agreed upon party necessary provide technical assistance reasonably necessary assist macrogenics start manufacturing such reverted product material obtaining regulatory approval reverted product addition action contemplated this section nbsp company shall take such other action execute such other instrument assignment document reasonably requested macrogenics necessary effect transfer right such product hereunder macrogenics style margin margin bottom margin left text indent font size font family time roman subject payment amount required under section nbsp company shall have right sell otherwise dispose inventory reverted product hand time such termination process manufacturing provided however macrogenics request company shall transfer macrogenics product that been sold used following such termination cost style margin margin bottom margin left text indent font size font family time roman viii company shall transfer macrogenics regulatory material controlled company effective date termination extent such regulatory material relate solely reverted product including inds regulatory approval application regulatory approval style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left nbsp align left valign portion this exhibit have been omitted pursuant request confidential treatment table table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left nbsp align left valign unredacted version this exhibit been filed separately with commission table style page break before always size style color width align center style margin margin bottom margin left font size font family time roman solely related reverted product upon macrogenics request company shall make available macrogenics other relevant information controlled company effective date termination extent such information relates such regulatory material shall provide right reference regulatory material controlled company effective date termination extent such regulatory material necessary macrogenics licensee develop commercialize reverted product transferred macrogenics hereunder style margin margin bottom margin left text indent font size font family time roman macrogenics shall have right assume preparation filing prosecution maintenance enforcement activity under article with respect macrogenics patent which company assumed right authority prepare file prosecute maintain enforce company will cooperate with macrogenics provide macrogenics with reasonable assistance with preparation filing prosecution maintenance enforcement activity with respect such macrogenics patent step right granted macrogenics with respect joint patent under section shall remain effect macrogenics shall have right enforce company patent solely extent license granted under this section nbsp against third party infringers style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign consequence certain termination company event termination this agreement company pursuant section nbsp section nbsp following provision this section nbsp shall apply from after effective date termination table style margin margin bottom margin left text indent font size font family time roman without limiting effect that such termination shall have provision this agreement other than those provision that this agreement expressly provides shall survive such termination right license granted herein macrogenics shall terminate other than license granted macrogenics under section nbsp which shall survive such termination macrogenics shall cease development manufacturing commercialization activity including promotion activity with respect product soon reasonably practicable under applicable style margin margin bottom margin left text indent font size font family time roman payment obligation hereunder shall continue including those payment obligation that accrued unpaid effective date such termination provided that company pursue remedy under section nbsp offset damage cost provided section nbsp style margin margin bottom margin left text indent font size font family time roman company shall thereafter continue have right previously licensed company hereunder itself with third party through third party sublicensee develop manufacture commercialize product company discretion accordance with subject term condition this agreement style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left nbsp align left valign portion this exhibit have been omitted pursuant request confidential treatment table table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left nbsp align left valign unredacted version this exhibit been filed separately with commission table style page break before always size style color width align center style margin margin bottom margin left text indent font size font family time roman license granted company shall continue full force effect accordance with subject term condition this agreement right macrogenics with respect promote option shall cease style margin margin bottom margin left text indent font size font family time roman then existence committee formed party purpose effecting transition responsibility then existence shall coordinate wind down macrogenics effort under this agreement macrogenics soon reasonably practicable after effective date such termination shall provide company applicable extent permitted under applicable third party contract material information including copy clinical trial data result controlled macrogenics that relates solely product macrogenics will cooperate with company provide transfer such material information company request macrogenics shall reasonable effort nbsp assign company third party agreement which macrogenics affiliate party that relate exclusively development commercialization manufacture product field territory nbsp such assignment permitted under relevant third party agreement nbsp grant company other right provide company benefit such assignable agreement company expense extent permitted under term such assignable agreement nbsp extent permitted under term such assignable agreement party shall discus good faith alternative solution enable company receive company expense benefit term such assignable agreement event more product material relating such product manufactured macrogenics affiliate then upon written request company macrogenics shall supply company with such product material transitional period mutually agreed upon party necessary provide technical assistance reasonably necessary assist company start manufacturing such product material obtaining regulatory approval such product addition action contemplated this section nbsp macrogenics shall take such other action execute such other instrument assignment document reasonably requested company necessary effect transfer right such product hereunder company style margin margin bottom font size font family time roman remedy except otherwise explicitly forth this agreement termination expiration this agreement shall relieve party liability obligation which accrued hereunder prior effective date such termination expiration prejudice either party right obtain performance obligation each party shall free pursuant article seek without restriction number time seek damage cost remedy that available under applicable equity shall entitled offset amount damage cost obtained against other party final determination under section nbsp against amount otherwise such other party under this agreement style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left nbsp align left valign portion this exhibit have been omitted pursuant request confidential treatment table table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left nbsp align left valign unredacted version this exhibit been filed separately with commission table style page break before always size style color width align center style margin margin bottom font size font family time roman survival event termination expiration this agreement addition provision this agreement that continue effect accordance with their term following provision this agreement shall survive article definition applicable article confidentiality article term termination article dispute resolution article indemnification solely activity arising during term activity conducted course party exercise license surviving term article miscellaneous section implied license record company responsibility solely with respect activity undertaken prior effective date expiration termination this agreement currency return audit late payment ownership invention section nbsp disclosure invention other representation warranty other provision this agreement that necessary interpret effectuate intent foregoing provision style margin margin bottom font size font family time roman align center article style margin margin bottom font size font family time roman align center dispute resolution style margin margin bottom font size font family time roman exclusive dispute resolution mechanism party agree that procedure forth this article shall exclusive mechanism resolving dispute controversy claim between party that arise from time time pursuant this agreement relating either party right obligation hereunder each dispute collectively dispute that resolved through good faith negotiation between party avoidance doubt this article shall apply decision with respect which party final decision making authority hereunder dispute including dispute that involve parent company subsidiary affiliate under common control party shall resolved accordance with this article style margin margin bottom font size font family time roman resolution executive officer except otherwise provided this article event dispute regarding construction interpretation this agreement right duty liability either party hereunder party shall first attempt good faith resolve such dispute negotiation consultation between themselves event that such dispute resolved such basis within unless otherwise agreed party either party written notice other party refer dispute executive officer attempted resolution good faith negotiation within after such notice received unless otherwise agreed party each party discretion seek resolution dispute that resolved under this section nbsp accordance with section nbsp style margin margin bottom font size font family time roman arbitration party fail resolve dispute pursuant section nbsp party desire pursue resolution dispute dispute shall submitted either party resolution arbitration pursuant then current except where they conflict with these provision which case these provision control arbitration will held aspect arbitration shall treated confidential style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left nbsp align left valign portion this exhibit have been omitted pursuant request confidential treatment table table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left nbsp align left valign unredacted version this exhibit been filed separately with commission table style page break before always size style color width align center table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign arbitrator table style margin margin bottom margin left text indent font size font family time roman arbitrator will chosen from unless candidate such panel approved both party each arbitrator shall lawyer with least experience with firm corporate department over lawyer judge court general jurisdiction extent that dispute requires special expertise party will inform prior beginning selection process style margin margin bottom margin left text indent font size font family time roman arbitration tribunal shall consist arbitrator whom each party shall designate accordance with screened appointment procedure provided rule chair will chosen accordance with rule however aggregate award sought party than equitable relief sought single arbitrator shall chosen accordance with rule style margin margin bottom margin left text indent font size font family time roman party agree select arbitrator within initiation arbitration style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign procedure table style margin margin bottom margin left text indent font size font family time roman hearing will concluded within after selection arbitrator award will rendered within conclusion hearing font style white space nowrap post hearing font briefing which briefing will completed both side within after conclusion hearing event party agree upon schedule then arbitrator shall schedule following time limit forth above closely practical style margin margin bottom margin left text indent font size font family time roman hearing will concluded multiple hearing will scheduled consecutively greatest extent possible transcript testimony adduced hearing shall made shall made available each party style margin margin bottom margin left text indent font size font family time roman arbitrator shall guided bound protocol party will attempt agree mode document disclosure electronic discovery witness presentation within parameter protocol party agree discovery presentation issue arbitrator shall decide presentation mode provide discovery within protocol understanding that party contemplate reasonable discovery style margin margin bottom margin left text indent font size font family time roman arbitrator shall decide merit dispute accordance with governing this agreement without application principle conflict that would result reference different arbitrator apply principle such amiable compositeur natural justice equity style margin margin bottom margin left text indent font size font family time roman arbitrator expressly empowered decide dispositive motion advance hearing shall endeavor decide such motion would united state district court judge sitting jurisdiction whose substantive governs style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left nbsp align left valign portion this exhibit have been omitted pursuant request confidential treatment table table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left nbsp align left valign unredacted version this exhibit been filed separately with commission table style page break before always size style color width align center style margin margin bottom margin left text indent font size font family time roman arbitrator shall render written opinion stating reason upon which award based party consent jurisdiction united state district court district which arbitration held enforcement these provision entry judgment award rendered hereunder should such court reason lack jurisdiction court with jurisdiction same fashion style margin margin bottom font size font family time roman provisional remedy each party right seek from appropriate court provisional remedy such attachment preliminary injunction replevin avoid irreparable harm maintain status preserve subject matter dispute apply this agreement style margin margin bottom font size font family time roman confidentiality activity conducted under this article shall deemed confidential information each party shall subject article above style margin margin bottom font size font family time roman align center article style margin margin bottom font size font family time roman align center indemnification style margin margin bottom font size font family time roman indemnification company company hereby agrees defend indemnify hold harmless macrogenics affiliate each their respective director officer employee agent representative each macrogenics indemnitee from against claim suit action demand liability expense loss including reasonable legal expense attorney collectively loss which macrogenics indemnitee become subject result claim demand action other proceeding third party each claim extent such loss arise directly indirectly nbsp practice company affiliate sublicensee license granted under this agreement nbsp manufacture handling storage sale marketing export import other disposition compound product company affiliate sublicensee nbsp breach company warranty representation covenant agreement made company this agreement macrogenics exercise promote option promotion agreement nbsp gross negligence illegal conduct willful misconduct including extent such gross negligence illegal conduct willful misconduct give rise product liability claim under legal theory company affiliate sublicensee officer director employee agent representative thereof except with respect each clause nbsp through nbsp above extent such loss arise directly indirectly from negligence gross negligence illegal conduct willful misconduct macrogenics indemnitee breach macrogenics warranty representation covenant agreement made macrogenics this agreement notwithstanding foregoing this section nbsp shall apply loss macrogenics indemnitee that arise during funding term extent such loss commercialization expense that included macrogenics allocation profit loss style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left nbsp align left valign portion this exhibit have been omitted pursuant request confidential treatment table table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left nbsp align left valign unredacted version this exhibit been filed separately with commission table style page break before always size style color width align center style margin margin bottom font size font family time roman indemnification macrogenics macrogenics hereby agrees defend indemnify hold harmless company affiliate each their respective director officer employee agent representative each company indemnitee from against loss which company indemnitee become subject result claim extent such loss arise directly indirectly nbsp practice macrogenics affiliate licensee other than company affiliate sublicensee retained reverted license right under article develop manufacture commercialize compound product pursuant term this agreement macrogenics exercise promote option promotion agreement nbsp manufacture handling storage sale other disposition compound product macrogenics affiliate licensee other than company affiliate sublicensee nbsp breach macrogenics warranty representation covenant agreement made macrogenics this agreement macrogenics exercise promote option promotion agreement nbsp gross negligence illegal conduct willful misconduct including extent such gross negligence illegal conduct willful misconduct give rise product liability claim under legal theory macrogenics affiliate licensee other than company affiliate sublicensee officer director employee agent representative thereof except with respect each clause nbsp through nbsp above extent such loss arise directly indirectly from negligence gross negligence illegal conduct willful misconduct company indemnitee breach company warranty representation covenant agreement made company this agreement notwithstanding foregoing this section nbsp shall apply loss company indemnitee that arise during funding term extent such loss commercialization expense that included company allocation profit loss style margin margin bottom font size font family time roman indemnification procedure style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign notice promptly after macrogenics indemnitee company indemnitee each indemnitee receives notice pending threatened claim such indemnitee shall give written notice claim party from whom indemnitee entitled receive indemnification pursuant section nbsp applicable indemnifying party however indemnitee delay providing failure provide such notice shall relieve indemnifying party indemnification obligation except extent demonstrate prejudice delay lack notice table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign align left style font family time roman font size defense upon receipt notice under this section nbsp from indemnitee indemnifying party will have duty either compromise defend expense counsel reasonably satisfactory indemnitee such claim indemnifying party will promptly event more than after receipt indemnitee original notice notify indemnitee writing that acknowledges obligation which acknowledgment shall deemed construed admission liability either under this article otherwise indemnify indemnitee with respect claim pursuant this article intention compromise defend such claim once table style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left nbsp align left valign portion this exhibit have been omitted pursuant request confidential treatment table table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left nbsp align left valign unredacted version this exhibit been filed separately with commission table style page break before always size style color width align center table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp align left valign indemnifying party give such notice indemnitee indemnifying party liable indemnitee other counsel other expense subsequently incurred indemnitee connection with such defense other than indemnitee reasonable third party expense related investigation cooperation claim which indemnifying party assumed control under this section nbsp indemnitee shall have right employ separate counsel participate defense claim reasonably directed indemnifying party expense table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign cooperation indemnitee will cooperate fully with indemnifying party legal representative investigation defense claim indemnifying party shall keep indemnitee informed reasonable timely basis status such claim extent indemnitee participating defense such claim conduct defense such claim prudent manner table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign settlement indemnifying party assumes defense claim compromise settlement such claim effected indemnifying party without indemnitee written consent such consent unreasonably withheld delayed conditioned unless nbsp there finding admission violation violation right person effect other claim that made against indemnitee nbsp sole relief provided monetary damage that paid full indemnifying party nbsp indemnitee right under this agreement adversely affected indemnifying party fails assume defense claim within reasonable time indemnitee settle such claim such term deems appropriate with consent indemnifying party such consent unreasonably withheld delayed conditioned indemnifying party shall obligated indemnify indemnitee such settlement provided this article table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign product liability claim solely purpose coordinating defense claim third party involving that could result product liability included definition global development cost such claim will treated they were claim covered this section nbsp company shall deemed indemnifying party under this section nbsp such claim table style margin margin bottom font size font family time roman insurance each party shall expense procure maintain during period commencing execution date through period commercialization period thereafter insurance policy including product liability insurance adequate cover obligation hereunder which consistent with normal business practice prudent company similarly situated provided however that event shall such product liability insurance written amount than annual aggregate such insurance shall include worldwide coverage prior initiation clinical trial party responsible such clinical trial shall secure maintain full force effect clinical trial insurance required applicable those territory where such clinical trial shall conducted style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left nbsp align left valign portion this exhibit have been omitted pursuant request confidential treatment table table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left nbsp align left valign unredacted version this exhibit been filed separately with commission table style page break before always size style color width align center style margin margin bottom font size font family time roman upon request each party shall provide other party with certificate insurance evidencing coverage required under this section nbsp such insurance shall construed create limit party liability with respect indemnification obligation under this article each party shall provide other party with prompt written notice cancellation renewal material change such insurance that could materially adversely affect right such other party hereunder shall provide such notice within after such cancellation font style white space nowrap renewal font material change party acknowledge agree that company meet obligation under this section nbsp through self insurance style margin margin bottom font size font family time roman limitation liability except extent included loss resulting from third party claim which party obligated indemnify other party indemnitee such other party pursuant this article breach article confidentiality event will either party liable other party other party affiliate sublicensees connection with this agreement lost revenue lost profit lost saving loss damage goodwill consequential incidental special exemplary punitive indirect damage under theory including contract negligence strict liability even that party been placed notice possibility such damage style margin margin bottom font size font family time roman align center article style margin margin bottom font size font family time roman align center miscellaneous style margin margin bottom font size font family time roman notice notice other communication given made pursuant hereto shall writing shall deemed have been duly given date delivered delivered personally next business after being sent reputable overnight courier with delivery tracking provided signature required delivery prepaid each case party following address date sent confirmed electronic transmission telecopier number specified below such other address telecopier number party shall specified notice given accordance with this section nbsp style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign company table style margin margin bottom margin left text indent font size font family time roman janssen biotech style margin margin bottom margin left text indent font size font family time roman ridgeview drive style margin margin bottom margin left text indent font size font family time roman horsham style margin margin bottom margin left text indent font size font family time roman attention style margin margin bottom margin left text indent font size font family time roman style margin margin bottom margin left font size font family time roman with copy style margin margin bottom margin left text indent font size font family time roman johnson nbsp johnson department style margin margin bottom margin left text indent font size font family time roman johnson nbsp johnson plaza style margin margin bottom margin left text indent font size font family time roman brunswick style margin margin bottom margin left font size font family time roman attention style margin margin bottom margin left font size font family time roman style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left nbsp align left valign portion this exhibit have been omitted pursuant request confidential treatment table table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left nbsp align left valign unredacted version this exhibit been filed separately with commission table style page break before always size style color width align center table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign macrogenics table style margin margin bottom margin left font size font family time roman macrogenics style margin margin bottom margin left font size font family time roman medical center drive style margin margin bottom margin left font size font family time roman rockville style margin margin bottom margin left font size font family time roman attention style margin margin bottom margin left font size font family time roman with copy style margin margin bottom margin left font size font family time roman macrogenics style margin margin bottom margin left font size font family time roman medical center drive style margin margin bottom margin left font size font family time roman rockville style margin margin bottom margin left font size font family time roman attention style margin margin bottom font size font family time roman governing this agreement dispute arising related this agreement breach hereof shall governed construed under state without giving effect choice principle that would require application different state style margin margin bottom font size font family time roman change control macrogenics style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign macrogenics successor shall provide notice company change control macrogenics within after date upon which change control close otherwise becomes effective table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign before date that after date upon which change control macrogenics close otherwise becomes effective company terminate this agreement entirety company sole absolute discretion company require macrogenics successor shall perform applicable more following action nbsp party shall dissolve after such dissolution company shall solely have right including decision making right shall perform activity assigned this agreement nbsp macrogenics successor shall adopt reasonable written procedure approved company prevent disclosure company confidential information table style margin margin bottom font size font family time roman assignment neither party assign transfer this agreement right obligation hereunder without prior written consent other party being understood that neither merger respect which such party constituent corporation entity change beneficial ownership voting security such party shall deemed assignment purpose this section nbsp except that party make such assignment style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left nbsp align left valign portion this exhibit have been omitted pursuant request confidential treatment table table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left nbsp align left valign unredacted version this exhibit been filed separately with commission table style page break before always size style color width align center style margin margin bottom font size font family time roman without other party consent nbsp affiliate nbsp subject section nbsp above acquirer substantially property asset party sale asset other similar transaction successor assignee right obligation permitted hereunder shall writing other party expressly assume performance such right obligation permitted assignment shall binding successor assigning party assignment attempted assignment either party violation term this section nbsp shall null void legal effect style margin margin bottom font size font family time roman designation affiliate each party discharge obligation exercise right hereunder through delegation obligation right affiliate each party hereby guarantee performance affiliate such party obligation under this agreement shall cause affiliate comply with provision this agreement connection with such performance breach party affiliate such party obligation under this agreement shall deemed breach such party other party proceed directly against such party without obligation first proceed against such party affiliate style margin margin bottom font size font family time roman relationship party expressly agreed that macrogenics hand company other hand independent contractor that relationship between party shall constitute partnership joint venture agency neither macrogenics company shall have authority make statement representation commitment kind take action which shall binding other without prior written consent other party individual employed party shall employee that party other party cost obligation incurred reason such employment shall account expense such party style margin margin bottom font size font family time roman force majeure both party shall excused from performance their obligation under this agreement extent that such performance prevented force majeure nonperforming party promptly provides notice such force majeure circumstance other party such excuse shall continued long condition constituting force majeure continues nonperforming party take reasonable effort remove condition notwithstanding foregoing party shall excused from making payment owed hereunder because force majeure affecting such party force majeure persists more than then party shall discus good faith modification party obligation under this agreement order mitigate delay caused such force majeure event party prevented from performing obligation under this agreement force majeure more than according this section nbsp other party shall have right terminate this agreement upon notice after expiration such period termination under this section nbsp either party shall treated termination under section nbsp above corresponding provision termination under section nbsp shall apply except extent affected party prevented from performing force majeure style margin margin bottom font size font family time roman entire agreement amendment this agreement including exhibit schedule hereto forth complete final exclusive agreement covenant promise agreement warranty representation condition understanding between party with respect subject matter hereof supersedes execution date prior style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left nbsp align left valign portion this exhibit have been omitted pursuant request confidential treatment table table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left nbsp align left valign unredacted version this exhibit been filed separately with commission table style page break before always size style color width align center style margin margin bottom font size font family time roman contemporaneous agreement understanding between party with respect subject matter hereof including prior there covenant promise agreement warranty representation condition understanding either oral written between party other than forth herein therein subsequent alteration amendment change addition this agreement shall binding upon party unless reduced writing signed authorized officer each party event inconsistency between body this agreement either exhibit schedule this agreement subsequent agreement ancillary this agreement unless otherwise express stated contrary such exhibit schedule ancillary agreement term contained this agreement shall control style margin margin bottom font size font family time roman severability more provision this agreement held invalid unenforceable court competent jurisdiction from which appeal taken provision shall considered severed from this agreement shall serve invalidate remaining provision hereof party shall make good faith effort replace invalid unenforceable provision with valid enforceable such that objective contemplated party when entering this agreement realized style margin margin bottom font size font family time roman english language this agreement shall written executed other communication under connection with this agreement shall english language translation into other language shall official version hereof thereof event conflict interpretation between english version such translation english version shall control style margin margin bottom font size font family time roman waiver exclusion remedy term condition this agreement waived time party that entitled benefit thereof such waiver shall effective unless forth written instrument duly executed behalf party waiving such term condition waiver either party right hereunder failure perform breach other party shall deemed waiver other right hereunder other breach failure such other party whether similar nature otherwise right remedy provided herein cumulative exclude other right remedy provided applicable otherwise available except expressly forth herein style margin margin bottom font size font family time roman further assurance each party shall duly execute deliver cause duly executed delivered such further instrument cause done such further thing including filing such assignment agreement document instrument necessary other party reasonably request connection with this agreement carry more effectively provision purpose hereof style margin margin bottom font size font family time roman heading heading each article section this agreement have been inserted convenience reference only intended limit expand meaning language contained particular article section style margin margin bottom font size font family time roman construction whenever this agreement refers number without using term otherwise defined herein such number refers calendar except where context otherwise requires nbsp wherever used singular shall include plural plural shall include style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left nbsp align left valign portion this exhibit have been omitted pursuant request confidential treatment table table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left nbsp align left valign unredacted version this exhibit been filed separately with commission table style page break before always size style color width align center style margin margin bottom font size font family time roman singular nbsp gender shall applicable gender nbsp term including include includes example shall limit generality description preceding such term used herein shall have same meaning including limited including without limitation nbsp word herein hereof hereunder word similar import refer this agreement entirety particular provision hereof nbsp word inclusive meaning that typically associated with phrase nbsp word will mean shall nbsp period time specified date from given business business event calculated exclusive that business nbsp dollar mean dollar nbsp reference particular person include such person successor assigns extent prohibited this agreement nbsp capitalized term defined herein reflecting different part speech than capitalized term which defined herein shall interpreted correlative manner nbsp definition reference agreement instrument other document herein shall construed referring such agreement instrument other document from time time amended supplemented otherwise modified subject restriction such amendment supplement modification forth herein language this agreement shall deemed language mutually chosen party rule strict construction shall applied against either party each party represents that been represented legal counsel connection with this agreement acknowledges that participated drafting hereof style margin margin bottom font size font family time roman counterpart this agreement executed nbsp more counterpart each which shall deemed original which together shall constitute same instrument this agreement executed other electronically transmitted signature such signature shall deemed bind each party they were original signature style margin margin bottom font size font family time roman align center signature page follows style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left nbsp align left valign portion this exhibit have been omitted pursuant request confidential treatment table table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left nbsp align left valign unredacted version this exhibit been filed separately with commission table style page break before always size style color width align center style margin margin bottom font size font family time roman align right execution version style margin margin bottom text indent font size font family time roman witness whereof party have signed this agreement date forth below style font size margin margin bottom nbsp table cellspacing cellpadding width border style border collapse collapse font family time roman font size width valign bottom width width style font family time roman font size valign colspan janssen biotech style font size height height colspan style font family time roman font size valign valign bottom valign bottom style margin margin bottom border bottom solid font size font family time roman scott white style font family time roman font size valign name valign bottom valign bottom scott white style font family time roman font size valign title valign bottom valign bottom vice president north america oncology style font family time roman font size valign date valign bottom valign bottom december style font size height colspan style font family time roman font size valign colspan macrogenics style font size height height colspan style font family time roman font size valign valign bottom valign bottom style margin margin bottom border bottom solid font size font family time roman scott koenig style font family time roman font size valign name valign bottom valign bottom scott koenig style font family time roman font size valign title valign bottom valign bottom president style font family time roman font size valign date valign bottom valign bottom december table style margin margin bottom font size nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left nbsp align left valign portion this exhibit have been omitted pursuant request confidential treatment table table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left nbsp align left valign unredacted version this exhibit been filed separately with commission table style page break before always size style color width align center style margin margin bottom font size font family time roman align right execution version style margin margin bottom font size font family time roman align center exhibit style margin margin bottom font size font family time roman align center commercialization expense style margin margin bottom text indent font size font family time roman advertising market research expense mean third party expense related nbsp conducting monitoring professional consumer appraisal northern american territory such market share service data pricing analysis special research testing focus group nbsp advertising promotion initial product northern american territory associated with product advertising style margin margin bottom text indent font size font family time roman commercialization expense mean those expense incurred either party detailed below purpose directly specifically attributable commercialization initial product northern american territory extent such expense incurred either party such party account nbsp expense nbsp detail paid macrogenics pursuant promotion agreement nbsp xiii nbsp loss damage cost other liability associated with arising except extent party solely responsible provided however that such expense incurred macrogenics shall deemed commercialization expense only extent that macrogenics permitted conduct underlying activity pursuant agreement promotion agreement extent that party mutually agree that macrogenics conduct underlying activity purpose clarity style margin margin bottom font size font family time roman commercialization expense shall include nbsp development expense including northern american territory addition there shall double counting expense deduction from sale that could fall within multiple category commercialization expense style margin margin bottom text indent font size font family time roman company detailing expense mean selling cost incurred party performance detail where such selling cost shall calculated basis style margin margin bottom text indent font size font family time roman cost mean style margin margin bottom text indent font size font family time roman distribution expense mean sale initial product northern american territory understood that such amount shall deemed cover third party expense cost identifiable distribution initial product northern american territory style margin margin bottom text indent font size font family time roman expense mean third party expense cost conduct early access program named patient program compassionate program northern american territory style margin margin bottom text indent font size font family time roman education expense mean third party expense specifically incurred educate health care professional licensed practice northern american territory with respect northern american territory through mean covered definition advertising marketing research expense including style margin margin bottom font size nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left nbsp align left valign portion this exhibit have been omitted pursuant request confidential treatment table table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left nbsp align left valign unredacted version this exhibit been filed separately with commission table style page break before always size style color width align center style margin margin bottom font size font family time roman align right execution version style margin margin bottom text indent font size font family time roman manufacturing expense mean with respect initial product reasonable necessary internal third party invoiced cost determined accordance with gaap term condition this agreement incurred manufacturing acquisition initial product sale northern american territory manufacturing cost acquisition cost comprised standard cost good manufactured cost variance other cost included standard where style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign standard cost good manufactured budgeted unit cost established facilitate inventory evaluation planning budgetary control well motivate optimal productivity efficiency including table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign cost variance actual cost manufacturing versus standard cost good manufactured include table style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width nbsp width valign align left align left valign other cost included standard actual cost manufacturing which incurred normal course business included standard cost good manufactured including table style margin margin bottom font size font family time roman clarity royalty payment macrogenics under this agreement shall included manufacturing expense style margin margin bottom text indent font size font family time roman marketing expense mean marketing management expense advertising market research expense education expense style margin margin bottom text indent font size font family time roman marketing management expense mean commercial cost either party arising from management commercialization activity provided that each case such cost allocated within across company operating unit provided further that such allocation made favorable than internal allocation company other product style margin margin bottom text indent font size font family time roman medical affair expense mean nbsp third party expense cost reasonably necessary identifiable incurred with respect medical scientific information response style margin margin bottom text indent font size font family time roman other cost mean including both product cost administrative cost that excluding funding allocated extent such provided that either commercialization then finance team party will align inclusion appropriate allocation methodology such legal cost directly related specifically attributable style margin margin bottom text indent font size font family time roman mean primary detailing equivalent provided however that prior first commercial sale initial product northern american territory shall determine adjust value style margin margin bottom text indent font size font family time roman phase trial expense mean third party expense incurred northern american territory company related phase trial initial product northern american territory including expense arising from nbsp activity related performance style margin margin bottom font size nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left nbsp align left valign portion this exhibit have been omitted pursuant request confidential treatment table table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left nbsp align left valign unredacted version this exhibit been filed separately with commission table style page break before always size style color width align center style margin margin bottom font size font family time roman align right execution version style margin margin bottom font size nbsp style margin margin bottom font size font family time roman phase trial nbsp manufacturing expense product used connection with such phase trial nbsp preparation filing maintenance related regulatory documentation nbsp product liability relating product being used course such phase trial provided that shall treated responsibility such provided that phase trial expense shall include expense relating phase trial which address requirement which there phase trial intended purpose clarity phase trial expense shall include phase trial shall include cost style margin margin bottom text indent font size font family time roman recall expense mean third party expense cost directly associated with notification retrieval return initial product northern american territory destruction such returned initial product replacement initial product distribution replacement initial product each case that incurred with respect recall conducted accordance with section nbsp agreement provided that foregoing recall expense limited recall that caused gross negligence illegal conduct willful misconduct party style margin margin bottom text indent font size font family time roman sale total mean total number pdes that full time equivalent sale planned deliver calendar year which number shall approved prior beginning each calendar year style margin margin bottom text indent font size font family time roman sale mean hour work devoted direct support detailing initial product northern american territory that carried nbsp more qualified employee contractor consultant company affiliate nbsp more qualified employee macrogenics affiliate style margin margin bottom text indent font size font family time roman sale rate mean rate sale calendar year prorated period beginning effective date ending last first calendar year term provided however that such rate shall increased decreased annually beginning january nbsp sale rate fully burdened cover employee salary benefit travel other cost style margin margin bottom text indent font size font family time roman selling cost mean total number pdes delivered behalf party multiplied cost style margin margin bottom text indent font size font family time roman third party obligation expense mean third party obligation incurred party with respect initial product northern american territory provided that with respect third party obligation that specifically allocated initial product northern american territory company shall reasonable method allocate portion such third party obligation initial product northern american territory purpose determining third party obligation expense style margin margin bottom font size font family time roman nothing this exhibit intended modify alter macrogenics right obligation grant additional right macrogenics perform development commercialization activity pursuant agreement style margin margin bottom font size nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left nbsp align left valign portion this exhibit have been omitted pursuant request confidential treatment table table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left nbsp align left valign unredacted version this exhibit been filed separately with commission table style page break before always size style color width align center style margin margin bottom font size font family time roman align right execution version style margin margin bottom font size font family time roman align center exhibit style margin margin bottom font size font family time roman align center global development plan style margin margin bottom font size font family time roman align center style margin margin bottom font size nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left nbsp align left valign portion this exhibit have been omitted pursuant request confidential treatment table table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left nbsp align left valign unredacted version this exhibit been filed separately with commission table style page break before always size style color width align center style margin margin bottom font size font family time roman align right execution version style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center exhibit style margin margin bottom font size font family time roman align center macrogenics patent style font size margin margin bottom nbsp table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width valign bottom width width style font family time roman font size valign bottom nowrap align center style border bottom solid style margin margin bottom font size font family time roman align center title valign bottom nbsp valign bottom align center style border bottom solid style margin margin bottom font size font family time roman align center pending nbsp application style margin margin bottom font size font family time roman align center number valign bottom nbsp valign bottom align center style border bottom solid style margin margin bottom font size font family time roman align center foreign nbsp right bgcolor cceeff style font family time roman font size valign align center style margin left text indent font size font family time roman align center valign bottom nbsp valign bottom align center valign bottom nbsp valign bottom align center style font family time roman font size valign align center style margin left text indent font size font family time roman align center valign bottom nbsp valign bottom align center valign bottom nbsp valign bottom align center bgcolor cceeff style font family time roman font size valign align center style margin left text indent font size font family time roman align center valign bottom nbsp valign bottom align center valign bottom nbsp valign bottom align center style font family time roman font size valign align center style margin left text indent font size font family time roman align center valign bottom nbsp valign bottom align center valign bottom nbsp valign bottom align center bgcolor cceeff style font family time roman font size valign align center style margin left text indent font size font family time roman align center valign bottom nbsp valign bottom align center valign bottom nbsp valign bottom align center style font family time roman font size valign align center style margin left text indent font size font family time roman align center valign bottom nbsp valign bottom align center valign bottom nbsp valign bottom align center bgcolor cceeff style font family time roman font size valign align center style margin left text indent font size font family time roman align center valign bottom nbsp valign bottom align center valign bottom nbsp valign bottom table style margin margin bottom font size nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left nbsp align left valign portion this exhibit have been omitted pursuant request confidential treatment table table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left nbsp align left valign unredacted version this exhibit been filed separately with commission table style page break before always size style color width align center style margin margin bottom font size font family time roman align right execution version style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center exhibit style margin margin bottom font size font family time roman align center style margin margin bottom font size font family time roman style margin margin bottom font size font family time roman style margin margin bottom font size font family time roman style margin margin bottom font size nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left nbsp align left valign portion this exhibit have been omitted pursuant request confidential treatment table table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left nbsp align left valign unredacted version this exhibit been filed separately with commission table style page break before always size style color width align center style margin margin bottom font size font family time roman align right execution version style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center exhibit style margin margin bottom font size font family time roman align center universal calendar style font size margin margin bottom nbsp style font size margin margin bottom nbsp style margin margin bottom align center logo style margin margin bottom font size nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left nbsp align left valign portion this exhibit have been omitted pursuant request confidential treatment table table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left nbsp align left valign unredacted version this exhibit been filed separately with commission table style page break before always size style color width align center style margin margin bottom font size font family time roman align right execution version style margin margin bottom font size nbsp style margin margin bottom align center logo style margin margin bottom font size nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left nbsp align left valign portion this exhibit have been omitted pursuant request confidential treatment table table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left nbsp align left valign unredacted version this exhibit been filed separately with commission table style page break before always size style color width align center style margin margin bottom font size font family time roman align right execution version style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center exhibit style margin margin bottom font size font family time roman align center form press release style margin margin bottom font size nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left nbsp align left valign portion this exhibit have been omitted pursuant request confidential treatment table table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left nbsp align left valign unredacted version this exhibit been filed separately with commission table style page break before always size style color width align center style margin margin bottom font size font family time roman align right execution version style margin margin bottom font size nbsp style font size margin margin bottom nbsp style margin margin bottom align center logo style margin margin bottom font size nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left nbsp align left valign portion this exhibit have been omitted pursuant request confidential treatment table table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left nbsp align left valign unredacted version this exhibit been filed separately with commission table style page break before always size style color width align center style margin margin bottom font size font family time roman align right execution version style margin margin bottom font size nbsp style font size margin margin bottom nbsp style margin margin bottom align center logo style margin margin bottom font size nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left nbsp align left valign portion this exhibit have been omitted pursuant request confidential treatment table table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left nbsp align left valign unredacted version this exhibit been filed separately with commission table style page break before always size style color width align center style margin margin bottom font size font family time roman align right execution version style margin margin bottom font size nbsp style font size margin margin bottom nbsp style margin margin bottom align center logo style margin margin bottom font size nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left nbsp align left valign portion this exhibit have been omitted pursuant request confidential treatment table table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left nbsp align left valign unredacted version this exhibit been filed separately with commission table style page break before always size style color width align center style margin margin bottom font size font family time roman align right execution version style margin margin bottom font size nbsp style margin margin bottom font size font family time roman align center schedule style margin margin bottom font size font family time roman align center macrogenics estimated binding manufacturing cost style margin margin bottom font size font family time roman estimated fully burdened manufacturing cost single clinical production style font size margin margin bottom nbsp table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width bgcolor cceeff style font family time roman font size valign style margin left text indent font size font family time roman valign bottom valign bottom nbsp valign bottom align right nowrap valign bottom nbsp style font family time roman font size valign style margin left text indent font size font family time roman valign bottom valign bottom nbsp valign bottom align right nowrap valign bottom nbsp bgcolor cceeff style font family time roman font size valign style margin left text indent font size font family time roman valign bottom valign bottom nbsp valign bottom align right nowrap valign bottom nbsp style font family time roman font size valign style margin left text indent font size font family time roman valign bottom valign bottom nbsp valign bottom align right nowrap valign bottom nbsp table style margin margin bottom font size font family time roman style margin margin bottom font size font family time roman this estimate based expanded capacity that macrogenics will creating over nbsp since production under additional capacity will circumstance this estimate still subject change style margin margin bottom font size nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left nbsp align left valign portion this exhibit have been omitted pursuant request confidential treatment unredacted version this exhibit been filed separately with commission table body html text document